id	sid	tid	token	lemma	pos
dpc-3843	1	1	dermatology	dermatology	NOUN
dpc-3843	1	2	:	:	PUNCT
dpc-3843	1	3	practical	practical	ADJ
dpc-3843	1	4	and	and	CCONJ
dpc-3843	1	5	conceptual	conceptual	ADJ
dpc-3843	1	6	original	original	ADJ
dpc-3843	1	7	article	article	NOUN
dpc-3843	1	8	|	|	ADV
dpc-3843	1	9	dermatol	dermatol	ADJ
dpc-3843	1	10	pract	pract	NOUN
dpc-3843	1	11	concept	concept	NOUN
dpc-3843	1	12	.	.	PUNCT
dpc-3843	2	1	2024;14(1):e2024095	2024;14(1):e2024095	NUM
dpc-3843	2	2	1	1	NUM
dpc-3843	2	3	circulating	circulate	VERB
dpc-3843	2	4	podocalyxin	podocalyxin	NOUN
dpc-3843	2	5	,	,	PUNCT
dpc-3843	2	6	tumstatin	tumstatin	NOUN
dpc-3843	2	7	/	/	SYM
dpc-3843	2	8	col	col	NOUN
dpc-3843	2	9	-	-	ADJ
dpc-3843	2	10	ivα3	ivα3	PROPN
dpc-3843	2	11	and	and	CCONJ
dpc-3843	2	12	chitinase	chitinase	VERB
dpc-3843	2	13	1	1	NUM
dpc-3843	2	14	:	:	PUNCT
dpc-3843	2	15	new	new	ADJ
dpc-3843	2	16	culprits	culprit	NOUN
dpc-3843	2	17	in	in	ADP
dpc-3843	2	18	vitiligo	vitiligo	ADJ
dpc-3843	2	19	occurrence	occurrence	NOUN
dpc-3843	2	20	şule	şule	PROPN
dpc-3843	2	21	gençoğlu	gençoğlu	PROPN
dpc-3843	2	22	department	department	PROPN
dpc-3843	2	23	of	of	ADP
dpc-3843	2	24	dermatology	dermatology	NOUN
dpc-3843	2	25	,	,	PUNCT
dpc-3843	2	26	gozde	gozde	NOUN
dpc-3843	2	27	academy	academy	NOUN
dpc-3843	2	28	hospitals	hospital	NOUN
dpc-3843	2	29	,	,	PUNCT
dpc-3843	2	30	malatya	malatya	PROPN
dpc-3843	2	31	,	,	PUNCT
dpc-3843	2	32	turkey	turkey	NOUN
dpc-3843	2	33	key	key	ADJ
dpc-3843	2	34	words	word	NOUN
dpc-3843	2	35	:	:	PUNCT
dpc-3843	2	36	vitiligo	vitiligo	NOUN
dpc-3843	2	37	,	,	PUNCT
dpc-3843	2	38	inflammation	inflammation	NOUN
dpc-3843	2	39	,	,	PUNCT
dpc-3843	2	40	adhesion	adhesion	NOUN
dpc-3843	2	41	,	,	PUNCT
dpc-3843	2	42	angiogenesis	angiogenesis	NOUN
dpc-3843	2	43	,	,	PUNCT
dpc-3843	2	44	immunity	immunity	NOUN
dpc-3843	2	45	citation	citation	NOUN
dpc-3843	2	46	:	:	PUNCT
dpc-3843	3	1	gençoğlu	gençoğlu	PROPN
dpc-3843	3	2	s.	s.	PROPN
dpc-3843	3	3	circulating	circulate	VERB
dpc-3843	3	4	podocalyxin	podocalyxin	NOUN
dpc-3843	3	5	,	,	PUNCT
dpc-3843	3	6	tumstatin	tumstatin	NOUN
dpc-3843	3	7	/	/	SYM
dpc-3843	3	8	col	col	NOUN
dpc-3843	3	9	-	-	ADJ
dpc-3843	3	10	ivα3	ivα3	PROPN
dpc-3843	3	11	and	and	CCONJ
dpc-3843	3	12	chitinase	chitinase	VERB
dpc-3843	3	13	1	1	NUM
dpc-3843	3	14	:	:	PUNCT
dpc-3843	3	15	new	new	ADJ
dpc-3843	3	16	culprits	culprit	NOUN
dpc-3843	3	17	in	in	ADP
dpc-3843	3	18	vitiligo	vitiligo	NOUN
dpc-3843	3	19	occurrence	occurrence	NOUN
dpc-3843	3	20	.	.	PUNCT
dpc-3843	4	1	dermatol	dermatol	NOUN
dpc-3843	4	2	pract	pract	PROPN
dpc-3843	4	3	concept	concept	NOUN
dpc-3843	4	4	.	.	PUNCT
dpc-3843	5	1	2024;14(1):e2024095	2024;14(1):e2024095	X
dpc-3843	5	2	.	.	PUNCT
dpc-3843	5	3	doi	doi	PROPN
dpc-3843	5	4	:	:	PUNCT
dpc-3843	5	5	https://doi.org/10.5826/dpc.1401a95	https://doi.org/10.5826/dpc.1401a95	NOUN
dpc-3843	5	6	accepted	accept	VERB
dpc-3843	5	7	:	:	PUNCT
dpc-3843	5	8	december	december	PROPN
dpc-3843	5	9	26	26	NUM
dpc-3843	5	10	,	,	PUNCT
dpc-3843	5	11	2023	2023	NUM
dpc-3843	5	12	;	;	PUNCT
dpc-3843	5	13	published	publish	VERB
dpc-3843	5	14	:	:	PUNCT
dpc-3843	5	15	january	january	PROPN
dpc-3843	5	16	2024	2024	NUM
dpc-3843	5	17	copyright	copyright	NOUN
dpc-3843	5	18	:	:	PUNCT
dpc-3843	5	19	©	©	PROPN
dpc-3843	5	20	2024	2024	NUM
dpc-3843	5	21	gençoğlu	gençoğlu	NOUN
dpc-3843	5	22	.	.	PUNCT
dpc-3843	6	1	this	this	PRON
dpc-3843	6	2	is	be	AUX
dpc-3843	6	3	an	an	DET
dpc-3843	6	4	open	open	ADJ
dpc-3843	6	5	-	-	PUNCT
dpc-3843	6	6	access	access	NOUN
dpc-3843	6	7	article	article	NOUN
dpc-3843	6	8	distributed	distribute	VERB
dpc-3843	6	9	under	under	ADP
dpc-3843	6	10	the	the	DET
dpc-3843	6	11	terms	term	NOUN
dpc-3843	6	12	of	of	ADP
dpc-3843	6	13	the	the	DET
dpc-3843	6	14	creative	creative	ADJ
dpc-3843	6	15	commons	common	NOUN
dpc-3843	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3843	6	17	license	license	NOUN
dpc-3843	6	18	(	(	PUNCT
dpc-3843	6	19	by	by	ADP
dpc-3843	6	20	-	-	PUNCT
dpc-3843	6	21	nc-4.0	nc-4.0	NOUN
dpc-3843	6	22	)	)	PUNCT
dpc-3843	6	23	,	,	PUNCT
dpc-3843	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3843	6	25	,	,	PUNCT
dpc-3843	6	26	which	which	PRON
dpc-3843	6	27	permits	permit	VERB
dpc-3843	6	28	unrestricted	unrestricted	ADJ
dpc-3843	6	29	noncommercial	noncommercial	ADJ
dpc-3843	6	30	use	use	NOUN
dpc-3843	6	31	,	,	PUNCT
dpc-3843	6	32	distribution	distribution	NOUN
dpc-3843	6	33	,	,	PUNCT
dpc-3843	6	34	and	and	CCONJ
dpc-3843	6	35	reproduction	reproduction	NOUN
dpc-3843	6	36	in	in	ADP
dpc-3843	6	37	any	any	DET
dpc-3843	6	38	medium	medium	NOUN
dpc-3843	6	39	,	,	PUNCT
dpc-3843	6	40	provided	provide	VERB
dpc-3843	6	41	the	the	DET
dpc-3843	6	42	original	original	ADJ
dpc-3843	6	43	authors	author	NOUN
dpc-3843	6	44	and	and	CCONJ
dpc-3843	6	45	source	source	NOUN
dpc-3843	6	46	are	be	AUX
dpc-3843	6	47	credited	credit	VERB
dpc-3843	6	48	.	.	PUNCT
dpc-3843	7	1	funding	funding	NOUN
dpc-3843	7	2	:	:	PUNCT
dpc-3843	7	3	none	none	NOUN
dpc-3843	7	4	.	.	PUNCT
dpc-3843	8	1	competing	compete	VERB
dpc-3843	8	2	interests	interest	NOUN
dpc-3843	8	3	:	:	PUNCT
dpc-3843	8	4	none	none	NOUN
dpc-3843	8	5	.	.	PUNCT
dpc-3843	9	1	corresponding	correspond	VERB
dpc-3843	9	2	author	author	NOUN
dpc-3843	9	3	:	:	PUNCT
dpc-3843	9	4	şule	şule	PROPN
dpc-3843	9	5	gençoğlu	gençoğlu	PROPN
dpc-3843	9	6	,	,	PUNCT
dpc-3843	9	7	md	md	PROPN
dpc-3843	9	8	,	,	PUNCT
dpc-3843	9	9	department	department	PROPN
dpc-3843	9	10	of	of	ADP
dpc-3843	9	11	dermatology	dermatology	NOUN
dpc-3843	9	12	,	,	PUNCT
dpc-3843	9	13	gozde	gozde	NOUN
dpc-3843	9	14	academy	academy	NOUN
dpc-3843	9	15	hospitals	hospital	NOUN
dpc-3843	9	16	,	,	PUNCT
dpc-3843	9	17	gozde	gozde	NOUN
dpc-3843	9	18	academy	academy	NOUN
dpc-3843	9	19	hospital	hospital	NOUN
dpc-3843	9	20	,	,	PUNCT
dpc-3843	9	21	ankara	ankara	PROPN
dpc-3843	9	22	asfaltı	asfaltı	VERB
dpc-3843	9	23	6	6	NUM
dpc-3843	9	24	.	.	PUNCT
dpc-3843	10	1	km	km	PROPN
dpc-3843	10	2	.	.	PUNCT
dpc-3843	10	3	no:219	no:219	PROPN
dpc-3843	10	4	(	(	PUNCT
dpc-3843	10	5	makro	makro	ADJ
dpc-3843	10	6	market	market	NOUN
dpc-3843	10	7	karşısı	karşısı	NOUN
dpc-3843	10	8	.	.	PUNCT
dpc-3843	10	9	)	)	PUNCT
dpc-3843	11	1	malatya	malatya	PROPN
dpc-3843	11	2	,	,	PUNCT
dpc-3843	11	3	turkey	turkey	PROPN
dpc-3843	11	4	.	.	PUNCT
dpc-3843	12	1	phone	phone	NOUN
dpc-3843	12	2	:	:	PUNCT
dpc-3843	13	1	+9(0	+9(0	SYM
dpc-3843	13	2	)	)	PUNCT
dpc-3843	13	3	422	422	NUM
dpc-3843	13	4	238	238	NUM
dpc-3843	13	5	25	25	NUM
dpc-3843	13	6	25	25	NUM
dpc-3843	13	7	e	e	NOUN
dpc-3843	13	8	-	-	NOUN
dpc-3843	13	9	mail	mail	NOUN
dpc-3843	13	10	:	:	PUNCT
dpc-3843	13	11	sulegencoglu2309@gmail.com	sulegencoglu2309@gmail.com	X
dpc-3843	13	12	introduction	introduction	NOUN
dpc-3843	13	13	:	:	PUNCT
dpc-3843	13	14	the	the	DET
dpc-3843	13	15	roles	role	NOUN
dpc-3843	13	16	of	of	ADP
dpc-3843	13	17	anti	anti	ADJ
dpc-3843	13	18	-	-	ADJ
dpc-3843	13	19	adhesive	adhesive	ADJ
dpc-3843	13	20	podocalyxin	podocalyxin	NOUN
dpc-3843	13	21	(	(	PUNCT
dpc-3843	13	22	podxl	podxl	PROPN
dpc-3843	13	23	)	)	PUNCT
dpc-3843	13	24	,	,	PUNCT
dpc-3843	13	25	anti	anti	ADJ
dpc-3843	13	26	-	-	ADJ
dpc-3843	13	27	angiogenetic	angiogenetic	ADJ
dpc-3843	13	28	tumstatin/	tumstatin/	NUM
dpc-3843	13	29	col	col	NOUN
dpc-3843	13	30	-	-	ADJ
dpc-3843	13	31	ivα3	ivα3	ADJ
dpc-3843	13	32	and	and	CCONJ
dpc-3843	13	33	neuro	neuro	NOUN
dpc-3843	13	34	-	-	PUNCT
dpc-3843	13	35	inflammation	inflammation	NOUN
dpc-3843	13	36	and	and	CCONJ
dpc-3843	13	37	innate	innate	ADJ
dpc-3843	13	38	immunity	immunity	NOUN
dpc-3843	13	39	modulator	modulator	NOUN
dpc-3843	13	40	chitinase	chitinase	NOUN
dpc-3843	13	41	1	1	NUM
dpc-3843	13	42	(	(	PUNCT
dpc-3843	13	43	chit-1	chit-1	PROPN
dpc-3843	13	44	)	)	PUNCT
dpc-3843	13	45	in	in	ADP
dpc-3843	13	46	the	the	DET
dpc-3843	13	47	etiology	etiology	NOUN
dpc-3843	13	48	of	of	ADP
dpc-3843	13	49	vitiligo	vitiligo	NOUN
dpc-3843	13	50	have	have	AUX
dpc-3843	13	51	not	not	PART
dpc-3843	13	52	been	be	AUX
dpc-3843	13	53	studied	study	VERB
dpc-3843	13	54	yet	yet	ADV
dpc-3843	13	55	.	.	PUNCT
dpc-3843	14	1	objectives	objective	NOUN
dpc-3843	14	2	:	:	PUNCT
dpc-3843	14	3	this	this	DET
dpc-3843	14	4	study	study	NOUN
dpc-3843	14	5	was	be	AUX
dpc-3843	14	6	planned	plan	VERB
dpc-3843	14	7	to	to	PART
dpc-3843	14	8	detect	detect	VERB
dpc-3843	14	9	changes	change	NOUN
dpc-3843	14	10	in	in	ADP
dpc-3843	14	11	serum	serum	NOUN
dpc-3843	14	12	podxl	podxl	NOUN
dpc-3843	14	13	,	,	PUNCT
dpc-3843	14	14	tumstatin	tumstatin	NOUN
dpc-3843	14	15	/	/	SYM
dpc-3843	14	16	col	col	NOUN
dpc-3843	14	17	-	-	ADJ
dpc-3843	14	18	ivα3	ivα3	ADJ
dpc-3843	14	19	and	and	CCONJ
dpc-3843	14	20	chit1	chit1	NOUN
dpc-3843	14	21	levels	level	NOUN
dpc-3843	14	22	in	in	ADP
dpc-3843	14	23	vitiligo	vitiligo	NOUN
dpc-3843	14	24	patients	patient	NOUN
dpc-3843	14	25	.	.	PUNCT
dpc-3843	15	1	methods	method	NOUN
dpc-3843	15	2	:	:	PUNCT
dpc-3843	15	3	this	this	DET
dpc-3843	15	4	case	case	NOUN
dpc-3843	15	5	-	-	PUNCT
dpc-3843	15	6	controlled	control	VERB
dpc-3843	15	7	study	study	NOUN
dpc-3843	15	8	was	be	AUX
dpc-3843	15	9	performed	perform	VERB
dpc-3843	15	10	on	on	ADP
dpc-3843	15	11	a	a	DET
dpc-3843	15	12	total	total	NOUN
dpc-3843	15	13	of	of	ADP
dpc-3843	15	14	50	50	NUM
dpc-3843	15	15	patients	patient	NOUN
dpc-3843	15	16	,	,	PUNCT
dpc-3843	15	17	25	25	NUM
dpc-3843	15	18	with	with	ADP
dpc-3843	15	19	vitiligo	vitiligo	NOUN
dpc-3843	15	20	and	and	CCONJ
dpc-3843	15	21	25	25	NUM
dpc-3843	15	22	 	 	SPACE
dpc-3843	15	23	healthy	healthy	ADJ
dpc-3843	15	24	controls	control	NOUN
dpc-3843	15	25	.	.	PUNCT
dpc-3843	16	1	participants	participant	NOUN
dpc-3843	16	2	in	in	ADP
dpc-3843	16	3	the	the	DET
dpc-3843	16	4	vitiligo	vitiligo	NOUN
dpc-3843	16	5	and	and	CCONJ
dpc-3843	16	6	control	control	NOUN
dpc-3843	16	7	groups	group	NOUN
dpc-3843	16	8	were	be	AUX
dpc-3843	16	9	matched	match	VERB
dpc-3843	16	10	in	in	ADP
dpc-3843	16	11	pairs	pair	NOUN
dpc-3843	16	12	for	for	ADP
dpc-3843	16	13	age	age	NOUN
dpc-3843	16	14	and	and	CCONJ
dpc-3843	16	15	sex	sex	NOUN
dpc-3843	16	16	.	.	PUNCT
dpc-3843	17	1	at	at	ADV
dpc-3843	17	2	least	least	ADJ
dpc-3843	17	3	8	8	NUM
dpc-3843	17	4	-	-	SYM
dpc-3843	17	5	10	10	NUM
dpc-3843	17	6	hours	hour	NOUN
dpc-3843	17	7	of	of	ADP
dpc-3843	17	8	overnight	overnight	ADJ
dpc-3843	17	9	fasting	fasting	NOUN
dpc-3843	17	10	,	,	PUNCT
dpc-3843	17	11	venous	venous	ADJ
dpc-3843	17	12	blood	blood	NOUN
dpc-3843	17	13	samples	sample	NOUN
dpc-3843	17	14	were	be	AUX
dpc-3843	17	15	taken	take	VERB
dpc-3843	17	16	from	from	ADP
dpc-3843	17	17	the	the	DET
dpc-3843	17	18	participants	participant	NOUN
dpc-3843	17	19	in	in	ADP
dpc-3843	17	20	both	both	DET
dpc-3843	17	21	groups	group	NOUN
dpc-3843	17	22	and	and	CCONJ
dpc-3843	17	23	serum	serum	NOUN
dpc-3843	17	24	levels	level	NOUN
dpc-3843	17	25	of	of	ADP
dpc-3843	17	26	podocalyxin	podocalyxin	NOUN
dpc-3843	17	27	,	,	PUNCT
dpc-3843	17	28	tumstatin	tumstatin	NOUN
dpc-3843	17	29	/	/	SYM
dpc-3843	17	30	col	col	NOUN
dpc-3843	17	31	-	-	ADJ
dpc-3843	17	32	ivα3	ivα3	PROPN
dpc-3843	17	33	and	and	CCONJ
dpc-3843	17	34	chit	chit	NOUN
dpc-3843	17	35	1	1	NUM
dpc-3843	17	36	levels	level	NOUN
dpc-3843	17	37	were	be	AUX
dpc-3843	17	38	measured	measure	VERB
dpc-3843	17	39	by	by	ADP
dpc-3843	17	40	sandwich	sandwich	NOUN
dpc-3843	17	41	enzyme	enzyme	NOUN
dpc-3843	17	42	immunoassay	immunoassay	PROPN
dpc-3843	17	43	.	.	PUNCT
dpc-3843	18	1	results	result	NOUN
dpc-3843	18	2	:	:	PUNCT
dpc-3843	18	3	in	in	ADP
dpc-3843	18	4	the	the	DET
dpc-3843	18	5	classification	classification	NOUN
dpc-3843	18	6	made	make	VERB
dpc-3843	18	7	according	accord	VERB
dpc-3843	18	8	to	to	ADP
dpc-3843	18	9	the	the	DET
dpc-3843	18	10	vitiligo	vitiligo	ADJ
dpc-3843	18	11	european	european	PROPN
dpc-3843	18	12	task	task	PROPN
dpc-3843	18	13	force	force	PROPN
dpc-3843	18	14	evaluation	evaluation	NOUN
dpc-3843	18	15	criteria	criterion	NOUN
dpc-3843	18	16	,	,	PUNCT
dpc-3843	18	17	18	18	NUM
dpc-3843	18	18	 	 	SPACE
dpc-3843	18	19	of	of	ADP
dpc-3843	18	20	25	25	NUM
dpc-3843	18	21	vitiligo	vitiligo	NOUN
dpc-3843	18	22	patients	patient	NOUN
dpc-3843	18	23	were	be	AUX
dpc-3843	18	24	in	in	ADP
dpc-3843	18	25	the	the	DET
dpc-3843	18	26	slowly	slowly	ADV
dpc-3843	18	27	progressive	progressive	ADJ
dpc-3843	18	28	phase	phase	NOUN
dpc-3843	18	29	and	and	CCONJ
dpc-3843	18	30	7	7	NUM
dpc-3843	18	31	patients	patient	NOUN
dpc-3843	18	32	were	be	AUX
dpc-3843	18	33	in	in	ADP
dpc-3843	18	34	the	the	DET
dpc-3843	18	35	active	active	ADJ
dpc-3843	18	36	progressive	progressive	ADJ
dpc-3843	18	37	phase	phase	NOUN
dpc-3843	18	38	.	.	PUNCT
dpc-3843	19	1	serum	serum	NOUN
dpc-3843	19	2	podocalyxin	podocalyxin	PROPN
dpc-3843	19	3	levels	level	NOUN
dpc-3843	19	4	increased	increase	VERB
dpc-3843	19	5	significantly	significantly	ADV
dpc-3843	19	6	in	in	ADP
dpc-3843	19	7	the	the	DET
dpc-3843	19	8	vitiligo	vitiligo	NOUN
dpc-3843	19	9	group	group	NOUN
dpc-3843	19	10	compared	compare	VERB
dpc-3843	19	11	to	to	ADP
dpc-3843	19	12	the	the	DET
dpc-3843	19	13	controls	control	NOUN
dpc-3843	19	14	(	(	PUNCT
dpc-3843	19	15	7.03±2.09	7.03±2.09	PROPN
dpc-3843	19	16	ng	ng	PROPN
dpc-3843	19	17	/	/	SYM
dpc-3843	19	18	ml	ml	PROPN
dpc-3843	19	19	vs.	vs.	X
dpc-3843	19	20	4.99±1.20	4.99±1.20	PROPN
dpc-3843	19	21	ng	ng	PROPN
dpc-3843	19	22	/	/	SYM
dpc-3843	19	23	ml	ml	PROPN
dpc-3843	19	24	,	,	PUNCT
dpc-3843	19	25	p<0.02	p<0.02	PROPN
dpc-3843	19	26	)	)	PUNCT
dpc-3843	19	27	.	.	PUNCT
dpc-3843	20	1	however	however	ADV
dpc-3843	20	2	,	,	PUNCT
dpc-3843	20	3	serum	serum	NOUN
dpc-3843	20	4	tumstatin	tumstatin	NOUN
dpc-3843	20	5	levels	level	NOUN
dpc-3843	20	6	in	in	ADP
dpc-3843	20	7	vitiligo	vitiligo	ADJ
dpc-3843	20	8	patients	patient	NOUN
dpc-3843	20	9	showed	show	VERB
dpc-3843	20	10	a	a	DET
dpc-3843	20	11	significantly	significantly	ADV
dpc-3843	20	12	lower	low	ADJ
dpc-3843	20	13	course	course	NOUN
dpc-3843	20	14	compared	compare	VERB
dpc-3843	20	15	to	to	ADP
dpc-3843	20	16	controls	control	NOUN
dpc-3843	20	17	(	(	PUNCT
dpc-3843	20	18	4.88±1.76	4.88±1.76	NUM
dpc-3843	20	19	ng	ng	PROPN
dpc-3843	20	20	/	/	SYM
dpc-3843	20	21	ml	ml	PROPN
dpc-3843	20	22	vs.	vs.	ADP
dpc-3843	20	23	6.05±2.19	6.05±2.19	NUM
dpc-3843	20	24	ng	ng	PROPN
dpc-3843	20	25	/	/	SYM
dpc-3843	20	26	nl	nl	PROPN
dpc-3843	20	27	,	,	PUNCT
dpc-3843	20	28	p<0.03	p<0.03	NOUN
dpc-3843	20	29	)	)	PUNCT
dpc-3843	20	30	.	.	PUNCT
dpc-3843	21	1	serum	serum	PROPN
dpc-3843	21	2	chit-1	chit-1	NUM
dpc-3843	21	3	levels	level	NOUN
dpc-3843	21	4	of	of	ADP
dpc-3843	21	5	vitiligo	vitiligo	ADJ
dpc-3843	21	6	patients	patient	NOUN
dpc-3843	21	7	(	(	PUNCT
dpc-3843	21	8	42.4±7.22	42.4±7.22	NUM
dpc-3843	21	9	ng	ng	NOUN
dpc-3843	21	10	/	/	SYM
dpc-3843	21	11	ml	ml	PROPN
dpc-3843	21	12	)	)	PUNCT
dpc-3843	21	13	were	be	AUX
dpc-3843	21	14	found	find	VERB
dpc-3843	21	15	to	to	PART
dpc-3843	21	16	be	be	AUX
dpc-3843	21	17	significantly	significantly	ADV
dpc-3843	21	18	higher	high	ADJ
dpc-3843	21	19	than	than	ADP
dpc-3843	21	20	the	the	DET
dpc-3843	21	21	serum	serum	NOUN
dpc-3843	21	22	levels	level	NOUN
dpc-3843	21	23	of	of	ADP
dpc-3843	21	24	the	the	DET
dpc-3843	21	25	control	control	NOUN
dpc-3843	21	26	group	group	NOUN
dpc-3843	21	27	(	(	PUNCT
dpc-3843	21	28	34.5±5.33	34.5±5.33	NUM
dpc-3843	21	29	ng	ng	PROPN
dpc-3843	21	30	/	/	SYM
dpc-3843	21	31	ml	ml	PROPN
dpc-3843	21	32	)	)	PUNCT
dpc-3843	21	33	(	(	PUNCT
dpc-3843	21	34	p<0.01	p<0.01	PROPN
dpc-3843	21	35	)	)	PUNCT
dpc-3843	21	36	.	.	PUNCT
dpc-3843	22	1	conclusion	conclusion	NOUN
dpc-3843	22	2	:	:	PUNCT
dpc-3843	22	3	high	high	ADJ
dpc-3843	22	4	podocalyxin	podocalyxin	NOUN
dpc-3843	22	5	and	and	CCONJ
dpc-3843	22	6	chit1versus	chit1versus	PROPN
dpc-3843	22	7	low	low	ADJ
dpc-3843	22	8	tumstatin	tumstatin	PROPN
dpc-3843	22	9	levels	level	NOUN
dpc-3843	22	10	are	be	AUX
dpc-3843	22	11	new	new	ADJ
dpc-3843	22	12	biomarkers	biomarker	NOUN
dpc-3843	22	13	that	that	PRON
dpc-3843	22	14	support	support	VERB
dpc-3843	22	15	the	the	DET
dpc-3843	22	16	role	role	NOUN
dpc-3843	22	17	of	of	ADP
dpc-3843	22	18	anti	anti	ADJ
dpc-3843	22	19	-	-	ADJ
dpc-3843	22	20	adhesive	adhesive	ADJ
dpc-3843	22	21	,	,	PUNCT
dpc-3843	22	22	anti	anti	ADJ
dpc-3843	22	23	-	-	ADJ
dpc-3843	22	24	angiogenic	angiogenic	ADJ
dpc-3843	22	25	and	and	CCONJ
dpc-3843	22	26	neuroinflammatory	neuroinflammatory	ADJ
dpc-3843	22	27	pathways	pathway	NOUN
dpc-3843	22	28	in	in	ADP
dpc-3843	22	29	the	the	DET
dpc-3843	22	30	formation	formation	NOUN
dpc-3843	22	31	of	of	ADP
dpc-3843	22	32	vitiligo	vitiligo	NOUN
dpc-3843	22	33	.	.	PUNCT
dpc-3843	23	1	abstract	abstract	ADJ
dpc-3843	23	2	2	2	NUM
dpc-3843	23	3	original	original	ADJ
dpc-3843	23	4	article	article	NOUN
dpc-3843	23	5	|	|	ADV
dpc-3843	23	6	dermatol	dermatol	ADJ
dpc-3843	23	7	pract	pract	NOUN
dpc-3843	23	8	concept	concept	NOUN
dpc-3843	23	9	.	.	PUNCT
dpc-3843	24	1	2024;14(1):e2024095	2024;14(1):e2024095	NUM
dpc-3843	24	2	introduction	introduction	NOUN
dpc-3843	24	3	vitiligo	vitiligo	NOUN
dpc-3843	24	4	is	be	AUX
dpc-3843	24	5	the	the	DET
dpc-3843	24	6	most	most	ADV
dpc-3843	24	7	common	common	ADJ
dpc-3843	24	8	autoimmune	autoimmune	ADJ
dpc-3843	24	9	,	,	PUNCT
dpc-3843	24	10	polygenic	polygenic	ADJ
dpc-3843	24	11	and	and	CCONJ
dpc-3843	24	12	multifactorial	multifactorial	ADJ
dpc-3843	24	13	cutaneous	cutaneous	ADJ
dpc-3843	24	14	depigmentation	depigmentation	NOUN
dpc-3843	24	15	disease	disease	NOUN
dpc-3843	24	16	characterized	characterize	VERB
dpc-3843	24	17	by	by	ADP
dpc-3843	24	18	selective	selective	ADJ
dpc-3843	24	19	loss	loss	NOUN
dpc-3843	24	20	of	of	ADP
dpc-3843	24	21	melanocytes	melanocyte	NOUN
dpc-3843	24	22	and	and	CCONJ
dpc-3843	24	23	melanin	melanin	NOUN
dpc-3843	24	24	pigment	pigment	NOUN
dpc-3843	24	25	[	[	X
dpc-3843	24	26	1	1	NUM
dpc-3843	24	27	]	]	PUNCT
dpc-3843	24	28	.	.	PUNCT
dpc-3843	25	1	although	although	SCONJ
dpc-3843	25	2	it	it	PRON
dpc-3843	25	3	varies	vary	VERB
dpc-3843	25	4	according	accord	VERB
dpc-3843	25	5	to	to	ADP
dpc-3843	25	6	the	the	DET
dpc-3843	25	7	population	population	NOUN
dpc-3843	25	8	studied	study	VERB
dpc-3843	25	9	,	,	PUNCT
dpc-3843	25	10	the	the	DET
dpc-3843	25	11	incidence	incidence	NOUN
dpc-3843	25	12	in	in	ADP
dpc-3843	25	13	the	the	DET
dpc-3843	25	14	general	general	ADJ
dpc-3843	25	15	population	population	NOUN
dpc-3843	25	16	approaches	approach	NOUN
dpc-3843	25	17	is	be	AUX
dpc-3843	25	18	0.5%2.9	0.5%2.9	ADJ
dpc-3843	25	19	%	%	NOUN
dpc-3843	25	20	[	[	X
dpc-3843	25	21	2	2	NUM
dpc-3843	25	22	]	]	PUNCT
dpc-3843	25	23	.	.	PUNCT
dpc-3843	26	1	the	the	DET
dpc-3843	26	2	absence	absence	NOUN
dpc-3843	26	3	of	of	ADP
dpc-3843	26	4	melanocytes	melanocyte	NOUN
dpc-3843	26	5	leads	lead	VERB
dpc-3843	26	6	to	to	ADP
dpc-3843	26	7	depigmentation	depigmentation	NOUN
dpc-3843	26	8	and	and	CCONJ
dpc-3843	26	9	a	a	DET
dpc-3843	26	10	skin	skin	NOUN
dpc-3843	26	11	appearance	appearance	NOUN
dpc-3843	26	12	characterized	characterize	VERB
dpc-3843	26	13	by	by	ADP
dpc-3843	26	14	chalky	chalky	ADJ
dpc-3843	26	15	-	-	PUNCT
dpc-3843	26	16	white	white	ADJ
dpc-3843	26	17	macules	macule	NOUN
dpc-3843	26	18	[	[	X
dpc-3843	26	19	3	3	NUM
dpc-3843	26	20	]	]	PUNCT
dpc-3843	26	21	.	.	PUNCT
dpc-3843	27	1	although	although	SCONJ
dpc-3843	27	2	the	the	DET
dpc-3843	27	3	critical	critical	ADJ
dpc-3843	27	4	role	role	NOUN
dpc-3843	27	5	of	of	ADP
dpc-3843	27	6	inherent	inherent	ADJ
dpc-3843	27	7	and	and	CCONJ
dpc-3843	27	8	environmental	environmental	ADJ
dpc-3843	27	9	factors	factor	NOUN
dpc-3843	27	10	in	in	ADP
dpc-3843	27	11	the	the	DET
dpc-3843	27	12	development	development	NOUN
dpc-3843	27	13	of	of	ADP
dpc-3843	27	14	the	the	DET
dpc-3843	27	15	disease	disease	NOUN
dpc-3843	27	16	is	be	AUX
dpc-3843	27	17	well	well	ADV
dpc-3843	27	18	known	know	VERB
dpc-3843	27	19	,	,	PUNCT
dpc-3843	27	20	a	a	DET
dpc-3843	27	21	complex	complex	ADJ
dpc-3843	27	22	set	set	NOUN
dpc-3843	27	23	of	of	ADP
dpc-3843	27	24	mechanisms	mechanism	NOUN
dpc-3843	27	25	consisting	consist	VERB
dpc-3843	27	26	of	of	ADP
dpc-3843	27	27	oxidative	oxidative	ADJ
dpc-3843	27	28	stress	stress	NOUN
dpc-3843	27	29	,	,	PUNCT
dpc-3843	27	30	angiogenesis	angiogenesis	NOUN
dpc-3843	27	31	and	and	CCONJ
dpc-3843	27	32	proinflammatory	proinflammatory	ADJ
dpc-3843	27	33	pathway	pathway	NOUN
dpc-3843	27	34	defects	defect	NOUN
dpc-3843	27	35	lie	lie	VERB
dpc-3843	27	36	behind	behind	ADP
dpc-3843	27	37	the	the	DET
dpc-3843	27	38	autoimmune	autoimmune	ADJ
dpc-3843	27	39	picture	picture	NOUN
dpc-3843	27	40	[	[	X
dpc-3843	27	41	4	4	NUM
dpc-3843	27	42	]	]	PUNCT
dpc-3843	27	43	.	.	PUNCT
dpc-3843	28	1	according	accord	VERB
dpc-3843	28	2	to	to	ADP
dpc-3843	28	3	the	the	DET
dpc-3843	28	4	convergence	convergence	NOUN
dpc-3843	28	5	theory	theory	NOUN
dpc-3843	28	6	,	,	PUNCT
dpc-3843	28	7	the	the	DET
dpc-3843	28	8	progressive	progressive	ADJ
dpc-3843	28	9	loss	loss	NOUN
dpc-3843	28	10	of	of	ADP
dpc-3843	28	11	melanocytes	melanocyte	NOUN
dpc-3843	28	12	is	be	AUX
dpc-3843	28	13	caused	cause	VERB
dpc-3843	28	14	by	by	ADP
dpc-3843	28	15	more	more	ADJ
dpc-3843	28	16	than	than	ADP
dpc-3843	28	17	one	one	NUM
dpc-3843	28	18	factor	factor	NOUN
dpc-3843	28	19	or	or	CCONJ
dpc-3843	28	20	mechanism	mechanism	NOUN
dpc-3843	28	21	,	,	PUNCT
dpc-3843	28	22	suggesting	suggest	VERB
dpc-3843	28	23	that	that	SCONJ
dpc-3843	28	24	the	the	DET
dpc-3843	28	25	disease	disease	NOUN
dpc-3843	28	26	develops	develop	VERB
dpc-3843	28	27	on	on	ADP
dpc-3843	28	28	a	a	DET
dpc-3843	28	29	multifactorial	multifactorial	ADJ
dpc-3843	28	30	basis	basis	NOUN
dpc-3843	29	1	[	[	X
dpc-3843	29	2	4–6	4–6	X
dpc-3843	29	3	]	]	X
dpc-3843	29	4	.	.	PUNCT
dpc-3843	30	1	as	as	ADP
dpc-3843	30	2	a	a	DET
dpc-3843	30	3	result	result	NOUN
dpc-3843	30	4	of	of	ADP
dpc-3843	30	5	a	a	DET
dpc-3843	30	6	defect	defect	NOUN
dpc-3843	30	7	in	in	ADP
dpc-3843	30	8	the	the	DET
dpc-3843	30	9	innate	innate	ADJ
dpc-3843	30	10	and	and	CCONJ
dpc-3843	30	11	adaptive	adaptive	ADJ
dpc-3843	30	12	immune	immune	ADJ
dpc-3843	30	13	system	system	NOUN
dpc-3843	30	14	,	,	PUNCT
dpc-3843	30	15	the	the	DET
dpc-3843	30	16	immune	immune	ADJ
dpc-3843	30	17	attack	attack	NOUN
dpc-3843	30	18	to	to	ADP
dpc-3843	30	19	the	the	DET
dpc-3843	30	20	basal	basal	ADJ
dpc-3843	30	21	cell	cell	NOUN
dpc-3843	30	22	layer	layer	NOUN
dpc-3843	30	23	,	,	PUNCT
dpc-3843	30	24	where	where	SCONJ
dpc-3843	30	25	melanocytes	melanocyte	NOUN
dpc-3843	30	26	are	be	AUX
dpc-3843	30	27	located	locate	VERB
dpc-3843	30	28	,	,	PUNCT
dpc-3843	30	29	damages	damage	VERB
dpc-3843	30	30	both	both	DET
dpc-3843	30	31	melanocytes	melanocyte	NOUN
dpc-3843	30	32	and	and	CCONJ
dpc-3843	30	33	neighboring	neighboring	NOUN
dpc-3843	30	34	basal	basal	NOUN
dpc-3843	30	35	cells	cell	NOUN
dpc-3843	30	36	.	.	PUNCT
dpc-3843	31	1	the	the	DET
dpc-3843	31	2	close	close	ADJ
dpc-3843	31	3	neighborhood	neighborhood	NOUN
dpc-3843	31	4	of	of	ADP
dpc-3843	31	5	the	the	DET
dpc-3843	31	6	dermis	dermis	NOUN
dpc-3843	31	7	and	and	CCONJ
dpc-3843	31	8	basal	basal	ADJ
dpc-3843	31	9	layer	layer	NOUN
dpc-3843	31	10	cells	cell	NOUN
dpc-3843	31	11	contains	contain	VERB
dpc-3843	31	12	abundant	abundant	ADJ
dpc-3843	31	13	sensorial	sensorial	ADJ
dpc-3843	31	14	,	,	PUNCT
dpc-3843	31	15	vascular	vascular	ADJ
dpc-3843	31	16	and	and	CCONJ
dpc-3843	31	17	neuronal	neuronal	ADJ
dpc-3843	31	18	components	component	NOUN
dpc-3843	31	19	,	,	PUNCT
dpc-3843	31	20	which	which	PRON
dpc-3843	31	21	are	be	AUX
dpc-3843	31	22	necessary	necessary	ADJ
dpc-3843	31	23	structures	structure	NOUN
dpc-3843	31	24	for	for	SCONJ
dpc-3843	31	25	melanocytes	melanocyte	NOUN
dpc-3843	31	26	to	to	PART
dpc-3843	31	27	be	be	AUX
dpc-3843	31	28	exposed	expose	VERB
dpc-3843	31	29	to	to	ADP
dpc-3843	31	30	immune	immune	ADJ
dpc-3843	31	31	attack	attack	NOUN
dpc-3843	31	32	[	[	X
dpc-3843	31	33	1	1	NUM
dpc-3843	31	34	,	,	PUNCT
dpc-3843	31	35	4	4	NUM
dpc-3843	31	36	]	]	PUNCT
dpc-3843	31	37	.	.	PUNCT
dpc-3843	32	1	although	although	SCONJ
dpc-3843	32	2	the	the	DET
dpc-3843	32	3	disease	disease	NOUN
dpc-3843	32	4	is	be	AUX
dpc-3843	32	5	characterized	characterize	VERB
dpc-3843	32	6	by	by	ADP
dpc-3843	32	7	the	the	DET
dpc-3843	32	8	loss	loss	NOUN
dpc-3843	32	9	of	of	ADP
dpc-3843	32	10	melanocytes	melanocyte	NOUN
dpc-3843	32	11	,	,	PUNCT
dpc-3843	32	12	all	all	DET
dpc-3843	32	13	cells	cell	NOUN
dpc-3843	32	14	in	in	ADP
dpc-3843	32	15	the	the	DET
dpc-3843	32	16	vicinity	vicinity	NOUN
dpc-3843	32	17	of	of	ADP
dpc-3843	32	18	the	the	DET
dpc-3843	32	19	dermis	dermis	NOUN
dpc-3843	32	20	and	and	CCONJ
dpc-3843	32	21	basal	basal	ADJ
dpc-3843	32	22	plate	plate	NOUN
dpc-3843	32	23	should	should	AUX
dpc-3843	32	24	be	be	AUX
dpc-3843	32	25	affected	affect	VERB
dpc-3843	32	26	by	by	ADP
dpc-3843	32	27	the	the	DET
dpc-3843	32	28	immune	immune	ADJ
dpc-3843	32	29	attack	attack	NOUN
dpc-3843	32	30	,	,	PUNCT
dpc-3843	32	31	albeit	albeit	SCONJ
dpc-3843	32	32	at	at	ADP
dpc-3843	32	33	different	different	ADJ
dpc-3843	32	34	rates	rate	NOUN
dpc-3843	32	35	[	[	X
dpc-3843	32	36	6	6	NUM
dpc-3843	32	37	]	]	PUNCT
dpc-3843	32	38	.	.	PUNCT
dpc-3843	33	1	if	if	SCONJ
dpc-3843	33	2	the	the	DET
dpc-3843	33	3	loss	loss	NOUN
dpc-3843	33	4	of	of	ADP
dpc-3843	33	5	melanocyte	melanocyte	NOUN
dpc-3843	33	6	causes	cause	VERB
dpc-3843	33	7	degeneration	degeneration	NOUN
dpc-3843	33	8	and	and	CCONJ
dpc-3843	33	9	detachment	detachment	NOUN
dpc-3843	33	10	in	in	ADP
dpc-3843	33	11	neighboring	neighboring	NOUN
dpc-3843	33	12	cells	cell	NOUN
dpc-3843	33	13	,	,	PUNCT
dpc-3843	33	14	some	some	DET
dpc-3843	33	15	degradation	degradation	NOUN
dpc-3843	33	16	products	product	NOUN
dpc-3843	33	17	must	must	AUX
dpc-3843	33	18	be	be	AUX
dpc-3843	33	19	going	go	VERB
dpc-3843	33	20	into	into	ADP
dpc-3843	33	21	the	the	DET
dpc-3843	33	22	systemic	systemic	ADJ
dpc-3843	33	23	circulation	circulation	NOUN
dpc-3843	33	24	.	.	PUNCT
dpc-3843	34	1	the	the	DET
dpc-3843	34	2	main	main	ADJ
dpc-3843	34	3	initiator	initiator	NOUN
dpc-3843	34	4	in	in	ADP
dpc-3843	34	5	the	the	DET
dpc-3843	34	6	formation	formation	NOUN
dpc-3843	34	7	of	of	ADP
dpc-3843	34	8	both	both	CCONJ
dpc-3843	34	9	segmental	segmental	ADJ
dpc-3843	34	10	and	and	CCONJ
dpc-3843	34	11	non	non	ADJ
dpc-3843	34	12	-	-	ADJ
dpc-3843	34	13	segmental	segmental	ADJ
dpc-3843	34	14	forms	form	NOUN
dpc-3843	34	15	of	of	ADP
dpc-3843	34	16	vitiligo	vitiligo	NOUN
dpc-3843	34	17	is	be	AUX
dpc-3843	34	18	an	an	DET
dpc-3843	34	19	external	external	ADJ
dpc-3843	34	20	or	or	CCONJ
dpc-3843	34	21	internal	internal	ADJ
dpc-3843	34	22	injury	injury	NOUN
dpc-3843	34	23	.	.	PUNCT
dpc-3843	35	1	this	this	PRON
dpc-3843	35	2	is	be	AUX
dpc-3843	35	3	followed	follow	VERB
dpc-3843	35	4	by	by	ADP
dpc-3843	35	5	an	an	DET
dpc-3843	35	6	increase	increase	NOUN
dpc-3843	35	7	in	in	ADP
dpc-3843	35	8	the	the	DET
dpc-3843	35	9	release	release	NOUN
dpc-3843	35	10	of	of	ADP
dpc-3843	35	11	inflammatory	inflammatory	ADJ
dpc-3843	35	12	cytokines	cytokine	NOUN
dpc-3843	35	13	and	and	CCONJ
dpc-3843	35	14	neuropeptides	neuropeptide	NOUN
dpc-3843	35	15	and	and	CCONJ
dpc-3843	35	16	a	a	DET
dpc-3843	35	17	widespread	widespread	ADJ
dpc-3843	35	18	vasodilation	vasodilation	NOUN
dpc-3843	35	19	process	process	NOUN
dpc-3843	35	20	at	at	ADP
dpc-3843	35	21	the	the	DET
dpc-3843	35	22	dermis	dermis	NOUN
dpc-3843	35	23	-	-	PUNCT
dpc-3843	35	24	stratum	stratum	NOUN
dpc-3843	35	25	basale	basale	ADJ
dpc-3843	35	26	border	border	NOUN
dpc-3843	35	27	.	.	PUNCT
dpc-3843	36	1	changes	change	NOUN
dpc-3843	36	2	in	in	ADP
dpc-3843	36	3	the	the	DET
dpc-3843	36	4	vascular	vascular	ADJ
dpc-3843	36	5	bed	bed	NOUN
dpc-3843	36	6	cause	cause	VERB
dpc-3843	36	7	a	a	DET
dpc-3843	36	8	large	large	ADJ
dpc-3843	36	9	number	number	NOUN
dpc-3843	36	10	of	of	ADP
dpc-3843	36	11	immune	immune	ADJ
dpc-3843	36	12	cells	cell	NOUN
dpc-3843	36	13	from	from	ADP
dpc-3843	36	14	the	the	DET
dpc-3843	36	15	dermal	dermal	ADJ
dpc-3843	36	16	segment	segment	NOUN
dpc-3843	36	17	to	to	PART
dpc-3843	36	18	target	target	VERB
dpc-3843	36	19	melanocytes	melanocyte	NOUN
dpc-3843	36	20	and	and	CCONJ
dpc-3843	36	21	neighboring	neighboring	NOUN
dpc-3843	36	22	cells	cell	NOUN
dpc-3843	36	23	in	in	ADP
dpc-3843	36	24	the	the	DET
dpc-3843	36	25	basal	basal	ADJ
dpc-3843	36	26	segment	segment	NOUN
dpc-3843	37	1	[	[	X
dpc-3843	37	2	5	5	NUM
dpc-3843	37	3	,	,	PUNCT
dpc-3843	37	4	6	6	NUM
dpc-3843	37	5	]	]	PUNCT
dpc-3843	37	6	.	.	PUNCT
dpc-3843	38	1	as	as	ADP
dpc-3843	38	2	a	a	DET
dpc-3843	38	3	result	result	NOUN
dpc-3843	38	4	,	,	PUNCT
dpc-3843	38	5	the	the	DET
dpc-3843	38	6	chain	chain	NOUN
dpc-3843	38	7	of	of	ADP
dpc-3843	38	8	autoimmune	autoimmune	ADJ
dpc-3843	38	9	reactions	reaction	NOUN
dpc-3843	38	10	that	that	PRON
dpc-3843	38	11	occur	occur	VERB
dpc-3843	38	12	in	in	ADP
dpc-3843	38	13	the	the	DET
dpc-3843	38	14	affected	affected	ADJ
dpc-3843	38	15	area	area	NOUN
dpc-3843	38	16	leads	lead	VERB
dpc-3843	38	17	to	to	ADP
dpc-3843	38	18	the	the	DET
dpc-3843	38	19	loss	loss	NOUN
dpc-3843	38	20	of	of	ADP
dpc-3843	38	21	melanocytes	melanocyte	NOUN
dpc-3843	38	22	,	,	PUNCT
dpc-3843	38	23	leading	lead	VERB
dpc-3843	38	24	to	to	ADP
dpc-3843	38	25	the	the	DET
dpc-3843	38	26	emergence	emergence	NOUN
dpc-3843	38	27	of	of	ADP
dpc-3843	38	28	the	the	DET
dpc-3843	38	29	disease	disease	NOUN
dpc-3843	38	30	picture	picture	NOUN
dpc-3843	38	31	characterized	characterize	VERB
dpc-3843	38	32	by	by	ADP
dpc-3843	38	33	depigmentation	depigmentation	NOUN
dpc-3843	38	34	[	[	X
dpc-3843	38	35	4	4	NUM
dpc-3843	38	36	,	,	PUNCT
dpc-3843	38	37	6	6	NUM
dpc-3843	38	38	,	,	PUNCT
dpc-3843	38	39	7	7	NUM
dpc-3843	38	40	]	]	PUNCT
dpc-3843	38	41	.	.	PUNCT
dpc-3843	39	1	this	this	DET
dpc-3843	39	2	study	study	NOUN
dpc-3843	39	3	was	be	AUX
dpc-3843	39	4	designed	design	VERB
dpc-3843	39	5	considering	consider	VERB
dpc-3843	39	6	that	that	SCONJ
dpc-3843	39	7	proinflammatory	proinflammatory	ADJ
dpc-3843	39	8	reactions	reaction	NOUN
dpc-3843	39	9	occurring	occur	VERB
dpc-3843	39	10	at	at	ADP
dpc-3843	39	11	the	the	DET
dpc-3843	39	12	dermis	dermis	NOUN
dpc-3843	39	13	-	-	PUNCT
dpc-3843	39	14	stratum	stratum	NOUN
dpc-3843	39	15	basale	basale	PROPN
dpc-3843	39	16	border	border	NOUN
dpc-3843	39	17	provide	provide	VERB
dpc-3843	39	18	detachment	detachment	NOUN
dpc-3843	39	19	and	and	CCONJ
dpc-3843	39	20	degeneration	degeneration	NOUN
dpc-3843	39	21	in	in	ADP
dpc-3843	39	22	melanocytes	melanocyte	NOUN
dpc-3843	39	23	,	,	PUNCT
dpc-3843	39	24	keratinocytes	keratinocyte	NOUN
dpc-3843	39	25	,	,	PUNCT
dpc-3843	39	26	basal	basal	NOUN
dpc-3843	39	27	and	and	CCONJ
dpc-3843	39	28	dermis	dermis	NOUN
dpc-3843	39	29	cells	cell	NOUN
dpc-3843	39	30	through	through	ADP
dpc-3843	39	31	(	(	PUNCT
dpc-3843	39	32	i	i	NOUN
dpc-3843	39	33	)	)	PUNCT
dpc-3843	39	34	vascular	vascular	VERB
dpc-3843	39	35	endothelial	endothelial	ADJ
dpc-3843	39	36	damage	damage	NOUN
dpc-3843	39	37	,	,	PUNCT
dpc-3843	39	38	(	(	PUNCT
dpc-3843	39	39	ii	ii	NOUN
dpc-3843	39	40	)	)	PUNCT
dpc-3843	39	41	apical	apical	ADJ
dpc-3843	39	42	/	/	SYM
dpc-3843	39	43	basal	basal	ADJ
dpc-3843	39	44	membrane	membrane	NOUN
dpc-3843	39	45	protein	protein	NOUN
dpc-3843	39	46	degradation	degradation	NOUN
dpc-3843	39	47	and	and	CCONJ
dpc-3843	39	48	(	(	PUNCT
dpc-3843	39	49	iii	iii	NOUN
dpc-3843	39	50	)	)	PUNCT
dpc-3843	39	51	innate	innate	ADJ
dpc-3843	39	52	immunity	immunity	NOUN
dpc-3843	39	53	[	[	X
dpc-3843	39	54	3–6	3–6	NUM
dpc-3843	39	55	]	]	X
dpc-3843	39	56	.	.	PUNCT
dpc-3843	40	1	to	to	PART
dpc-3843	40	2	confirm	confirm	VERB
dpc-3843	40	3	the	the	DET
dpc-3843	40	4	presence	presence	NOUN
dpc-3843	40	5	of	of	ADP
dpc-3843	40	6	vascular	vascular	ADJ
dpc-3843	40	7	endothelial	endothelial	ADJ
dpc-3843	40	8	destruction	destruction	NOUN
dpc-3843	40	9	,	,	PUNCT
dpc-3843	40	10	we	we	PRON
dpc-3843	40	11	measured	measure	VERB
dpc-3843	40	12	the	the	DET
dpc-3843	40	13	levels	level	NOUN
dpc-3843	40	14	of	of	ADP
dpc-3843	40	15	tumstatin	tumstatin	NOUN
dpc-3843	40	16	,	,	PUNCT
dpc-3843	40	17	the	the	DET
dpc-3843	40	18	nc1	nc1	PROPN
dpc-3843	40	19	domain	domain	NOUN
dpc-3843	40	20	of	of	ADP
dpc-3843	40	21	type	type	NOUN
dpc-3843	40	22	iv	iv	NUM
dpc-3843	40	23	collagen	collagen	NOUN
dpc-3843	40	24	alpha	alpha	NOUN
dpc-3843	40	25	3	3	NUM
dpc-3843	40	26	,	,	PUNCT
dpc-3843	40	27	which	which	PRON
dpc-3843	40	28	is	be	AUX
dpc-3843	40	29	widely	widely	ADV
dpc-3843	40	30	expressed	express	VERB
dpc-3843	40	31	in	in	ADP
dpc-3843	40	32	the	the	DET
dpc-3843	40	33	vascular	vascular	ADJ
dpc-3843	40	34	basement	basement	NOUN
dpc-3843	40	35	membrane	membrane	NOUN
dpc-3843	40	36	.	.	PUNCT
dpc-3843	41	1	tumstatin	tumstatin	NOUN
dpc-3843	41	2	is	be	AUX
dpc-3843	41	3	a	a	DET
dpc-3843	41	4	breakdown	breakdown	ADJ
dpc-3843	41	5	product	product	NOUN
dpc-3843	41	6	of	of	ADP
dpc-3843	41	7	type	type	NOUN
dpc-3843	41	8	4	4	NUM
dpc-3843	41	9	collagen	collagen	NOUN
dpc-3843	41	10	and	and	CCONJ
dpc-3843	41	11	prevents	prevent	VERB
dpc-3843	41	12	endothelial	endothelial	ADJ
dpc-3843	41	13	proliferation	proliferation	NOUN
dpc-3843	41	14	and	and	CCONJ
dpc-3843	41	15	angiogenesis	angiogenesis	NOUN
dpc-3843	42	1	[	[	X
dpc-3843	42	2	8	8	NUM
dpc-3843	42	3	,	,	PUNCT
dpc-3843	42	4	9	9	NUM
dpc-3843	42	5	]	]	PUNCT
dpc-3843	42	6	.	.	PUNCT
dpc-3843	43	1	basal	basal	ADJ
dpc-3843	43	2	membrane	membrane	NOUN
dpc-3843	43	3	expression	expression	NOUN
dpc-3843	43	4	of	of	ADP
dpc-3843	43	5	tumstatin	tumstatin	NOUN
dpc-3843	43	6	is	be	AUX
dpc-3843	43	7	controlled	control	VERB
dpc-3843	43	8	by	by	ADP
dpc-3843	43	9	matrix	matrix	NOUN
dpc-3843	43	10	metalloproteinase-9	metalloproteinase-9	NUM
dpc-3843	43	11	,	,	PUNCT
dpc-3843	43	12	and	and	CCONJ
dpc-3843	43	13	when	when	SCONJ
dpc-3843	43	14	it	it	PRON
dpc-3843	43	15	binds	bind	VERB
dpc-3843	43	16	to	to	PART
dpc-3843	43	17	alphav	alphav	VERB
dpc-3843	43	18	beta3	beta3	PROPN
dpc-3843	43	19	integrin	integrin	NOUN
dpc-3843	43	20	it	it	PRON
dpc-3843	43	21	also	also	ADV
dpc-3843	43	22	blocks	block	VERB
dpc-3843	43	23	new	new	ADJ
dpc-3843	43	24	endothelial	endothelial	ADJ
dpc-3843	43	25	formation	formation	NOUN
dpc-3843	44	1	[	[	X
dpc-3843	44	2	8	8	NUM
dpc-3843	44	3	]	]	PUNCT
dpc-3843	44	4	.	.	PUNCT
dpc-3843	45	1	to	to	PART
dpc-3843	45	2	demonstrate	demonstrate	VERB
dpc-3843	45	3	apical	apical	ADJ
dpc-3843	45	4	/	/	SYM
dpc-3843	45	5	basal	basal	ADJ
dpc-3843	45	6	membrane	membrane	NOUN
dpc-3843	45	7	and	and	CCONJ
dpc-3843	45	8	keratinocytes	keratinocyte	VERB
dpc-3843	45	9	damage	damage	NOUN
dpc-3843	45	10	,	,	PUNCT
dpc-3843	45	11	we	we	PRON
dpc-3843	45	12	evaluated	evaluate	VERB
dpc-3843	45	13	the	the	DET
dpc-3843	45	14	levels	level	NOUN
dpc-3843	45	15	of	of	ADP
dpc-3843	45	16	podocalyxin	podocalyxin	NOUN
dpc-3843	45	17	(	(	PUNCT
dpc-3843	45	18	podxl	podxl	PROPN
dpc-3843	45	19	)	)	PUNCT
dpc-3843	45	20	,	,	PUNCT
dpc-3843	45	21	an	an	DET
dpc-3843	45	22	anti	anti	ADJ
dpc-3843	45	23	-	-	ADJ
dpc-3843	45	24	adhesive	adhesive	ADJ
dpc-3843	45	25	molecule	molecule	NOUN
dpc-3843	45	26	.	.	PUNCT
dpc-3843	46	1	podxl	podxl	PROPN
dpc-3843	46	2	is	be	AUX
dpc-3843	46	3	a	a	DET
dpc-3843	46	4	glycosylated	glycosylated	ADJ
dpc-3843	46	5	sialomucin	sialomucin	NOUN
dpc-3843	46	6	of	of	ADP
dpc-3843	46	7	the	the	DET
dpc-3843	46	8	cd34	cd34	PROPN
dpc-3843	46	9	family	family	NOUN
dpc-3843	46	10	expressed	express	VERB
dpc-3843	46	11	on	on	ADP
dpc-3843	46	12	apical	apical	ADJ
dpc-3843	46	13	cell	cell	NOUN
dpc-3843	46	14	surfaces	surface	NOUN
dpc-3843	46	15	[	[	X
dpc-3843	46	16	10	10	NUM
dpc-3843	46	17	,	,	PUNCT
dpc-3843	46	18	11	11	NUM
dpc-3843	46	19	]	]	PUNCT
dpc-3843	46	20	.	.	PUNCT
dpc-3843	47	1	the	the	DET
dpc-3843	47	2	expression	expression	NOUN
dpc-3843	47	3	of	of	ADP
dpc-3843	47	4	podxl	podxl	PROPN
dpc-3843	47	5	levels	level	NOUN
dpc-3843	47	6	in	in	ADP
dpc-3843	47	7	the	the	DET
dpc-3843	47	8	vascular	vascular	ADJ
dpc-3843	47	9	endothelium	endothelium	NOUN
dpc-3843	47	10	,	,	PUNCT
dpc-3843	47	11	mesothelial	mesothelial	ADJ
dpc-3843	47	12	cells	cell	NOUN
dpc-3843	47	13	and	and	CCONJ
dpc-3843	47	14	neurons	neuron	NOUN
dpc-3843	47	15	in	in	ADP
dpc-3843	47	16	addition	addition	NOUN
dpc-3843	47	17	to	to	ADP
dpc-3843	47	18	the	the	DET
dpc-3843	47	19	apical	apical	ADJ
dpc-3843	47	20	membranes	membrane	NOUN
dpc-3843	47	21	may	may	AUX
dpc-3843	47	22	help	help	VERB
dpc-3843	47	23	us	we	PRON
dpc-3843	47	24	to	to	PART
dpc-3843	47	25	explain	explain	VERB
dpc-3843	47	26	the	the	DET
dpc-3843	47	27	membrane	membrane	NOUN
dpc-3843	47	28	damage	damage	NOUN
dpc-3843	47	29	in	in	ADP
dpc-3843	47	30	the	the	DET
dpc-3843	47	31	dermis	dermis	NOUN
dpc-3843	47	32	-	-	PUNCT
dpc-3843	47	33	stratum	stratum	NOUN
dpc-3843	47	34	basale	basale	PROPN
dpc-3843	47	35	region	region	NOUN
dpc-3843	48	1	[	[	X
dpc-3843	48	2	12	12	NUM
dpc-3843	48	3	]	]	PUNCT
dpc-3843	48	4	.	.	PUNCT
dpc-3843	49	1	objectives	objective	VERB
dpc-3843	49	2	the	the	DET
dpc-3843	49	3	aim	aim	NOUN
dpc-3843	49	4	of	of	ADP
dpc-3843	49	5	this	this	DET
dpc-3843	49	6	study	study	NOUN
dpc-3843	49	7	was	be	AUX
dpc-3843	49	8	we	we	PRON
dpc-3843	49	9	tried	try	VERB
dpc-3843	49	10	to	to	PART
dpc-3843	49	11	determine	determine	VERB
dpc-3843	49	12	whether	whether	SCONJ
dpc-3843	49	13	there	there	PRON
dpc-3843	49	14	is	be	VERB
dpc-3843	49	15	a	a	DET
dpc-3843	49	16	defect	defect	NOUN
dpc-3843	49	17	in	in	ADP
dpc-3843	49	18	innate	innate	ADJ
dpc-3843	49	19	immunity	immunity	NOUN
dpc-3843	49	20	by	by	ADP
dpc-3843	49	21	measuring	measure	VERB
dpc-3843	49	22	serum	serum	NOUN
dpc-3843	49	23	chitinase	chitinase	NOUN
dpc-3843	49	24	1	1	NUM
dpc-3843	49	25	(	(	PUNCT
dpc-3843	49	26	chit-1	chit-1	PROPN
dpc-3843	49	27	)	)	PUNCT
dpc-3843	49	28	levels	level	NOUN
dpc-3843	49	29	.	.	PUNCT
dpc-3843	50	1	chit1	chit1	NOUN
dpc-3843	50	2	is	be	AUX
dpc-3843	50	3	a	a	DET
dpc-3843	50	4	member	member	NOUN
dpc-3843	50	5	of	of	ADP
dpc-3843	50	6	a	a	DET
dpc-3843	50	7	chitinase	chitinase	NOUN
dpc-3843	50	8	family	family	NOUN
dpc-3843	50	9	produced	produce	VERB
dpc-3843	50	10	and	and	CCONJ
dpc-3843	50	11	secreted	secrete	VERB
dpc-3843	50	12	by	by	ADP
dpc-3843	50	13	macrophages	macrophage	NOUN
dpc-3843	50	14	and	and	CCONJ
dpc-3843	50	15	neutrophils	neutrophil	NOUN
dpc-3843	50	16	and	and	CCONJ
dpc-3843	50	17	has	have	VERB
dpc-3843	50	18	a	a	DET
dpc-3843	50	19	critical	critical	ADJ
dpc-3843	50	20	role	role	NOUN
dpc-3843	50	21	in	in	ADP
dpc-3843	50	22	the	the	DET
dpc-3843	50	23	homeostasis	homeostasis	NOUN
dpc-3843	50	24	of	of	ADP
dpc-3843	50	25	innate	innate	ADJ
dpc-3843	50	26	immunity	immunity	NOUN
dpc-3843	50	27	[	[	X
dpc-3843	50	28	13	13	NUM
dpc-3843	50	29	]	]	PUNCT
dpc-3843	50	30	.	.	PUNCT
dpc-3843	51	1	its	its	PRON
dpc-3843	51	2	levels	level	NOUN
dpc-3843	51	3	increase	increase	VERB
dpc-3843	51	4	in	in	ADP
dpc-3843	51	5	autoimmune	autoimmune	ADJ
dpc-3843	51	6	reactions	reaction	NOUN
dpc-3843	51	7	and	and	CCONJ
dpc-3843	51	8	th2	th2	PROPN
dpc-3843	51	9	-	-	PUNCT
dpc-3843	51	10	mediated	mediate	VERB
dpc-3843	51	11	inflammation	inflammation	NOUN
dpc-3843	51	12	[	[	X
dpc-3843	51	13	14	14	NUM
dpc-3843	51	14	]	]	PUNCT
dpc-3843	51	15	.	.	PUNCT
dpc-3843	52	1	there	there	PRON
dpc-3843	52	2	is	be	VERB
dpc-3843	52	3	no	no	DET
dpc-3843	52	4	study	study	NOUN
dpc-3843	52	5	investigating	investigate	VERB
dpc-3843	52	6	serum	serum	NOUN
dpc-3843	52	7	podxl	podxl	NOUN
dpc-3843	52	8	,	,	PUNCT
dpc-3843	52	9	tumstatin	tumstatin	NOUN
dpc-3843	52	10	and	and	CCONJ
dpc-3843	52	11	chit-1	chit-1	NUM
dpc-3843	52	12	levels	level	NOUN
dpc-3843	52	13	in	in	ADP
dpc-3843	52	14	studies	study	NOUN
dpc-3843	52	15	on	on	ADP
dpc-3843	52	16	etiology	etiology	NOUN
dpc-3843	52	17	in	in	ADP
dpc-3843	52	18	vitiligo	vitiligo	NOUN
dpc-3843	52	19	patients	patient	NOUN
dpc-3843	52	20	.	.	PUNCT
dpc-3843	53	1	since	since	SCONJ
dpc-3843	53	2	vitiligo	vitiligo	PROPN
dpc-3843	53	3	is	be	AUX
dpc-3843	53	4	thought	think	VERB
dpc-3843	53	5	to	to	PART
dpc-3843	53	6	develop	develop	VERB
dpc-3843	53	7	at	at	ADP
dpc-3843	53	8	the	the	DET
dpc-3843	53	9	dermis	dermis	NOUN
dpc-3843	53	10	-	-	PUNCT
dpc-3843	53	11	stratum	stratum	NOUN
dpc-3843	53	12	basal	basal	VERB
dpc-3843	53	13	border	border	NOUN
dpc-3843	53	14	as	as	ADP
dpc-3843	53	15	a	a	DET
dpc-3843	53	16	result	result	NOUN
dpc-3843	53	17	of	of	ADP
dpc-3843	53	18	melanocyte	melanocyte	NOUN
dpc-3843	53	19	-	-	PUNCT
dpc-3843	53	20	keratinocyte	keratinocyte	NOUN
dpc-3843	53	21	separation	separation	NOUN
dpc-3843	53	22	due	due	ADP
dpc-3843	53	23	to	to	ADP
dpc-3843	53	24	endothelial	endothelial	ADJ
dpc-3843	53	25	damage	damage	NOUN
dpc-3843	53	26	and	and	CCONJ
dpc-3843	53	27	basement	basement	NOUN
dpc-3843	53	28	membrane	membrane	NOUN
dpc-3843	53	29	disruption	disruption	NOUN
dpc-3843	53	30	,	,	PUNCT
dpc-3843	53	31	podxl	podxl	PROPN
dpc-3843	53	32	,	,	PUNCT
dpc-3843	53	33	col	col	NOUN
dpc-3843	53	34	-	-	ADJ
dpc-3843	53	35	ivα3	ivα3	PROPN
dpc-3843	53	36	and	and	CCONJ
dpc-3843	53	37	1	1	NUM
dpc-3843	53	38	chit-1	chit-1	NUM
dpc-3843	53	39	protein	protein	NOUN
dpc-3843	53	40	analysis	analysis	NOUN
dpc-3843	53	41	was	be	AUX
dpc-3843	53	42	performed	perform	VERB
dpc-3843	53	43	to	to	PART
dpc-3843	53	44	represent	represent	VERB
dpc-3843	53	45	each	each	DET
dpc-3843	53	46	parameter	parameter	NOUN
dpc-3843	53	47	[	[	X
dpc-3843	53	48	3	3	NUM
dpc-3843	53	49	-	-	SYM
dpc-3843	53	50	6	6	NUM
dpc-3843	53	51	]	]	PUNCT
dpc-3843	53	52	.	.	PUNCT
dpc-3843	54	1	methods	method	NOUN
dpc-3843	54	2	this	this	DET
dpc-3843	54	3	case	case	NOUN
dpc-3843	54	4	-	-	PUNCT
dpc-3843	54	5	controlled	control	VERB
dpc-3843	54	6	study	study	NOUN
dpc-3843	54	7	was	be	AUX
dpc-3843	54	8	performed	perform	VERB
dpc-3843	54	9	on	on	ADP
dpc-3843	54	10	a	a	DET
dpc-3843	54	11	total	total	NOUN
dpc-3843	54	12	of	of	ADP
dpc-3843	54	13	50	50	NUM
dpc-3843	54	14	 	 	SPACE
dpc-3843	54	15	patients	patient	NOUN
dpc-3843	54	16	,	,	PUNCT
dpc-3843	54	17	25	25	NUM
dpc-3843	54	18	with	with	ADP
dpc-3843	54	19	vitiligo	vitiligo	NOUN
dpc-3843	54	20	and	and	CCONJ
dpc-3843	54	21	25	25	NUM
dpc-3843	54	22	healthy	healthy	ADJ
dpc-3843	54	23	controls	control	NOUN
dpc-3843	54	24	.	.	PUNCT
dpc-3843	55	1	participants	participant	NOUN
dpc-3843	55	2	in	in	ADP
dpc-3843	55	3	the	the	DET
dpc-3843	55	4	vitiligo	vitiligo	NOUN
dpc-3843	55	5	and	and	CCONJ
dpc-3843	55	6	control	control	NOUN
dpc-3843	55	7	groups	group	NOUN
dpc-3843	55	8	were	be	AUX
dpc-3843	55	9	matched	match	VERB
dpc-3843	55	10	in	in	ADP
dpc-3843	55	11	pairs	pair	NOUN
dpc-3843	55	12	for	for	ADP
dpc-3843	55	13	age	age	NOUN
dpc-3843	55	14	and	and	CCONJ
dpc-3843	55	15	sex	sex	NOUN
dpc-3843	55	16	.	.	PUNCT
dpc-3843	56	1	patients	patient	NOUN
dpc-3843	56	2	over	over	ADP
dpc-3843	56	3	45	45	NUM
dpc-3843	56	4	years	year	NOUN
dpc-3843	56	5	of	of	ADP
dpc-3843	56	6	age	age	NOUN
dpc-3843	56	7	were	be	AUX
dpc-3843	56	8	not	not	PART
dpc-3843	56	9	included	include	VERB
dpc-3843	56	10	in	in	ADP
dpc-3843	56	11	the	the	DET
dpc-3843	56	12	study	study	NOUN
dpc-3843	56	13	due	due	ADP
dpc-3843	56	14	to	to	ADP
dpc-3843	56	15	possible	possible	ADJ
dpc-3843	56	16	age	age	NOUN
dpc-3843	56	17	-	-	PUNCT
dpc-3843	56	18	related	relate	VERB
dpc-3843	56	19	changes	change	NOUN
dpc-3843	56	20	in	in	ADP
dpc-3843	56	21	the	the	DET
dpc-3843	56	22	dermis	dermis	NOUN
dpc-3843	56	23	vascular	vascular	ADJ
dpc-3843	56	24	endothelium	endothelium	NOUN
dpc-3843	56	25	.	.	PUNCT
dpc-3843	57	1	a	a	DET
dpc-3843	57	2	total	total	NOUN
dpc-3843	57	3	of	of	ADP
dpc-3843	57	4	25	25	NUM
dpc-3843	57	5	patients	patient	NOUN
dpc-3843	57	6	diagnosed	diagnose	VERB
dpc-3843	57	7	with	with	ADP
dpc-3843	57	8	nonsegmental	nonsegmental	NOUN
dpc-3843	57	9	vitiligo	vitiligo	NOUN
dpc-3843	57	10	(	(	PUNCT
dpc-3843	57	11	nsv	nsv	PROPN
dpc-3843	57	12	)	)	PUNCT
dpc-3843	57	13	or	or	CCONJ
dpc-3843	57	14	segmental	segmental	ADJ
dpc-3843	57	15	vitiligo	vitiligo	NOUN
dpc-3843	57	16	(	(	PUNCT
dpc-3843	57	17	sv	sv	NOUN
dpc-3843	57	18	)	)	PUNCT
dpc-3843	57	19	according	accord	VERB
dpc-3843	57	20	to	to	ADP
dpc-3843	57	21	the	the	DET
dpc-3843	57	22	2011	2011	NUM
dpc-3843	57	23	international	international	ADJ
dpc-3843	57	24	vitiligo	vitiligo	NOUN
dpc-3843	57	25	classification	classification	NOUN
dpc-3843	57	26	constituted	constitute	VERB
dpc-3843	57	27	the	the	DET
dpc-3843	57	28	study	study	NOUN
dpc-3843	57	29	group	group	NOUN
dpc-3843	57	30	[	[	X
dpc-3843	57	31	15	15	NUM
dpc-3843	57	32	]	]	PUNCT
dpc-3843	57	33	.	.	PUNCT
dpc-3843	58	1	mucosal	mucosal	ADJ
dpc-3843	58	2	,	,	PUNCT
dpc-3843	58	3	acrofacial	acrofacial	ADJ
dpc-3843	58	4	,	,	PUNCT
dpc-3843	58	5	generalized	generalize	VERB
dpc-3843	58	6	,	,	PUNCT
dpc-3843	58	7	universal	universal	ADJ
dpc-3843	58	8	and	and	CCONJ
dpc-3843	58	9	mixed	mixed	ADJ
dpc-3843	58	10	localized	localize	VERB
dpc-3843	58	11	forms	form	NOUN
dpc-3843	58	12	formed	form	VERB
dpc-3843	58	13	nsv	nsv	PROPN
dpc-3843	58	14	,	,	PUNCT
dpc-3843	58	15	while	while	SCONJ
dpc-3843	58	16	unisegmental	unisegmental	ADJ
dpc-3843	58	17	,	,	PUNCT
dpc-3843	58	18	bisegmental	bisegmental	ADJ
dpc-3843	58	19	or	or	CCONJ
dpc-3843	58	20	multisegmental	multisegmental	ADJ
dpc-3843	58	21	vitiligos	vitiligo	NOUN
dpc-3843	58	22	formed	form	VERB
dpc-3843	58	23	the	the	DET
dpc-3843	58	24	sv	sv	PROPN
dpc-3843	58	25	group	group	PROPN
dpc-3843	58	26	.	.	PUNCT
dpc-3843	59	1	the	the	DET
dpc-3843	59	2	control	control	NOUN
dpc-3843	59	3	group	group	NOUN
dpc-3843	59	4	was	be	AUX
dpc-3843	59	5	selected	select	VERB
dpc-3843	59	6	from	from	ADP
dpc-3843	59	7	25	25	NUM
dpc-3843	59	8	healthy	healthy	ADJ
dpc-3843	59	9	individuals	individual	NOUN
dpc-3843	59	10	without	without	ADP
dpc-3843	59	11	systemic	systemic	ADJ
dpc-3843	59	12	disease	disease	NOUN
dpc-3843	59	13	and	and	CCONJ
dpc-3843	59	14	depigmented	depigmented	ADJ
dpc-3843	59	15	skin	skin	NOUN
dpc-3843	59	16	lesions	lesion	NOUN
dpc-3843	59	17	.	.	PUNCT
dpc-3843	60	1	the	the	DET
dpc-3843	60	2	diagnosis	diagnosis	NOUN
dpc-3843	60	3	of	of	ADP
dpc-3843	60	4	vitiligo	vitiligo	NOUN
dpc-3843	60	5	was	be	AUX
dpc-3843	60	6	made	make	VERB
dpc-3843	60	7	by	by	ADP
dpc-3843	60	8	two	two	NUM
dpc-3843	60	9	experienced	experienced	ADJ
dpc-3843	60	10	dermatologists	dermatologist	NOUN
dpc-3843	60	11	based	base	VERB
dpc-3843	60	12	on	on	ADP
dpc-3843	60	13	the	the	DET
dpc-3843	60	14	typical	typical	ADJ
dpc-3843	60	15	clinical	clinical	ADJ
dpc-3843	60	16	appearance	appearance	NOUN
dpc-3843	60	17	of	of	ADP
dpc-3843	60	18	the	the	DET
dpc-3843	60	19	depigmented	depigmented	ADJ
dpc-3843	60	20	lesions	lesion	NOUN
dpc-3843	60	21	and	and	CCONJ
dpc-3843	60	22	the	the	DET
dpc-3843	60	23	images	image	NOUN
dpc-3843	60	24	obtained	obtain	VERB
dpc-3843	60	25	in	in	ADP
dpc-3843	60	26	the	the	DET
dpc-3843	60	27	wood	wood	NOUN
dpc-3843	60	28	‘s	‘s	NOUN
dpc-3843	60	29	lamp	lamp	PROPN
dpc-3843	60	30	examination	examination	NOUN
dpc-3843	60	31	.	.	PUNCT
dpc-3843	61	1	vitiligo	vitiligo	PROPN
dpc-3843	61	2	was	be	AUX
dpc-3843	61	3	diagnosed	diagnose	VERB
dpc-3843	61	4	in	in	ADP
dpc-3843	61	5	the	the	DET
dpc-3843	61	6	presence	presence	NOUN
dpc-3843	61	7	of	of	ADP
dpc-3843	61	8	an	an	DET
dpc-3843	61	9	amelatonic	amelatonic	ADJ
dpc-3843	61	10	,	,	PUNCT
dpc-3843	61	11	sharp	sharp	ADV
dpc-3843	61	12	-	-	PUNCT
dpc-3843	61	13	edged	edge	VERB
dpc-3843	61	14	and	and	CCONJ
dpc-3843	61	15	chalky	chalky	ADJ
dpc-3843	61	16	-	-	PUNCT
dpc-3843	61	17	white	white	ADJ
dpc-3843	61	18	macular	macular	ADJ
dpc-3843	61	19	lesion	lesion	NOUN
dpc-3843	61	20	.	.	PUNCT
dpc-3843	62	1	we	we	PRON
dpc-3843	62	2	strengthened	strengthen	VERB
dpc-3843	62	3	our	our	PRON
dpc-3843	62	4	diagnosis	diagnosis	NOUN
dpc-3843	62	5	in	in	ADP
dpc-3843	62	6	the	the	DET
dpc-3843	62	7	presence	presence	NOUN
dpc-3843	62	8	of	of	ADP
dpc-3843	62	9	a	a	DET
dpc-3843	62	10	sharply	sharply	ADV
dpc-3843	62	11	demarcated	demarcate	VERB
dpc-3843	62	12	,	,	PUNCT
dpc-3843	62	13	bright	bright	ADJ
dpc-3843	62	14	blue	blue	ADJ
dpc-3843	62	15	-	-	PUNCT
dpc-3843	62	16	white	white	ADJ
dpc-3843	62	17	fluorescent	fluorescent	ADJ
dpc-3843	62	18	lesion	lesion	NOUN
dpc-3843	62	19	on	on	ADP
dpc-3843	62	20	wood	wood	NOUN
dpc-3843	62	21	’s	’s	PART
dpc-3843	62	22	light	light	ADJ
dpc-3843	62	23	original	original	ADJ
dpc-3843	62	24	article	article	NOUN
dpc-3843	62	25	|	|	ADV
dpc-3843	62	26	dermatol	dermatol	ADJ
dpc-3843	62	27	pract	pract	NOUN
dpc-3843	62	28	concept	concept	NOUN
dpc-3843	62	29	.	.	PUNCT
dpc-3843	63	1	2024;14(1):e2024095	2024;14(1):e2024095	NUM
dpc-3843	63	2	3	3	NUM
dpc-3843	63	3	examination	examination	NOUN
dpc-3843	63	4	.	.	PUNCT
dpc-3843	64	1	since	since	SCONJ
dpc-3843	64	2	no	no	DET
dpc-3843	64	3	biopsy	biopsy	NOUN
dpc-3843	64	4	or	or	CCONJ
dpc-3843	64	5	laboratory	laboratory	NOUN
dpc-3843	64	6	test	test	NOUN
dpc-3843	64	7	was	be	AUX
dpc-3843	64	8	required	require	VERB
dpc-3843	64	9	for	for	ADP
dpc-3843	64	10	the	the	DET
dpc-3843	64	11	diagnosis	diagnosis	NOUN
dpc-3843	64	12	of	of	ADP
dpc-3843	64	13	vitiligo	vitiligo	NOUN
dpc-3843	64	14	,	,	PUNCT
dpc-3843	64	15	these	these	DET
dpc-3843	64	16	procedures	procedure	NOUN
dpc-3843	64	17	were	be	AUX
dpc-3843	64	18	not	not	PART
dpc-3843	64	19	performed	perform	VERB
dpc-3843	64	20	.	.	PUNCT
dpc-3843	65	1	all	all	DET
dpc-3843	65	2	applications	application	NOUN
dpc-3843	65	3	in	in	ADP
dpc-3843	65	4	the	the	DET
dpc-3843	65	5	study	study	NOUN
dpc-3843	65	6	were	be	AUX
dpc-3843	65	7	carried	carry	VERB
dpc-3843	65	8	out	out	ADP
dpc-3843	65	9	in	in	ADP
dpc-3843	65	10	accordance	accordance	NOUN
dpc-3843	65	11	with	with	ADP
dpc-3843	65	12	the	the	DET
dpc-3843	65	13	principles	principle	NOUN
dpc-3843	65	14	of	of	ADP
dpc-3843	65	15	the	the	DET
dpc-3843	65	16	declaration	declaration	NOUN
dpc-3843	65	17	of	of	ADP
dpc-3843	65	18	helsinki	helsinki	PROPN
dpc-3843	65	19	.	.	PUNCT
dpc-3843	66	1	the	the	DET
dpc-3843	66	2	study	study	NOUN
dpc-3843	66	3	was	be	AUX
dpc-3843	66	4	initiated	initiate	VERB
dpc-3843	66	5	after	after	SCONJ
dpc-3843	66	6	the	the	DET
dpc-3843	66	7	protocol	protocol	NOUN
dpc-3843	66	8	was	be	AUX
dpc-3843	66	9	approved	approve	VERB
dpc-3843	66	10	by	by	ADP
dpc-3843	66	11	the	the	DET
dpc-3843	66	12	malatya	malatya	PROPN
dpc-3843	66	13	turgut	turgut	PROPN
dpc-3843	66	14	özal	özal	VERB
dpc-3843	66	15	universty	universty	PROPN
dpc-3843	66	16	ethics	ethic	NOUN
dpc-3843	66	17	review	review	PROPN
dpc-3843	66	18	board	board	NOUN
dpc-3843	66	19	and	and	CCONJ
dpc-3843	66	20	patient	patient	ADJ
dpc-3843	66	21	consent	consent	NOUN
dpc-3843	66	22	was	be	AUX
dpc-3843	66	23	obtained	obtain	VERB
dpc-3843	66	24	.	.	PUNCT
dpc-3843	67	1	due	due	ADP
dpc-3843	67	2	to	to	ADP
dpc-3843	67	3	the	the	DET
dpc-3843	67	4	close	close	ADJ
dpc-3843	67	5	relationship	relationship	NOUN
dpc-3843	67	6	between	between	ADP
dpc-3843	67	7	vitiligo	vitiligo	NOUN
dpc-3843	67	8	and	and	CCONJ
dpc-3843	67	9	other	other	ADJ
dpc-3843	67	10	autoimmune	autoimmune	ADJ
dpc-3843	67	11	diseases	disease	NOUN
dpc-3843	67	12	,	,	PUNCT
dpc-3843	67	13	patients	patient	NOUN
dpc-3843	67	14	diagnosed	diagnose	VERB
dpc-3843	67	15	with	with	ADP
dpc-3843	67	16	hashimoto	hashimoto	NOUN
dpc-3843	67	17	thyroiditis	thyroiditis	NOUN
dpc-3843	67	18	,	,	PUNCT
dpc-3843	67	19	addison	addison	PROPN
dpc-3843	67	20	disease	disease	NOUN
dpc-3843	67	21	,	,	PUNCT
dpc-3843	67	22	psoriasis	psoriasis	NOUN
dpc-3843	67	23	,	,	PUNCT
dpc-3843	67	24	diabetes	diabetes	NOUN
dpc-3843	67	25	mellitus	mellitus	NOUN
dpc-3843	67	26	,	,	PUNCT
dpc-3843	67	27	systemic	systemic	ADJ
dpc-3843	67	28	lupus	lupus	NOUN
dpc-3843	67	29	erythematosus	erythematosus	NOUN
dpc-3843	67	30	or	or	CCONJ
dpc-3843	67	31	melanoma	melanoma	NOUN
dpc-3843	67	32	-	-	PUNCT
dpc-3843	67	33	associated	associate	VERB
dpc-3843	67	34	leucoderma	leucoderma	NOUN
dpc-3843	67	35	and	and	CCONJ
dpc-3843	67	36	those	those	PRON
dpc-3843	67	37	with	with	ADP
dpc-3843	67	38	other	other	ADJ
dpc-3843	67	39	endocrinopathy	endocrinopathy	ADJ
dpc-3843	67	40	were	be	AUX
dpc-3843	67	41	excluded	exclude	VERB
dpc-3843	67	42	from	from	ADP
dpc-3843	67	43	the	the	DET
dpc-3843	67	44	study	study	NOUN
dpc-3843	67	45	.	.	PUNCT
dpc-3843	68	1	patients	patient	NOUN
dpc-3843	68	2	with	with	ADP
dpc-3843	68	3	a	a	DET
dpc-3843	68	4	history	history	NOUN
dpc-3843	68	5	of	of	ADP
dpc-3843	68	6	systemic	systemic	ADJ
dpc-3843	68	7	or	or	CCONJ
dpc-3843	68	8	topical	topical	ADJ
dpc-3843	68	9	drug	drug	NOUN
dpc-3843	68	10	-	-	PUNCT
dpc-3843	68	11	induced	induce	VERB
dpc-3843	68	12	depigmentation	depigmentation	NOUN
dpc-3843	68	13	were	be	AUX
dpc-3843	68	14	also	also	ADV
dpc-3843	68	15	excluded	exclude	VERB
dpc-3843	68	16	from	from	ADP
dpc-3843	68	17	the	the	DET
dpc-3843	68	18	study	study	NOUN
dpc-3843	68	19	.	.	PUNCT
dpc-3843	69	1	patients	patient	NOUN
dpc-3843	69	2	who	who	PRON
dpc-3843	69	3	were	be	AUX
dpc-3843	69	4	pregnant	pregnant	ADJ
dpc-3843	69	5	or	or	CCONJ
dpc-3843	69	6	lactating	lactate	VERB
dpc-3843	69	7	,	,	PUNCT
dpc-3843	69	8	those	those	PRON
dpc-3843	69	9	who	who	PRON
dpc-3843	69	10	had	have	VERB
dpc-3843	69	11	acute	acute	ADJ
dpc-3843	69	12	viral	viral	ADJ
dpc-3843	69	13	or	or	CCONJ
dpc-3843	69	14	bacterial	bacterial	ADJ
dpc-3843	69	15	infections	infection	NOUN
dpc-3843	69	16	and	and	CCONJ
dpc-3843	69	17	those	those	PRON
dpc-3843	69	18	who	who	PRON
dpc-3843	69	19	had	have	VERB
dpc-3843	69	20	an	an	DET
dpc-3843	69	21	additional	additional	ADJ
dpc-3843	69	22	dermatological	dermatological	ADJ
dpc-3843	69	23	disease	disease	NOUN
dpc-3843	69	24	were	be	AUX
dpc-3843	69	25	not	not	PART
dpc-3843	69	26	included	include	VERB
dpc-3843	69	27	in	in	ADP
dpc-3843	69	28	the	the	DET
dpc-3843	69	29	study	study	NOUN
dpc-3843	69	30	.	.	PUNCT
dpc-3843	70	1	cases	case	NOUN
dpc-3843	70	2	with	with	ADP
dpc-3843	70	3	a	a	DET
dpc-3843	70	4	family	family	NOUN
dpc-3843	70	5	history	history	NOUN
dpc-3843	70	6	of	of	ADP
dpc-3843	70	7	depigmented	depigmented	ADJ
dpc-3843	70	8	skin	skin	NOUN
dpc-3843	70	9	lesions	lesion	NOUN
dpc-3843	70	10	and	and	CCONJ
dpc-3843	70	11	a	a	DET
dpc-3843	70	12	tendency	tendency	NOUN
dpc-3843	70	13	to	to	ADP
dpc-3843	70	14	depigmentation	depigmentation	NOUN
dpc-3843	70	15	due	due	ADP
dpc-3843	70	16	to	to	ADP
dpc-3843	70	17	topical	topical	ADJ
dpc-3843	70	18	or	or	CCONJ
dpc-3843	70	19	systemic	systemic	ADJ
dpc-3843	70	20	drug	drug	NOUN
dpc-3843	70	21	application	application	NOUN
dpc-3843	70	22	were	be	AUX
dpc-3843	70	23	not	not	PART
dpc-3843	70	24	included	include	VERB
dpc-3843	70	25	in	in	ADP
dpc-3843	70	26	the	the	DET
dpc-3843	70	27	control	control	NOUN
dpc-3843	70	28	group	group	NOUN
dpc-3843	70	29	.	.	PUNCT
dpc-3843	71	1	similarly	similarly	ADV
dpc-3843	71	2	,	,	PUNCT
dpc-3843	71	3	those	those	PRON
dpc-3843	71	4	with	with	ADP
dpc-3843	71	5	a	a	DET
dpc-3843	71	6	history	history	NOUN
dpc-3843	71	7	of	of	ADP
dpc-3843	71	8	autoimmune	autoimmune	ADJ
dpc-3843	71	9	and	and	CCONJ
dpc-3843	71	10	endocrine	endocrine	NOUN
dpc-3843	71	11	diseases	disease	NOUN
dpc-3843	71	12	were	be	AUX
dpc-3843	71	13	not	not	PART
dpc-3843	71	14	included	include	VERB
dpc-3843	71	15	in	in	ADP
dpc-3843	71	16	the	the	DET
dpc-3843	71	17	control	control	NOUN
dpc-3843	71	18	group	group	NOUN
dpc-3843	71	19	.	.	PUNCT
dpc-3843	72	1	age	age	NOUN
dpc-3843	72	2	,	,	PUNCT
dpc-3843	72	3	gender	gender	NOUN
dpc-3843	72	4	,	,	PUNCT
dpc-3843	72	5	medical	medical	ADJ
dpc-3843	72	6	history	history	NOUN
dpc-3843	72	7	,	,	PUNCT
dpc-3843	72	8	family	family	NOUN
dpc-3843	72	9	history	history	NOUN
dpc-3843	72	10	and	and	CCONJ
dpc-3843	72	11	body	body	NOUN
dpc-3843	72	12	mass	mass	NOUN
dpc-3843	72	13	index	index	NOUN
dpc-3843	72	14	(	(	PUNCT
dpc-3843	72	15	bmi	bmi	PROPN
dpc-3843	72	16	)	)	PUNCT
dpc-3843	72	17	of	of	ADP
dpc-3843	72	18	the	the	DET
dpc-3843	72	19	participants	participant	NOUN
dpc-3843	72	20	in	in	ADP
dpc-3843	72	21	both	both	DET
dpc-3843	72	22	groups	group	NOUN
dpc-3843	72	23	were	be	AUX
dpc-3843	72	24	recorded	record	VERB
dpc-3843	72	25	.	.	PUNCT
dpc-3843	73	1	in	in	ADP
dpc-3843	73	2	the	the	DET
dpc-3843	73	3	classification	classification	NOUN
dpc-3843	73	4	made	make	VERB
dpc-3843	73	5	according	accord	VERB
dpc-3843	73	6	to	to	ADP
dpc-3843	73	7	the	the	DET
dpc-3843	73	8	vitiligo	vitiligo	ADJ
dpc-3843	73	9	european	european	PROPN
dpc-3843	73	10	task	task	PROPN
dpc-3843	73	11	force	force	PROPN
dpc-3843	73	12	evaluation	evaluation	NOUN
dpc-3843	73	13	criteria	criterion	NOUN
dpc-3843	73	14	,	,	PUNCT
dpc-3843	73	15	18	18	NUM
dpc-3843	73	16	of	of	ADP
dpc-3843	73	17	25	25	NUM
dpc-3843	73	18	vitiligo	vitiligo	NOUN
dpc-3843	73	19	patients	patient	NOUN
dpc-3843	73	20	were	be	AUX
dpc-3843	73	21	in	in	ADP
dpc-3843	73	22	the	the	DET
dpc-3843	73	23	slowly	slowly	ADV
dpc-3843	73	24	progressive	progressive	ADJ
dpc-3843	73	25	phase	phase	NOUN
dpc-3843	73	26	and	and	CCONJ
dpc-3843	73	27	7	7	NUM
dpc-3843	73	28	patients	patient	NOUN
dpc-3843	73	29	were	be	AUX
dpc-3843	73	30	in	in	ADP
dpc-3843	73	31	the	the	DET
dpc-3843	73	32	active	active	ADJ
dpc-3843	73	33	progressive	progressive	ADJ
dpc-3843	73	34	phase	phase	NOUN
dpc-3843	73	35	.	.	PUNCT
dpc-3843	74	1	after	after	ADP
dpc-3843	74	2	at	at	ADV
dpc-3843	74	3	least	least	ADV
dpc-3843	74	4	8	8	NUM
dpc-3843	74	5	-	-	SYM
dpc-3843	74	6	10	10	NUM
dpc-3843	74	7	hours	hour	NOUN
dpc-3843	74	8	of	of	ADP
dpc-3843	74	9	overnight	overnight	ADJ
dpc-3843	74	10	fasting	fasting	NOUN
dpc-3843	74	11	,	,	PUNCT
dpc-3843	74	12	venous	venous	ADJ
dpc-3843	74	13	blood	blood	NOUN
dpc-3843	74	14	samples	sample	NOUN
dpc-3843	74	15	were	be	AUX
dpc-3843	74	16	taken	take	VERB
dpc-3843	74	17	from	from	ADP
dpc-3843	74	18	the	the	DET
dpc-3843	74	19	participants	participant	NOUN
dpc-3843	74	20	in	in	ADP
dpc-3843	74	21	both	both	DET
dpc-3843	74	22	groups	group	NOUN
dpc-3843	74	23	and	and	CCONJ
dpc-3843	74	24	stored	store	VERB
dpc-3843	74	25	at	at	ADP
dpc-3843	74	26	20	20	NUM
dpc-3843	74	27	◦	◦	NOUN
dpc-3843	74	28	c	c	NOUN
dpc-3843	74	29	until	until	ADP
dpc-3843	74	30	analysis	analysis	NOUN
dpc-3843	74	31	.	.	PUNCT
dpc-3843	75	1	blood	blood	NOUN
dpc-3843	75	2	samples	sample	NOUN
dpc-3843	75	3	were	be	AUX
dpc-3843	75	4	collected	collect	VERB
dpc-3843	75	5	on	on	ADP
dpc-3843	75	6	the	the	DET
dpc-3843	75	7	third	third	ADJ
dpc-3843	75	8	day	day	NOUN
dpc-3843	75	9	of	of	ADP
dpc-3843	75	10	the	the	DET
dpc-3843	75	11	menstrual	menstrual	ADJ
dpc-3843	75	12	cycle	cycle	NOUN
dpc-3843	75	13	in	in	ADP
dpc-3843	75	14	female	female	ADJ
dpc-3843	75	15	participants	participant	NOUN
dpc-3843	75	16	of	of	ADP
dpc-3843	75	17	reproductive	reproductive	ADJ
dpc-3843	75	18	age	age	NOUN
dpc-3843	75	19	.	.	PUNCT
dpc-3843	76	1	measurement	measurement	NOUN
dpc-3843	76	2	of	of	ADP
dpc-3843	76	3	serum	serum	NOUN
dpc-3843	76	4	podocalyxin	podocalyxin	NOUN
dpc-3843	76	5	,	,	PUNCT
dpc-3843	76	6	collagen	collagen	NOUN
dpc-3843	76	7	type	type	NOUN
dpc-3843	76	8	iv	iv	NUM
dpc-3843	76	9	alpha	alpha	NOUN
dpc-3843	76	10	3	3	NUM
dpc-3843	76	11	and	and	CCONJ
dpc-3843	76	12	chit	chit	NOUN
dpc-3843	76	13	1	1	NUM
dpc-3843	76	14	levels	level	NOUN
dpc-3843	76	15	by	by	ADP
dpc-3843	76	16	sandwich	sandwich	NOUN
dpc-3843	76	17	enzyme	enzyme	NOUN
dpc-3843	76	18	immunoassay	immunoassay	ADJ
dpc-3843	76	19	podocalyxin	podocalyxin	NOUN
dpc-3843	76	20	,	,	PUNCT
dpc-3843	76	21	collagen	collagen	NOUN
dpc-3843	76	22	type	type	NOUN
dpc-3843	76	23	iv	iv	NUM
dpc-3843	76	24	alpha	alpha	NOUN
dpc-3843	76	25	3	3	NUM
dpc-3843	76	26	and	and	CCONJ
dpc-3843	76	27	chit	chit	NOUN
dpc-3843	76	28	1	1	NUM
dpc-3843	76	29	levels	level	NOUN
dpc-3843	76	30	were	be	AUX
dpc-3843	76	31	measured	measure	VERB
dpc-3843	76	32	in	in	ADP
dpc-3843	76	33	frozen	freeze	VERB
dpc-3843	76	34	-	-	PUNCT
dpc-3843	76	35	thawed	thaw	VERB
dpc-3843	76	36	serum	serum	NOUN
dpc-3843	76	37	samples	sample	NOUN
dpc-3843	76	38	using	use	VERB
dpc-3843	76	39	the	the	DET
dpc-3843	76	40	quantitative	quantitative	ADJ
dpc-3843	76	41	sandwich	sandwich	NOUN
dpc-3843	76	42	enzyme	enzyme	NOUN
dpc-3843	76	43	immunoassay	immunoassay	ADJ
dpc-3843	76	44	principle	principle	NOUN
dpc-3843	76	45	.	.	PUNCT
dpc-3843	77	1	commercially	commercially	ADV
dpc-3843	77	2	available	available	ADJ
dpc-3843	77	3	human	human	ADJ
dpc-3843	77	4	podocalyxin	podocalyxin	NOUN
dpc-3843	77	5	elisa	elisa	PROPN
dpc-3843	77	6	kit	kit	NOUN
dpc-3843	77	7	(	(	PUNCT
dpc-3843	77	8	sunred	sunre	VERB
dpc-3843	77	9	biotechnology	biotechnology	NOUN
dpc-3843	77	10	company	company	NOUN
dpc-3843	77	11	,	,	PUNCT
dpc-3843	77	12	shanghai	shanghai	PROPN
dpc-3843	77	13	,	,	PUNCT
dpc-3843	77	14	china	china	PROPN
dpc-3843	77	15	)	)	PUNCT
dpc-3843	77	16	,	,	PUNCT
dpc-3843	77	17	collagen	collagen	NOUN
dpc-3843	77	18	type	type	NOUN
dpc-3843	77	19	iv	iv	NUM
dpc-3843	77	20	alpha	alpha	NOUN
dpc-3843	77	21	3	3	NUM
dpc-3843	77	22	kit	kit	NOUN
dpc-3843	77	23	(	(	PUNCT
dpc-3843	77	24	bioassay	bioassay	NOUN
dpc-3843	77	25	technology	technology	PROPN
dpc-3843	77	26	laboratory	laboratory	PROPN
dpc-3843	77	27	,	,	PUNCT
dpc-3843	77	28	shanghai	shanghai	PROPN
dpc-3843	77	29	,	,	PUNCT
dpc-3843	77	30	china	china	PROPN
dpc-3843	77	31	)	)	PUNCT
dpc-3843	77	32	and	and	CCONJ
dpc-3843	77	33	human	human	ADJ
dpc-3843	77	34	chit	chit	NOUN
dpc-3843	77	35	1	1	NUM
dpc-3843	77	36	elisa	elisa	NOUN
dpc-3843	77	37	kits	kit	NOUN
dpc-3843	77	38	(	(	PUNCT
dpc-3843	77	39	sunred	sunre	VERB
dpc-3843	77	40	biotechnology	biotechnology	NOUN
dpc-3843	77	41	company	company	NOUN
dpc-3843	77	42	,	,	PUNCT
dpc-3843	77	43	shanghai	shanghai	PROPN
dpc-3843	77	44	,	,	PUNCT
dpc-3843	77	45	china	china	PROPN
dpc-3843	77	46	)	)	PUNCT
dpc-3843	77	47	were	be	AUX
dpc-3843	77	48	used	use	VERB
dpc-3843	77	49	for	for	ADP
dpc-3843	77	50	the	the	DET
dpc-3843	77	51	measurements	measurement	NOUN
dpc-3843	77	52	.	.	PUNCT
dpc-3843	78	1	measurements	measurement	NOUN
dpc-3843	78	2	were	be	AUX
dpc-3843	78	3	made	make	VERB
dpc-3843	78	4	in	in	ADP
dpc-3843	78	5	accordance	accordance	NOUN
dpc-3843	78	6	with	with	ADP
dpc-3843	78	7	the	the	DET
dpc-3843	78	8	procedures	procedure	NOUN
dpc-3843	78	9	specified	specify	VERB
dpc-3843	78	10	in	in	ADP
dpc-3843	78	11	the	the	DET
dpc-3843	78	12	catalogues	catalogue	NOUN
dpc-3843	78	13	.	.	PUNCT
dpc-3843	79	1	the	the	DET
dpc-3843	79	2	absorbance	absorbance	NOUN
dpc-3843	79	3	of	of	ADP
dpc-3843	79	4	each	each	DET
dpc-3843	79	5	sample	sample	NOUN
dpc-3843	79	6	was	be	AUX
dpc-3843	79	7	measured	measure	VERB
dpc-3843	79	8	on	on	ADP
dpc-3843	79	9	the	the	DET
dpc-3843	79	10	bio	bio	PROPN
dpc-3843	79	11	-	-	PUNCT
dpc-3843	79	12	tek	tek	PROPN
dpc-3843	79	13	elx800	elx800	PROPN
dpc-3843	79	14	device	device	NOUN
dpc-3843	79	15	at	at	ADP
dpc-3843	79	16	a	a	DET
dpc-3843	79	17	wavelength	wavelength	NOUN
dpc-3843	79	18	of	of	ADP
dpc-3843	79	19	450	450	NUM
dpc-3843	79	20	nanometers	nanometer	NOUN
dpc-3843	79	21	.	.	PUNCT
dpc-3843	80	1	concentrations	concentration	NOUN
dpc-3843	80	2	of	of	ADP
dpc-3843	80	3	absorbances	absorbance	NOUN
dpc-3843	80	4	were	be	AUX
dpc-3843	80	5	calculated	calculate	VERB
dpc-3843	80	6	with	with	ADP
dpc-3843	80	7	the	the	DET
dpc-3843	80	8	formula	formula	NOUN
dpc-3843	80	9	obtained	obtain	VERB
dpc-3843	80	10	using	use	VERB
dpc-3843	80	11	the	the	DET
dpc-3843	80	12	standard	standard	ADJ
dpc-3843	80	13	curve	curve	NOUN
dpc-3843	80	14	graph	graph	NOUN
dpc-3843	80	15	.	.	PUNCT
dpc-3843	81	1	the	the	DET
dpc-3843	81	2	measuring	measure	VERB
dpc-3843	81	3	range	range	NOUN
dpc-3843	81	4	of	of	ADP
dpc-3843	81	5	the	the	DET
dpc-3843	81	6	podocalyxin	podocalyxin	NOUN
dpc-3843	81	7	kit	kit	NOUN
dpc-3843	81	8	was	be	AUX
dpc-3843	81	9	0.2–60	0.2–60	NOUN
dpc-3843	81	10	  	  	SPACE
dpc-3843	81	11	ng	ng	PROPN
dpc-3843	81	12	/	/	SYM
dpc-3843	81	13	ml	ml	PROPN
dpc-3843	81	14	,	,	PUNCT
dpc-3843	81	15	and	and	CCONJ
dpc-3843	81	16	the	the	DET
dpc-3843	81	17	minimum	minimum	ADJ
dpc-3843	81	18	measurable	measurable	ADJ
dpc-3843	81	19	level	level	NOUN
dpc-3843	81	20	was	be	AUX
dpc-3843	81	21	0.153	0.153	NUM
dpc-3843	81	22	ng	ng	PROPN
dpc-3843	81	23	/	/	SYM
dpc-3843	81	24	ml	ml	PROPN
dpc-3843	81	25	.	.	PUNCT
dpc-3843	82	1	the	the	DET
dpc-3843	82	2	measuring	measure	VERB
dpc-3843	82	3	range	range	NOUN
dpc-3843	82	4	of	of	ADP
dpc-3843	82	5	the	the	DET
dpc-3843	82	6	collagen	collagen	NOUN
dpc-3843	82	7	type	type	NOUN
dpc-3843	82	8	iv	iv	NUM
dpc-3843	82	9	alpha	alpha	NOUN
dpc-3843	82	10	3	3	NUM
dpc-3843	82	11	kit	kit	NOUN
dpc-3843	82	12	was	be	AUX
dpc-3843	82	13	0.2–70	0.2–70	PROPN
dpc-3843	82	14	ng	ng	PROPN
dpc-3843	82	15	/	/	SYM
dpc-3843	82	16	ml	ml	PROPN
dpc-3843	82	17	,	,	PUNCT
dpc-3843	82	18	and	and	CCONJ
dpc-3843	82	19	the	the	DET
dpc-3843	82	20	minimum	minimum	ADJ
dpc-3843	82	21	measurable	measurable	ADJ
dpc-3843	82	22	level	level	NOUN
dpc-3843	82	23	was	be	AUX
dpc-3843	82	24	0.12	0.12	NUM
dpc-3843	82	25	ng	ng	PROPN
dpc-3843	82	26	/	/	SYM
dpc-3843	82	27	ml	ml	PROPN
dpc-3843	82	28	.	.	PUNCT
dpc-3843	83	1	the	the	DET
dpc-3843	83	2	measurement	measurement	NOUN
dpc-3843	83	3	range	range	NOUN
dpc-3843	83	4	of	of	ADP
dpc-3843	83	5	the	the	DET
dpc-3843	83	6	chit	chit	NOUN
dpc-3843	83	7	1	1	NUM
dpc-3843	83	8	kit	kit	NOUN
dpc-3843	83	9	was	be	AUX
dpc-3843	83	10	0.5–120	0.5–120	PROPN
dpc-3843	83	11	ng	ng	PROPN
dpc-3843	83	12	/	/	SYM
dpc-3843	83	13	ml	ml	PROPN
dpc-3843	83	14	,	,	PUNCT
dpc-3843	83	15	and	and	CCONJ
dpc-3843	83	16	the	the	DET
dpc-3843	83	17	minimum	minimum	ADJ
dpc-3843	83	18	measurable	measurable	ADJ
dpc-3843	83	19	level	level	NOUN
dpc-3843	83	20	(	(	PUNCT
dpc-3843	83	21	sensitivity	sensitivity	NOUN
dpc-3843	83	22	)	)	PUNCT
dpc-3843	83	23	was	be	AUX
dpc-3843	83	24	0.433	0.433	NUM
dpc-3843	83	25	ng	ng	PROPN
dpc-3843	83	26	/	/	SYM
dpc-3843	83	27	ml	ml	NOUN
dpc-3843	83	28	.	.	PUNCT
dpc-3843	84	1	statistical	statistical	ADJ
dpc-3843	84	2	analysis	analysis	NOUN
dpc-3843	84	3	all	all	DET
dpc-3843	84	4	analyses	analysis	NOUN
dpc-3843	84	5	were	be	AUX
dpc-3843	84	6	performed	perform	VERB
dpc-3843	84	7	on	on	ADP
dpc-3843	84	8	ibm	ibm	PROPN
dpc-3843	84	9	spss	spss	PROPN
dpc-3843	84	10	statistics	statistic	NOUN
dpc-3843	84	11	for	for	ADP
dpc-3843	84	12	windows	window	NOUN
dpc-3843	84	13	,	,	PUNCT
dpc-3843	84	14	version	version	NOUN
dpc-3843	84	15	21.0	21.0	NUM
dpc-3843	84	16	(	(	PUNCT
dpc-3843	84	17	ibm	ibm	PROPN
dpc-3843	84	18	corp	corp	PROPN
dpc-3843	84	19	.	.	PROPN
dpc-3843	84	20	,	,	PUNCT
dpc-3843	84	21	armonk	armonk	PROPN
dpc-3843	84	22	,	,	PUNCT
dpc-3843	84	23	ny	ny	PROPN
dpc-3843	84	24	,	,	PUNCT
dpc-3843	84	25	usa	usa	PROPN
dpc-3843	84	26	)	)	PUNCT
dpc-3843	84	27	.	.	PUNCT
dpc-3843	85	1	for	for	ADP
dpc-3843	85	2	the	the	DET
dpc-3843	85	3	normality	normality	NOUN
dpc-3843	85	4	check	check	NOUN
dpc-3843	85	5	,	,	PUNCT
dpc-3843	85	6	the	the	DET
dpc-3843	85	7	shapiro	shapiro	PROPN
dpc-3843	85	8	-	-	PUNCT
dpc-3843	85	9	wilk	wilk	NOUN
dpc-3843	85	10	test	test	NOUN
dpc-3843	85	11	was	be	AUX
dpc-3843	85	12	used	use	VERB
dpc-3843	85	13	.	.	PUNCT
dpc-3843	86	1	data	datum	NOUN
dpc-3843	86	2	are	be	AUX
dpc-3843	86	3	given	give	VERB
dpc-3843	86	4	as	as	ADP
dpc-3843	86	5	mean	mean	PROPN
dpc-3843	86	6	±	±	NUM
dpc-3843	86	7	standard	standard	ADJ
dpc-3843	86	8	deviation	deviation	NOUN
dpc-3843	86	9	for	for	ADP
dpc-3843	86	10	continuous	continuous	ADJ
dpc-3843	86	11	variables	variable	NOUN
dpc-3843	86	12	according	accord	VERB
dpc-3843	86	13	to	to	ADP
dpc-3843	86	14	normality	normality	NOUN
dpc-3843	86	15	of	of	ADP
dpc-3843	86	16	distribution	distribution	NOUN
dpc-3843	86	17	and	and	CCONJ
dpc-3843	86	18	as	as	ADP
dpc-3843	86	19	frequency	frequency	NOUN
dpc-3843	86	20	(	(	PUNCT
dpc-3843	86	21	percentage	percentage	NOUN
dpc-3843	86	22	)	)	PUNCT
dpc-3843	86	23	for	for	ADP
dpc-3843	86	24	categorical	categorical	ADJ
dpc-3843	86	25	variables	variable	NOUN
dpc-3843	86	26	.	.	PUNCT
dpc-3843	87	1	continuous	continuous	ADJ
dpc-3843	87	2	variables	variable	NOUN
dpc-3843	87	3	were	be	AUX
dpc-3843	87	4	analyzed	analyze	VERB
dpc-3843	87	5	with	with	ADP
dpc-3843	87	6	the	the	DET
dpc-3843	87	7	independent	independent	ADJ
dpc-3843	87	8	samples	sample	NOUN
dpc-3843	87	9	t	t	NOUN
dpc-3843	87	10	test	test	NOUN
dpc-3843	87	11	or	or	CCONJ
dpc-3843	87	12	mann	mann	PROPN
dpc-3843	87	13	whitney	whitney	PROPN
dpc-3843	87	14	u	u	PROPN
dpc-3843	87	15	test	test	NOUN
dpc-3843	87	16	.	.	PUNCT
dpc-3843	88	1	categorical	categorical	ADJ
dpc-3843	88	2	variables	variable	NOUN
dpc-3843	88	3	were	be	AUX
dpc-3843	88	4	analyzed	analyze	VERB
dpc-3843	88	5	with	with	ADP
dpc-3843	88	6	the	the	DET
dpc-3843	88	7	chi	chi	ADJ
dpc-3843	88	8	-	-	PUNCT
dpc-3843	88	9	square	square	NOUN
dpc-3843	88	10	test	test	NOUN
dpc-3843	88	11	or	or	CCONJ
dpc-3843	88	12	fisher	fisher	PROPN
dpc-3843	88	13	’s	’s	PART
dpc-3843	88	14	exact	exact	ADJ
dpc-3843	88	15	test	test	NOUN
dpc-3843	88	16	.	.	PUNCT
dpc-3843	89	1	pearson	pearson	PROPN
dpc-3843	89	2	,	,	PUNCT
dpc-3843	89	3	spearman	spearman	NOUN
dpc-3843	89	4	correlation	correlation	NOUN
dpc-3843	89	5	coefficients	coefficient	NOUN
dpc-3843	89	6	was	be	AUX
dpc-3843	89	7	calculated	calculate	VERB
dpc-3843	89	8	to	to	PART
dpc-3843	89	9	evaluate	evaluate	VERB
dpc-3843	89	10	relationships	relationship	NOUN
dpc-3843	89	11	between	between	ADP
dpc-3843	89	12	serum	serum	NOUN
dpc-3843	89	13	markers	marker	NOUN
dpc-3843	89	14	and	and	CCONJ
dpc-3843	89	15	other	other	ADJ
dpc-3843	89	16	variables	variable	NOUN
dpc-3843	89	17	.	.	PUNCT
dpc-3843	90	1	p<0.05	p<0.05	NOUN
dpc-3843	90	2	was	be	AUX
dpc-3843	90	3	accepted	accept	VERB
dpc-3843	90	4	as	as	ADP
dpc-3843	90	5	statistically	statistically	ADV
dpc-3843	90	6	significant	significant	ADJ
dpc-3843	90	7	.	.	PUNCT
dpc-3843	91	1	results	result	VERB
dpc-3843	91	2	demographic	demographic	ADJ
dpc-3843	91	3	data	datum	NOUN
dpc-3843	91	4	of	of	ADP
dpc-3843	91	5	both	both	DET
dpc-3843	91	6	groups	group	NOUN
dpc-3843	91	7	as	as	ADV
dpc-3843	91	8	well	well	ADV
dpc-3843	91	9	as	as	ADP
dpc-3843	91	10	serum	serum	NOUN
dpc-3843	91	11	podocalyxin	podocalyxin	NOUN
dpc-3843	91	12	,	,	PUNCT
dpc-3843	91	13	chit-1	chit-1	NUM
dpc-3843	91	14	and	and	CCONJ
dpc-3843	91	15	tumstatin	tumstatin	NOUN
dpc-3843	91	16	levels	level	NOUN
dpc-3843	91	17	are	be	AUX
dpc-3843	91	18	presented	present	VERB
dpc-3843	91	19	in	in	ADP
dpc-3843	91	20	table	table	NOUN
dpc-3843	91	21	1	1	NUM
dpc-3843	91	22	in	in	ADP
dpc-3843	91	23	detail	detail	NOUN
dpc-3843	91	24	.	.	PUNCT
dpc-3843	92	1	the	the	DET
dpc-3843	92	2	number	number	NOUN
dpc-3843	92	3	of	of	ADP
dpc-3843	92	4	participants	participant	NOUN
dpc-3843	92	5	in	in	ADP
dpc-3843	92	6	the	the	DET
dpc-3843	92	7	vitiligo	vitiligo	NOUN
dpc-3843	92	8	and	and	CCONJ
dpc-3843	92	9	healthy	healthy	ADJ
dpc-3843	92	10	control	control	NOUN
dpc-3843	92	11	groups	group	NOUN
dpc-3843	92	12	was	be	AUX
dpc-3843	92	13	similar	similar	ADJ
dpc-3843	92	14	.	.	PUNCT
dpc-3843	93	1	although	although	SCONJ
dpc-3843	93	2	the	the	DET
dpc-3843	93	3	mean	mean	ADJ
dpc-3843	93	4	age	age	NOUN
dpc-3843	93	5	of	of	ADP
dpc-3843	93	6	the	the	DET
dpc-3843	93	7	vitiligo	vitiligo	NOUN
dpc-3843	93	8	group	group	NOUN
dpc-3843	93	9	was	be	AUX
dpc-3843	93	10	higher	high	ADJ
dpc-3843	93	11	than	than	ADP
dpc-3843	93	12	the	the	DET
dpc-3843	93	13	control	control	NOUN
dpc-3843	93	14	group	group	NOUN
dpc-3843	93	15	,	,	PUNCT
dpc-3843	93	16	the	the	DET
dpc-3843	93	17	difference	difference	NOUN
dpc-3843	93	18	did	do	AUX
dpc-3843	93	19	not	not	PART
dpc-3843	93	20	reach	reach	VERB
dpc-3843	93	21	statistical	statistical	ADJ
dpc-3843	93	22	significance	significance	NOUN
dpc-3843	93	23	.	.	PUNCT
dpc-3843	94	1	similarly	similarly	ADV
dpc-3843	94	2	,	,	PUNCT
dpc-3843	94	3	the	the	DET
dpc-3843	94	4	bmi	bmi	NOUN
dpc-3843	94	5	values	value	NOUN
dpc-3843	94	6	of	of	ADP
dpc-3843	94	7	both	both	DET
dpc-3843	94	8	groups	group	NOUN
dpc-3843	94	9	were	be	AUX
dpc-3843	94	10	similar	similar	ADJ
dpc-3843	94	11	and	and	CCONJ
dpc-3843	94	12	consistent	consistent	ADJ
dpc-3843	94	13	with	with	ADP
dpc-3843	94	14	the	the	DET
dpc-3843	94	15	overweight	overweight	ADJ
dpc-3843	94	16	category	category	NOUN
dpc-3843	94	17	values	value	NOUN
dpc-3843	94	18	.	.	PUNCT
dpc-3843	95	1	the	the	DET
dpc-3843	95	2	number	number	NOUN
dpc-3843	95	3	of	of	ADP
dpc-3843	95	4	male	male	ADJ
dpc-3843	95	5	participants	participant	NOUN
dpc-3843	95	6	in	in	ADP
dpc-3843	95	7	both	both	DET
dpc-3843	95	8	groups	group	NOUN
dpc-3843	95	9	was	be	AUX
dpc-3843	95	10	determined	determine	VERB
dpc-3843	95	11	as	as	ADP
dpc-3843	95	12	16	16	NUM
dpc-3843	95	13	and	and	CCONJ
dpc-3843	95	14	the	the	DET
dpc-3843	95	15	number	number	NOUN
dpc-3843	95	16	of	of	ADP
dpc-3843	95	17	female	female	ADJ
dpc-3843	95	18	participants	participant	NOUN
dpc-3843	95	19	as	as	ADP
dpc-3843	95	20	9	9	NUM
dpc-3843	95	21	.	.	PUNCT
dpc-3843	96	1	since	since	SCONJ
dpc-3843	96	2	there	there	PRON
dpc-3843	96	3	was	be	VERB
dpc-3843	96	4	male	male	ADJ
dpc-3843	96	5	dominance	dominance	NOUN
dpc-3843	96	6	table	table	NOUN
dpc-3843	96	7	1	1	NUM
dpc-3843	96	8	.	.	PUNCT
dpc-3843	96	9	comparison	comparison	NOUN
dpc-3843	96	10	of	of	ADP
dpc-3843	96	11	demographic	demographic	ADJ
dpc-3843	96	12	characteristics	characteristic	NOUN
dpc-3843	96	13	and	and	CCONJ
dpc-3843	96	14	potential	potential	ADJ
dpc-3843	96	15	new	new	ADJ
dpc-3843	96	16	serum	serum	NOUN
dpc-3843	96	17	markers	marker	NOUN
dpc-3843	96	18	pf	pf	PROPN
dpc-3843	96	19	patients	patient	NOUN
dpc-3843	96	20	in	in	ADP
dpc-3843	96	21	vitiligo	vitiligo	PROPN
dpc-3843	96	22	and	and	CCONJ
dpc-3843	96	23	control	control	NOUN
dpc-3843	96	24	groups	group	NOUN
dpc-3843	96	25	.	.	PUNCT
dpc-3843	97	1	vitiligo	vitiligo	VERB
dpc-3843	97	2	control	control	NOUN
dpc-3843	97	3	p	p	NOUN
dpc-3843	97	4	-	-	PUNCT
dpc-3843	97	5	values	value	NOUN
dpc-3843	97	6	*	*	NOUN
dpc-3843	97	7	n	n	PROPN
dpc-3843	97	8	(	(	PUNCT
dpc-3843	97	9	%	%	INTJ
dpc-3843	97	10	)	)	PUNCT
dpc-3843	97	11	25	25	NUM
dpc-3843	97	12	(	(	PUNCT
dpc-3843	97	13	50	50	NUM
dpc-3843	97	14	%	%	NOUN
dpc-3843	97	15	)	)	PUNCT
dpc-3843	97	16	25	25	NUM
dpc-3843	97	17	(	(	PUNCT
dpc-3843	97	18	50	50	NUM
dpc-3843	97	19	%	%	NOUN
dpc-3843	97	20	)	)	PUNCT
dpc-3843	97	21	0.23	0.23	NUM
dpc-3843	97	22	age	age	NOUN
dpc-3843	97	23	(	(	PUNCT
dpc-3843	97	24	years	year	NOUN
dpc-3843	97	25	)	)	PUNCT
dpc-3843	97	26	40.12±6.33	40.12±6.33	NOUN
dpc-3843	97	27	38.92±5.13µ	38.92±5.13µ	NUM
dpc-3843	97	28	0.08	0.08	NUM
dpc-3843	97	29	bmi	bmi	NOUN
dpc-3843	97	30	(	(	PUNCT
dpc-3843	97	31	kg	kg	NOUN
dpc-3843	97	32	/	/	SYM
dpc-3843	97	33	m2	m2	PROPN
dpc-3843	97	34	)	)	PUNCT
dpc-3843	98	1	26.3±3.98	26.3±3.98	NUM
dpc-3843	98	2	25.8±4.11	25.8±4.11	NUM
dpc-3843	98	3	0.44	0.44	NUM
dpc-3843	98	4	gender	gender	NOUN
dpc-3843	98	5	(	(	PUNCT
dpc-3843	98	6	female	female	ADJ
dpc-3843	98	7	or	or	CCONJ
dpc-3843	98	8	male	male	NOUN
dpc-3843	98	9	)	)	PUNCT
dpc-3843	98	10	f:9	f:9	X
dpc-3843	98	11	m:16	m:16	PROPN
dpc-3843	98	12	f:9	f:9	X
dpc-3843	98	13	m:16	m:16	NOUN
dpc-3843	98	14	na	na	INTJ
dpc-3843	98	15	podocalyxin	podocalyxin	X
dpc-3843	98	16	(	(	PUNCT
dpc-3843	98	17	ng	ng	PROPN
dpc-3843	98	18	/	/	SYM
dpc-3843	98	19	ml	ml	NOUN
dpc-3843	98	20	)	)	PUNCT
dpc-3843	98	21	7.03±2.09	7.03±2.09	NUM
dpc-3843	98	22	4.99±1.20	4.99±1.20	NOUN
dpc-3843	98	23	<	<	X
dpc-3843	98	24	0.02	0.02	NUM
dpc-3843	98	25	tumstatin	tumstatin	NOUN
dpc-3843	98	26	(	(	PUNCT
dpc-3843	98	27	collagen	collagen	NOUN
dpc-3843	98	28	type	type	NOUN
dpc-3843	98	29	iv	iv	NUM
dpc-3843	98	30	alpha	alpha	NOUN
dpc-3843	98	31	3	3	NUM
dpc-3843	98	32	)	)	PUNCT
dpc-3843	98	33	(	(	PUNCT
dpc-3843	98	34	ng	ng	PROPN
dpc-3843	98	35	/	/	SYM
dpc-3843	98	36	ml	ml	NOUN
dpc-3843	98	37	)	)	PUNCT
dpc-3843	98	38	4.88±1.76	4.88±1.76	NUM
dpc-3843	98	39	6.05±2.19	6.05±2.19	NOUN
dpc-3843	98	40	<	<	X
dpc-3843	98	41	0.03	0.03	NUM
dpc-3843	98	42	chit-1	chit-1	PROPN
dpc-3843	98	43	(	(	PUNCT
dpc-3843	98	44	ng	ng	PROPN
dpc-3843	98	45	/	/	SYM
dpc-3843	98	46	ml	ml	NOUN
dpc-3843	98	47	)	)	PUNCT
dpc-3843	98	48	42.4±7.22	42.4±7.22	NUM
dpc-3843	98	49	34.5±5.33	34.5±5.33	NUM
dpc-3843	98	50	<	<	NOUN
dpc-3843	98	51	0.01	0.01	NUM
dpc-3843	98	52	*	*	PUNCT
dpc-3843	98	53	results	result	NOUN
dpc-3843	98	54	are	be	AUX
dpc-3843	98	55	given	give	VERB
dpc-3843	98	56	as	as	ADP
dpc-3843	98	57	mean±sd	mean±sd	PROPN
dpc-3843	98	58	.	.	PUNCT
dpc-3843	98	59	µp<0.05	µp<0.05	NOUN
dpc-3843	98	60	was	be	AUX
dpc-3843	98	61	considered	consider	VERB
dpc-3843	98	62	significant	significant	ADJ
dpc-3843	98	63	.	.	PUNCT
dpc-3843	99	1	na	na	NOUN
dpc-3843	99	2	:	:	PUNCT
dpc-3843	99	3	not	not	PART
dpc-3843	99	4	applicable.chit	applicable.chit	ADJ
dpc-3843	99	5	:	:	PUNCT
dpc-3843	99	6	chitinase	chitinase	NOUN
dpc-3843	99	7	1	1	NUM
dpc-3843	99	8	;	;	PUNCT
dpc-3843	99	9	bmi	bmi	PROPN
dpc-3843	99	10	:	:	PUNCT
dpc-3843	99	11	body	body	NOUN
dpc-3843	99	12	mass	mass	PROPN
dpc-3843	99	13	index	index	NOUN
dpc-3843	99	14	4	4	NUM
dpc-3843	99	15	original	original	ADJ
dpc-3843	99	16	article	article	NOUN
dpc-3843	99	17	|	|	ADV
dpc-3843	99	18	dermatol	dermatol	ADJ
dpc-3843	99	19	pract	pract	NOUN
dpc-3843	99	20	concept	concept	NOUN
dpc-3843	99	21	.	.	PUNCT
dpc-3843	100	1	2024;14(1):e2024095	2024;14(1):e2024095	NUM
dpc-3843	100	2	different	different	ADJ
dpc-3843	100	3	serum	serum	NOUN
dpc-3843	100	4	markers	marker	NOUN
dpc-3843	100	5	that	that	PRON
dpc-3843	100	6	have	have	AUX
dpc-3843	100	7	not	not	PART
dpc-3843	100	8	been	be	AUX
dpc-3843	100	9	studied	study	VERB
dpc-3843	100	10	before	before	ADV
dpc-3843	100	11	.	.	PUNCT
dpc-3843	101	1	these	these	PRON
dpc-3843	101	2	are	be	AUX
dpc-3843	101	3	,	,	PUNCT
dpc-3843	101	4	respectively	respectively	ADV
dpc-3843	101	5	,	,	PUNCT
dpc-3843	101	6	melanocyte	melanocyte	NOUN
dpc-3843	101	7	adhesion	adhesion	NOUN
dpc-3843	101	8	defect	defect	NOUN
dpc-3843	101	9	,	,	PUNCT
dpc-3843	101	10	endothelial	endothelial	ADJ
dpc-3843	101	11	dysfunction	dysfunction	NOUN
dpc-3843	101	12	characterized	characterize	VERB
dpc-3843	101	13	by	by	ADP
dpc-3843	101	14	vascular	vascular	ADJ
dpc-3843	101	15	collagen	collagen	NOUN
dpc-3843	101	16	degradation	degradation	NOUN
dpc-3843	101	17	,	,	PUNCT
dpc-3843	101	18	and	and	CCONJ
dpc-3843	101	19	inherent	inherent	ADJ
dpc-3843	101	20	defect	defect	NOUN
dpc-3843	101	21	in	in	ADP
dpc-3843	101	22	innate	innate	ADJ
dpc-3843	101	23	immunity	immunity	NOUN
dpc-3843	101	24	.	.	PUNCT
dpc-3843	102	1	our	our	PRON
dpc-3843	102	2	first	first	ADJ
dpc-3843	102	3	focus	focus	NOUN
dpc-3843	102	4	is	be	AUX
dpc-3843	102	5	on	on	ADP
dpc-3843	102	6	melanocyte	melanocyte	NOUN
dpc-3843	102	7	degeneration	degeneration	NOUN
dpc-3843	102	8	and	and	CCONJ
dpc-3843	102	9	depigmentation	depigmentation	NOUN
dpc-3843	102	10	due	due	ADP
dpc-3843	102	11	to	to	ADP
dpc-3843	102	12	adhesion	adhesion	NOUN
dpc-3843	102	13	defect	defect	NOUN
dpc-3843	102	14	of	of	ADP
dpc-3843	102	15	melanocytes	melanocyte	NOUN
dpc-3843	102	16	.	.	PUNCT
dpc-3843	103	1	for	for	ADP
dpc-3843	103	2	this	this	DET
dpc-3843	103	3	purpose	purpose	NOUN
dpc-3843	103	4	,	,	PUNCT
dpc-3843	103	5	we	we	PRON
dpc-3843	103	6	evaluated	evaluate	VERB
dpc-3843	103	7	serum	serum	NOUN
dpc-3843	103	8	levels	level	NOUN
dpc-3843	103	9	of	of	ADP
dpc-3843	103	10	podacalyxin	podacalyxin	PROPN
dpc-3843	103	11	(	(	PUNCT
dpc-3843	103	12	podxl	podxl	PROPN
dpc-3843	103	13	)	)	PUNCT
dpc-3843	103	14	,	,	PUNCT
dpc-3843	103	15	an	an	DET
dpc-3843	103	16	anti	anti	ADJ
dpc-3843	103	17	-	-	ADJ
dpc-3843	103	18	adhesive	adhesive	ADJ
dpc-3843	103	19	molecule	molecule	NOUN
dpc-3843	103	20	.	.	PUNCT
dpc-3843	104	1	podxl	podxl	PROPN
dpc-3843	104	2	was	be	AUX
dpc-3843	104	3	significantly	significantly	ADV
dpc-3843	104	4	higher	high	ADJ
dpc-3843	104	5	in	in	ADP
dpc-3843	104	6	vitiligo	vitiligo	ADJ
dpc-3843	104	7	patients	patient	NOUN
dpc-3843	104	8	compared	compare	VERB
dpc-3843	104	9	to	to	ADP
dpc-3843	104	10	healthy	healthy	ADJ
dpc-3843	104	11	controls	control	NOUN
dpc-3843	104	12	.	.	PUNCT
dpc-3843	105	1	in	in	ADP
dpc-3843	105	2	the	the	DET
dpc-3843	105	3	presence	presence	NOUN
dpc-3843	105	4	of	of	ADP
dpc-3843	105	5	high	high	ADJ
dpc-3843	105	6	podxl	podxl	NOUN
dpc-3843	105	7	,	,	PUNCT
dpc-3843	105	8	strong	strong	ADJ
dpc-3843	105	9	adhesion	adhesion	NOUN
dpc-3843	105	10	of	of	ADP
dpc-3843	105	11	melanocytes	melanocyte	NOUN
dpc-3843	105	12	to	to	ADP
dpc-3843	105	13	keratinocytes	keratinocyte	NOUN
dpc-3843	105	14	does	do	AUX
dpc-3843	105	15	not	not	PART
dpc-3843	105	16	occur	occur	VERB
dpc-3843	105	17	because	because	SCONJ
dpc-3843	105	18	the	the	DET
dpc-3843	105	19	conditions	condition	NOUN
dpc-3843	105	20	are	be	AUX
dpc-3843	105	21	not	not	PART
dpc-3843	105	22	suitable	suitable	ADJ
dpc-3843	105	23	for	for	ADP
dpc-3843	105	24	a	a	DET
dpc-3843	105	25	healthy	healthy	ADJ
dpc-3843	105	26	adhesion	adhesion	NOUN
dpc-3843	105	27	.	.	PUNCT
dpc-3843	106	1	oxidative	oxidative	ADJ
dpc-3843	106	2	stress	stress	NOUN
dpc-3843	106	3	,	,	PUNCT
dpc-3843	106	4	inflammation	inflammation	NOUN
dpc-3843	106	5	and	and	CCONJ
dpc-3843	106	6	mechanical	mechanical	ADJ
dpc-3843	106	7	effects	effect	NOUN
dpc-3843	106	8	can	can	AUX
dpc-3843	106	9	cause	cause	VERB
dpc-3843	106	10	melanocytes	melanocyte	NOUN
dpc-3843	106	11	to	to	PART
dpc-3843	106	12	separate	separate	VERB
dpc-3843	106	13	and	and	CCONJ
dpc-3843	106	14	disappear	disappear	VERB
dpc-3843	106	15	easily	easily	ADV
dpc-3843	106	16	in	in	ADP
dpc-3843	106	17	the	the	DET
dpc-3843	106	18	presence	presence	NOUN
dpc-3843	106	19	of	of	ADP
dpc-3843	106	20	high	high	ADJ
dpc-3843	106	21	anti	anti	ADJ
dpc-3843	106	22	-	-	ADJ
dpc-3843	106	23	adhesive	adhesive	ADJ
dpc-3843	106	24	pdxl	pdxl	NOUN
dpc-3843	106	25	 	 	SPACE
dpc-3843	107	1	[	[	X
dpc-3843	107	2	19	19	NUM
dpc-3843	107	3	]	]	PUNCT
dpc-3843	107	4	.	.	PUNCT
dpc-3843	108	1	it	it	PRON
dpc-3843	108	2	has	have	AUX
dpc-3843	108	3	been	be	AUX
dpc-3843	108	4	previously	previously	ADV
dpc-3843	108	5	reported	report	VERB
dpc-3843	108	6	that	that	SCONJ
dpc-3843	108	7	the	the	DET
dpc-3843	108	8	expression	expression	NOUN
dpc-3843	108	9	of	of	ADP
dpc-3843	108	10	anti	anti	ADJ
dpc-3843	108	11	-	-	ADJ
dpc-3843	108	12	adhesive	adhesive	ADJ
dpc-3843	108	13	molecules	molecule	NOUN
dpc-3843	108	14	such	such	ADJ
dpc-3843	108	15	as	as	ADP
dpc-3843	108	16	tenascin	tenascin	PRON
dpc-3843	108	17	is	be	AUX
dpc-3843	108	18	increased	increase	VERB
dpc-3843	108	19	in	in	ADP
dpc-3843	108	20	vitiligo	vitiligo	ADJ
dpc-3843	108	21	patients	patient	NOUN
dpc-3843	108	22	[	[	X
dpc-3843	108	23	20	20	NUM
dpc-3843	108	24	]	]	PUNCT
dpc-3843	108	25	.	.	PUNCT
dpc-3843	109	1	because	because	SCONJ
dpc-3843	109	2	pdxl	pdxl	PROPN
dpc-3843	109	3	is	be	AUX
dpc-3843	109	4	expressed	express	VERB
dpc-3843	109	5	on	on	ADP
dpc-3843	109	6	apical	apical	ADJ
dpc-3843	109	7	?	?	PUNCT
dpc-3843	109	8	epidermal	epidermal	ADJ
dpc-3843	109	9	surfaces	surface	NOUN
dpc-3843	109	10	,	,	PUNCT
dpc-3843	109	11	basal	basal	ADJ
dpc-3843	109	12	membrane	membrane	NOUN
dpc-3843	109	13	,	,	PUNCT
dpc-3843	109	14	vascular	vascular	ADJ
dpc-3843	109	15	endothelium	endothelium	NOUN
dpc-3843	109	16	,	,	PUNCT
dpc-3843	109	17	and	and	CCONJ
dpc-3843	109	18	neurons	neuron	NOUN
dpc-3843	109	19	,	,	PUNCT
dpc-3843	109	20	its	its	PRON
dpc-3843	109	21	increased	increase	VERB
dpc-3843	109	22	expression	expression	NOUN
dpc-3843	109	23	in	in	ADP
dpc-3843	109	24	vitiligo	vitiligo	ADJ
dpc-3843	109	25	patients	patient	NOUN
dpc-3843	109	26	may	may	AUX
dpc-3843	109	27	affect	affect	VERB
dpc-3843	109	28	all	all	DET
dpc-3843	109	29	cells	cell	NOUN
dpc-3843	109	30	in	in	ADP
dpc-3843	109	31	these	these	DET
dpc-3843	109	32	regions	region	NOUN
dpc-3843	109	33	 	 	SPACE
dpc-3843	110	1	[	[	X
dpc-3843	110	2	12	12	NUM
dpc-3843	110	3	]	]	PUNCT
dpc-3843	110	4	.	.	PUNCT
dpc-3843	111	1	especially	especially	ADV
dpc-3843	111	2	since	since	SCONJ
dpc-3843	111	3	the	the	DET
dpc-3843	111	4	keratinocytes	keratinocyte	NOUN
dpc-3843	111	5	are	be	AUX
dpc-3843	111	6	affected	affect	VERB
dpc-3843	111	7	by	by	ADP
dpc-3843	111	8	the	the	DET
dpc-3843	111	9	increase	increase	NOUN
dpc-3843	111	10	in	in	ADP
dpc-3843	111	11	pdxl	pdxl	PROPN
dpc-3843	111	12	will	will	AUX
dpc-3843	111	13	prevent	prevent	VERB
dpc-3843	111	14	the	the	DET
dpc-3843	111	15	adhesion	adhesion	NOUN
dpc-3843	111	16	of	of	ADP
dpc-3843	111	17	melanocyte	melanocyte	NOUN
dpc-3843	111	18	and	and	CCONJ
dpc-3843	111	19	keratinocyte	keratinocyte	NOUN
dpc-3843	111	20	,	,	PUNCT
dpc-3843	111	21	melenocytes	melenocyte	NOUN
dpc-3843	111	22	will	will	AUX
dpc-3843	111	23	lose	lose	VERB
dpc-3843	111	24	their	their	PRON
dpc-3843	111	25	attachment	attachment	NOUN
dpc-3843	111	26	sites	site	NOUN
dpc-3843	111	27	.	.	PUNCT
dpc-3843	112	1	since	since	SCONJ
dpc-3843	112	2	keratinocytes	keratinocyte	NOUN
dpc-3843	112	3	and	and	CCONJ
dpc-3843	112	4	melanocytes	melanocyte	NOUN
dpc-3843	112	5	together	together	ADV
dpc-3843	112	6	form	form	VERB
dpc-3843	112	7	an	an	DET
dpc-3843	112	8	“	"	PUNCT
dpc-3843	112	9	epidermal	epidermal	ADJ
dpc-3843	112	10	-	-	PUNCT
dpc-3843	112	11	melanin	melanin	ADJ
dpc-3843	112	12	unit	unit	NOUN
dpc-3843	112	13	”	"	PUNCT
dpc-3843	112	14	,	,	PUNCT
dpc-3843	112	15	damage	damage	NOUN
dpc-3843	112	16	to	to	ADP
dpc-3843	112	17	one	one	NUM
dpc-3843	112	18	may	may	AUX
dpc-3843	112	19	cause	cause	VERB
dpc-3843	112	20	damage	damage	NOUN
dpc-3843	112	21	to	to	ADP
dpc-3843	112	22	the	the	DET
dpc-3843	112	23	other	other	ADJ
dpc-3843	112	24	[	[	X
dpc-3843	112	25	21	21	NUM
dpc-3843	112	26	]	]	PUNCT
dpc-3843	112	27	.	.	PUNCT
dpc-3843	113	1	the	the	DET
dpc-3843	113	2	risk	risk	NOUN
dpc-3843	113	3	of	of	ADP
dpc-3843	113	4	oxidative	oxidative	ADJ
dpc-3843	113	5	stress	stress	NOUN
dpc-3843	113	6	is	be	AUX
dpc-3843	113	7	higher	high	ADJ
dpc-3843	113	8	because	because	SCONJ
dpc-3843	113	9	the	the	DET
dpc-3843	113	10	keratinocytes	keratinocyte	NOUN
dpc-3843	113	11	of	of	ADP
dpc-3843	113	12	vitiligo	vitiligo	NOUN
dpc-3843	113	13	patients	patient	NOUN
dpc-3843	113	14	are	be	AUX
dpc-3843	113	15	defective	defective	ADJ
dpc-3843	113	16	in	in	ADP
dpc-3843	113	17	terms	term	NOUN
dpc-3843	113	18	of	of	ADP
dpc-3843	113	19	mitochondria	mitochondria	PROPN
dpc-3843	113	20	content	content	NOUN
dpc-3843	114	1	[	[	X
dpc-3843	114	2	22	22	NUM
dpc-3843	114	3	]	]	PUNCT
dpc-3843	114	4	.	.	PUNCT
dpc-3843	115	1	in	in	ADP
dpc-3843	115	2	the	the	DET
dpc-3843	115	3	presence	presence	NOUN
dpc-3843	115	4	of	of	ADP
dpc-3843	115	5	increased	increase	VERB
dpc-3843	115	6	reactivated	reactivate	VERB
dpc-3843	115	7	oxygen	oxygen	NOUN
dpc-3843	115	8	species	specie	NOUN
dpc-3843	115	9	,	,	PUNCT
dpc-3843	115	10	the	the	DET
dpc-3843	115	11	melanin	melanin	NOUN
dpc-3843	115	12	-	-	PUNCT
dpc-3843	115	13	keratinocyte	keratinocyte	NOUN
dpc-3843	115	14	unit	unit	NOUN
dpc-3843	115	15	will	will	AUX
dpc-3843	115	16	be	be	AUX
dpc-3843	115	17	damaged	damage	VERB
dpc-3843	115	18	,	,	PUNCT
dpc-3843	115	19	and	and	CCONJ
dpc-3843	115	20	melanocyte	melanocyte	NOUN
dpc-3843	115	21	loss	loss	NOUN
dpc-3843	115	22	and	and	CCONJ
dpc-3843	115	23	depigmentation	depigmentation	NOUN
dpc-3843	115	24	will	will	AUX
dpc-3843	115	25	also	also	ADV
dpc-3843	115	26	accelerate	accelerate	VERB
dpc-3843	115	27	.	.	PUNCT
dpc-3843	116	1	since	since	SCONJ
dpc-3843	116	2	there	there	PRON
dpc-3843	116	3	are	be	VERB
dpc-3843	116	4	no	no	DET
dpc-3843	116	5	knock	knock	NOUN
dpc-3843	116	6	out	out	ADP
dpc-3843	116	7	models	model	NOUN
dpc-3843	116	8	of	of	ADP
dpc-3843	116	9	the	the	DET
dpc-3843	116	10	anti	anti	ADJ
dpc-3843	116	11	-	-	ADJ
dpc-3843	116	12	adhesive	adhesive	ADJ
dpc-3843	116	13	effects	effect	NOUN
dpc-3843	116	14	of	of	ADP
dpc-3843	116	15	podxl	podxl	NOUN
dpc-3843	116	16	,	,	PUNCT
dpc-3843	116	17	we	we	PRON
dpc-3843	116	18	do	do	AUX
dpc-3843	116	19	not	not	PART
dpc-3843	116	20	have	have	VERB
dpc-3843	116	21	clear	clear	ADJ
dpc-3843	116	22	data	datum	NOUN
dpc-3843	116	23	on	on	ADP
dpc-3843	116	24	the	the	DET
dpc-3843	116	25	defective	defective	ADJ
dpc-3843	116	26	expression	expression	NOUN
dpc-3843	116	27	of	of	ADP
dpc-3843	116	28	this	this	DET
dpc-3843	116	29	molecule	molecule	NOUN
dpc-3843	116	30	in	in	ADP
dpc-3843	116	31	vitiligo	vitiligo	NOUN
dpc-3843	116	32	.	.	PUNCT
dpc-3843	117	1	in	in	ADP
dpc-3843	117	2	the	the	DET
dpc-3843	117	3	vitiligo	vitiligo	NOUN
dpc-3843	117	4	group	group	NOUN
dpc-3843	117	5	,	,	PUNCT
dpc-3843	117	6	appropriate	appropriate	ADJ
dpc-3843	117	7	selection	selection	NOUN
dpc-3843	117	8	was	be	AUX
dpc-3843	117	9	made	make	VERB
dpc-3843	117	10	in	in	ADP
dpc-3843	117	11	the	the	DET
dpc-3843	117	12	control	control	NOUN
dpc-3843	117	13	participants	participant	NOUN
dpc-3843	117	14	as	as	ADV
dpc-3843	117	15	well	well	ADV
dpc-3843	117	16	.	.	PUNCT
dpc-3843	118	1	serum	serum	NOUN
dpc-3843	118	2	podocalyxin	podocalyxin	NOUN
dpc-3843	118	3	levels	level	NOUN
dpc-3843	118	4	increased	increase	VERB
dpc-3843	118	5	significantly	significantly	ADV
dpc-3843	118	6	in	in	ADP
dpc-3843	118	7	the	the	DET
dpc-3843	118	8	vitiligo	vitiligo	NOUN
dpc-3843	118	9	group	group	NOUN
dpc-3843	118	10	compared	compare	VERB
dpc-3843	118	11	to	to	ADP
dpc-3843	118	12	the	the	DET
dpc-3843	118	13	controls	control	NOUN
dpc-3843	118	14	(	(	PUNCT
dpc-3843	118	15	7.03±2.09	7.03±2.09	PROPN
dpc-3843	118	16	ng	ng	PROPN
dpc-3843	118	17	/	/	SYM
dpc-3843	118	18	ml	ml	PROPN
dpc-3843	118	19	vs.	vs.	X
dpc-3843	118	20	4.99±1.20	4.99±1.20	PROPN
dpc-3843	118	21	ng	ng	PROPN
dpc-3843	118	22	/	/	SYM
dpc-3843	118	23	ml	ml	PROPN
dpc-3843	118	24	,	,	PUNCT
dpc-3843	118	25	p<0.02	p<0.02	PROPN
dpc-3843	118	26	)	)	PUNCT
dpc-3843	118	27	.	.	PUNCT
dpc-3843	119	1	however	however	ADV
dpc-3843	119	2	,	,	PUNCT
dpc-3843	119	3	serum	serum	NOUN
dpc-3843	119	4	tumstatin	tumstatin	NOUN
dpc-3843	119	5	levels	level	NOUN
dpc-3843	119	6	in	in	ADP
dpc-3843	119	7	vitiligo	vitiligo	ADJ
dpc-3843	119	8	patients	patient	NOUN
dpc-3843	119	9	showed	show	VERB
dpc-3843	119	10	a	a	DET
dpc-3843	119	11	significantly	significantly	ADV
dpc-3843	119	12	lower	low	ADJ
dpc-3843	119	13	course	course	NOUN
dpc-3843	119	14	compared	compare	VERB
dpc-3843	119	15	to	to	ADP
dpc-3843	119	16	controls	control	NOUN
dpc-3843	119	17	(	(	PUNCT
dpc-3843	119	18	4.88±1.76	4.88±1.76	NUM
dpc-3843	119	19	ng	ng	PROPN
dpc-3843	119	20	/	/	SYM
dpc-3843	119	21	ml	ml	PROPN
dpc-3843	119	22	vs.	vs.	ADP
dpc-3843	119	23	6.05±2.19	6.05±2.19	NUM
dpc-3843	119	24	ng	ng	PROPN
dpc-3843	119	25	/	/	SYM
dpc-3843	119	26	nl	nl	PROPN
dpc-3843	119	27	,	,	PUNCT
dpc-3843	119	28	p<0.03	p<0.03	NOUN
dpc-3843	119	29	)	)	PUNCT
dpc-3843	119	30	.	.	PUNCT
dpc-3843	120	1	serum	serum	PROPN
dpc-3843	120	2	chit-1	chit-1	NUM
dpc-3843	120	3	levels	level	NOUN
dpc-3843	120	4	of	of	ADP
dpc-3843	120	5	vitiligo	vitiligo	ADJ
dpc-3843	120	6	patients	patient	NOUN
dpc-3843	120	7	(	(	PUNCT
dpc-3843	120	8	42.4±7.22	42.4±7.22	NUM
dpc-3843	120	9	 	 	SPACE
dpc-3843	120	10	ng	ng	PROPN
dpc-3843	120	11	/	/	SYM
dpc-3843	120	12	ml	ml	PROPN
dpc-3843	120	13	)	)	PUNCT
dpc-3843	120	14	were	be	AUX
dpc-3843	120	15	found	find	VERB
dpc-3843	120	16	to	to	PART
dpc-3843	120	17	be	be	AUX
dpc-3843	120	18	significantly	significantly	ADV
dpc-3843	120	19	higher	high	ADJ
dpc-3843	120	20	than	than	ADP
dpc-3843	120	21	the	the	DET
dpc-3843	120	22	serum	serum	NOUN
dpc-3843	120	23	levels	level	NOUN
dpc-3843	120	24	of	of	ADP
dpc-3843	120	25	the	the	DET
dpc-3843	120	26	control	control	NOUN
dpc-3843	120	27	group	group	NOUN
dpc-3843	120	28	(	(	PUNCT
dpc-3843	120	29	34.5±5.33	34.5±5.33	NUM
dpc-3843	120	30	ng	ng	PROPN
dpc-3843	120	31	/	/	SYM
dpc-3843	120	32	ml	ml	PROPN
dpc-3843	120	33	)	)	PUNCT
dpc-3843	120	34	(	(	PUNCT
dpc-3843	120	35	p<0.01	p<0.01	PROPN
dpc-3843	120	36	)	)	PUNCT
dpc-3843	120	37	.	.	PUNCT
dpc-3843	121	1	there	there	PRON
dpc-3843	121	2	was	be	VERB
dpc-3843	121	3	no	no	DET
dpc-3843	121	4	significant	significant	ADJ
dpc-3843	121	5	correlation	correlation	NOUN
dpc-3843	121	6	between	between	ADP
dpc-3843	121	7	demographic	demographic	ADJ
dpc-3843	121	8	characteristics	characteristic	NOUN
dpc-3843	121	9	and	and	CCONJ
dpc-3843	121	10	serum	serum	NOUN
dpc-3843	121	11	elisa	elisa	PROPN
dpc-3843	121	12	markers	marker	NOUN
dpc-3843	121	13	in	in	ADP
dpc-3843	121	14	neither	neither	CCONJ
dpc-3843	121	15	vitiligo	vitiligo	NOUN
dpc-3843	121	16	nor	nor	CCONJ
dpc-3843	121	17	control	control	NOUN
dpc-3843	121	18	group	group	NOUN
dpc-3843	121	19	.	.	PUNCT
dpc-3843	122	1	figure	figure	NOUN
dpc-3843	122	2	1	1	NUM
dpc-3843	122	3	shows	show	VERB
dpc-3843	122	4	the	the	DET
dpc-3843	122	5	distribution	distribution	NOUN
dpc-3843	122	6	of	of	ADP
dpc-3843	122	7	serum	serum	NOUN
dpc-3843	122	8	podocalyxin	podocalyxin	NOUN
dpc-3843	122	9	,	,	PUNCT
dpc-3843	122	10	chit-1	chit-1	NUM
dpc-3843	122	11	and	and	CCONJ
dpc-3843	122	12	tumstatin	tumstatin	NOUN
dpc-3843	122	13	levels	level	NOUN
dpc-3843	122	14	between	between	ADP
dpc-3843	122	15	the	the	DET
dpc-3843	122	16	groups	group	NOUN
dpc-3843	122	17	.	.	PUNCT
dpc-3843	123	1	conclusions	conclusion	NOUN
dpc-3843	123	2	although	although	SCONJ
dpc-3843	123	3	studies	study	NOUN
dpc-3843	123	4	on	on	ADP
dpc-3843	123	5	the	the	DET
dpc-3843	123	6	etiology	etiology	NOUN
dpc-3843	123	7	and	and	CCONJ
dpc-3843	123	8	treatment	treatment	NOUN
dpc-3843	123	9	of	of	ADP
dpc-3843	123	10	vitiligo	vitiligo	NOUN
dpc-3843	123	11	have	have	AUX
dpc-3843	123	12	gained	gain	VERB
dpc-3843	123	13	weight	weight	NOUN
dpc-3843	123	14	in	in	ADP
dpc-3843	123	15	the	the	DET
dpc-3843	123	16	last	last	ADJ
dpc-3843	123	17	three	three	NUM
dpc-3843	123	18	decades	decade	NOUN
dpc-3843	123	19	,	,	PUNCT
dpc-3843	123	20	the	the	DET
dpc-3843	123	21	data	datum	NOUN
dpc-3843	123	22	on	on	ADP
dpc-3843	123	23	the	the	DET
dpc-3843	123	24	diagnosis	diagnosis	NOUN
dpc-3843	123	25	,	,	PUNCT
dpc-3843	123	26	treatment	treatment	NOUN
dpc-3843	123	27	and	and	CCONJ
dpc-3843	123	28	how	how	SCONJ
dpc-3843	123	29	this	this	DET
dpc-3843	123	30	disease	disease	NOUN
dpc-3843	123	31	occurs	occur	VERB
dpc-3843	123	32	dates	date	NOUN
dpc-3843	123	33	back	back	ADV
dpc-3843	123	34	to	to	ADP
dpc-3843	123	35	ancient	ancient	ADJ
dpc-3843	123	36	times	time	NOUN
dpc-3843	124	1	[	[	X
dpc-3843	124	2	16	16	NUM
dpc-3843	124	3	,	,	PUNCT
dpc-3843	124	4	17	17	NUM
dpc-3843	124	5	]	]	PUNCT
dpc-3843	124	6	.	.	PUNCT
dpc-3843	125	1	the	the	DET
dpc-3843	125	2	fact	fact	NOUN
dpc-3843	125	3	that	that	SCONJ
dpc-3843	125	4	autoimmune	autoimmune	ADJ
dpc-3843	125	5	diseases	disease	NOUN
dpc-3843	125	6	such	such	ADJ
dpc-3843	125	7	as	as	ADP
dpc-3843	125	8	hasimoto	hasimoto	NOUN
dpc-3843	125	9	,	,	PUNCT
dpc-3843	125	10	diabetes	diabetes	NOUN
dpc-3843	125	11	mellitus	mellitus	NOUN
dpc-3843	125	12	,	,	PUNCT
dpc-3843	125	13	alopecia	alopecia	NOUN
dpc-3843	125	14	and	and	CCONJ
dpc-3843	125	15	addison	addison	NOUN
dpc-3843	125	16	are	be	AUX
dpc-3843	125	17	more	more	ADV
dpc-3843	125	18	common	common	ADJ
dpc-3843	125	19	in	in	ADP
dpc-3843	125	20	vitiligo	vitiligo	ADJ
dpc-3843	125	21	patients	patient	NOUN
dpc-3843	125	22	suggested	suggest	VERB
dpc-3843	125	23	that	that	SCONJ
dpc-3843	125	24	vitiligo	vitiligo	NOUN
dpc-3843	125	25	is	be	AUX
dpc-3843	125	26	also	also	ADV
dpc-3843	125	27	an	an	DET
dpc-3843	125	28	autoimmune	autoimmune	ADJ
dpc-3843	125	29	pathology	pathology	NOUN
dpc-3843	126	1	[	[	X
dpc-3843	126	2	18	18	NUM
dpc-3843	126	3	]	]	PUNCT
dpc-3843	126	4	.	.	PUNCT
dpc-3843	127	1	however	however	ADV
dpc-3843	127	2	,	,	PUNCT
dpc-3843	127	3	a	a	DET
dpc-3843	127	4	general	general	ADJ
dpc-3843	127	5	consensus	consensus	NOUN
dpc-3843	127	6	has	have	AUX
dpc-3843	127	7	not	not	PART
dpc-3843	127	8	yet	yet	ADV
dpc-3843	127	9	been	be	AUX
dpc-3843	127	10	reached	reach	VERB
dpc-3843	127	11	on	on	ADP
dpc-3843	127	12	the	the	DET
dpc-3843	127	13	mechanisms	mechanism	NOUN
dpc-3843	127	14	that	that	PRON
dpc-3843	127	15	trigger	trigger	NOUN
dpc-3843	127	16	autoimmunity	autoimmunity	NOUN
dpc-3843	127	17	.	.	PUNCT
dpc-3843	128	1	many	many	ADJ
dpc-3843	128	2	factors	factor	NOUN
dpc-3843	128	3	have	have	AUX
dpc-3843	128	4	been	be	AUX
dpc-3843	128	5	held	hold	VERB
dpc-3843	128	6	responsible	responsible	ADJ
dpc-3843	128	7	in	in	ADP
dpc-3843	128	8	the	the	DET
dpc-3843	128	9	etiology	etiology	NOUN
dpc-3843	128	10	.	.	PUNCT
dpc-3843	129	1	melanocyte	melanocyte	NOUN
dpc-3843	129	2	adhesion	adhesion	NOUN
dpc-3843	129	3	defect	defect	NOUN
dpc-3843	129	4	and	and	CCONJ
dpc-3843	129	5	melanocyte	melanocyte	NOUN
dpc-3843	129	6	degeneration	degeneration	NOUN
dpc-3843	129	7	due	due	ADP
dpc-3843	129	8	to	to	ADP
dpc-3843	129	9	oxidative	oxidative	ADJ
dpc-3843	129	10	stress	stress	NOUN
dpc-3843	129	11	,	,	PUNCT
dpc-3843	129	12	microvascularization	microvascularization	NOUN
dpc-3843	129	13	defects	defect	NOUN
dpc-3843	129	14	due	due	ADJ
dpc-3843	129	15	to	to	ADP
dpc-3843	129	16	vascular	vascular	VERB
dpc-3843	129	17	endothelial	endothelial	ADJ
dpc-3843	129	18	damage	damage	NOUN
dpc-3843	129	19	,	,	PUNCT
dpc-3843	129	20	uncontrolled	uncontrolled	ADJ
dpc-3843	129	21	neuropeptide	neuropeptide	NOUN
dpc-3843	129	22	release	release	NOUN
dpc-3843	129	23	from	from	ADP
dpc-3843	129	24	local	local	ADJ
dpc-3843	129	25	nerve	nerve	NOUN
dpc-3843	129	26	endings	ending	NOUN
dpc-3843	129	27	,	,	PUNCT
dpc-3843	129	28	and	and	CCONJ
dpc-3843	129	29	inherent	inherent	ADJ
dpc-3843	129	30	defects	defect	NOUN
dpc-3843	129	31	in	in	ADP
dpc-3843	129	32	innate	innate	ADJ
dpc-3843	129	33	immunity	immunity	NOUN
dpc-3843	129	34	were	be	AUX
dpc-3843	129	35	the	the	DET
dpc-3843	129	36	most	most	ADV
dpc-3843	129	37	frequently	frequently	ADV
dpc-3843	129	38	accused	accuse	VERB
dpc-3843	129	39	mechanisms	mechanism	NOUN
dpc-3843	129	40	[	[	X
dpc-3843	129	41	16	16	NUM
dpc-3843	129	42	,	,	PUNCT
dpc-3843	129	43	18	18	NUM
dpc-3843	129	44	]	]	PUNCT
dpc-3843	129	45	.	.	PUNCT
dpc-3843	130	1	in	in	ADP
dpc-3843	130	2	the	the	DET
dpc-3843	130	3	current	current	ADJ
dpc-3843	130	4	study	study	NOUN
dpc-3843	130	5	,	,	PUNCT
dpc-3843	130	6	we	we	PRON
dpc-3843	130	7	will	will	AUX
dpc-3843	130	8	focus	focus	VERB
dpc-3843	130	9	focused	focus	VERB
dpc-3843	130	10	on	on	ADP
dpc-3843	130	11	three	three	NUM
dpc-3843	130	12	of	of	ADP
dpc-3843	130	13	the	the	DET
dpc-3843	130	14	possible	possible	ADJ
dpc-3843	130	15	mechanisms	mechanism	NOUN
dpc-3843	130	16	of	of	ADP
dpc-3843	130	17	vitiligo	vitiligo	ADJ
dpc-3843	130	18	etiology	etiology	NOUN
dpc-3843	130	19	through	through	ADP
dpc-3843	130	20	figure	figure	NOUN
dpc-3843	130	21	1	1	NUM
dpc-3843	130	22	.	.	PUNCT
dpc-3843	130	23	graphical	graphical	ADJ
dpc-3843	130	24	representation	representation	NOUN
dpc-3843	130	25	of	of	ADP
dpc-3843	130	26	the	the	DET
dpc-3843	130	27	distribution	distribution	NOUN
dpc-3843	130	28	of	of	ADP
dpc-3843	130	29	podocalyxin	podocalyxin	NOUN
dpc-3843	130	30	,	,	PUNCT
dpc-3843	130	31	cht-1	cht-1	PUNCT
dpc-3843	130	32	and	and	CCONJ
dpc-3843	130	33	tumstatin	tumstatin	NOUN
dpc-3843	130	34	levels	level	NOUN
dpc-3843	130	35	in	in	ADP
dpc-3843	130	36	vitiligo	vitiligo	NOUN
dpc-3843	130	37	and	and	CCONJ
dpc-3843	130	38	control	control	NOUN
dpc-3843	130	39	groups	group	NOUN
dpc-3843	130	40	.	.	PUNCT
dpc-3843	131	1	original	original	ADJ
dpc-3843	131	2	article	article	NOUN
dpc-3843	131	3	|	|	ADV
dpc-3843	131	4	dermatol	dermatol	ADJ
dpc-3843	131	5	pract	pract	NOUN
dpc-3843	131	6	concept	concept	NOUN
dpc-3843	131	7	.	.	PUNCT
dpc-3843	132	1	2024;14(1):e2024095	2024;14(1):e2024095	NUM
dpc-3843	132	2	5	5	NUM
dpc-3843	132	3	for	for	ADP
dpc-3843	132	4	tumstatin	tumstatin	NOUN
dpc-3843	132	5	to	to	PART
dpc-3843	132	6	act	act	VERB
dpc-3843	132	7	,	,	PUNCT
dpc-3843	132	8	αvβ3	αvβ3	NOUN
dpc-3843	132	9	integrin	integrin	NOUN
dpc-3843	132	10	receptors	receptor	NOUN
dpc-3843	132	11	are	be	AUX
dpc-3843	132	12	needed	need	VERB
dpc-3843	132	13	in	in	ADP
dpc-3843	132	14	newly	newly	ADV
dpc-3843	132	15	formed	form	VERB
dpc-3843	132	16	pathological	pathological	ADJ
dpc-3843	132	17	vessels	vessel	NOUN
dpc-3843	132	18	[	[	X
dpc-3843	132	19	26	26	NUM
dpc-3843	132	20	]	]	PUNCT
dpc-3843	132	21	.	.	PUNCT
dpc-3843	133	1	decreased	decrease	VERB
dpc-3843	133	2	tumstatin	tumstatin	NOUN
dpc-3843	133	3	levels	level	NOUN
dpc-3843	133	4	in	in	ADP
dpc-3843	133	5	vitiligo	vitiligo	ADJ
dpc-3843	133	6	patients	patient	NOUN
dpc-3843	133	7	may	may	AUX
dpc-3843	133	8	increase	increase	VERB
dpc-3843	133	9	neovascularization	neovascularization	NOUN
dpc-3843	133	10	and	and	CCONJ
dpc-3843	133	11	blood	blood	NOUN
dpc-3843	133	12	flow	flow	NOUN
dpc-3843	133	13	by	by	ADP
dpc-3843	133	14	stimulating	stimulate	VERB
dpc-3843	133	15	endothelial	endothelial	ADJ
dpc-3843	133	16	proliferation	proliferation	NOUN
dpc-3843	133	17	.	.	PUNCT
dpc-3843	134	1	increased	increase	VERB
dpc-3843	134	2	angiogenesis	angiogenesis	NOUN
dpc-3843	134	3	and	and	CCONJ
dpc-3843	134	4	detection	detection	NOUN
dpc-3843	134	5	of	of	ADP
dpc-3843	134	6	vegfr2	vegfr2	ADJ
dpc-3843	134	7	positive	positive	ADJ
dpc-3843	134	8	endothelial	endothelial	ADJ
dpc-3843	134	9	cells	cell	NOUN
dpc-3843	134	10	in	in	ADP
dpc-3843	134	11	animals	animal	NOUN
dpc-3843	134	12	with	with	ADP
dpc-3843	134	13	inherentdeletion	inherentdeletion	NOUN
dpc-3843	134	14	of	of	ADP
dpc-3843	134	15	col	col	NOUN
dpc-3843	134	16	-	-	ADJ
dpc-3843	134	17	ivα3/	ivα3/	ADJ
dpc-3843	134	18	tumstatin	tumstatin	NOUN
dpc-3843	134	19	support	support	VERB
dpc-3843	134	20	the	the	DET
dpc-3843	134	21	role	role	NOUN
dpc-3843	134	22	of	of	ADP
dpc-3843	134	23	tumstatin	tumstatin	NOUN
dpc-3843	134	24	in	in	ADP
dpc-3843	134	25	the	the	DET
dpc-3843	134	26	vascularization	vascularization	NOUN
dpc-3843	134	27	defect	defect	NOUN
dpc-3843	134	28	in	in	ADP
dpc-3843	134	29	vitiligo	vitiligo	ADJ
dpc-3843	134	30	patients	patient	NOUN
dpc-3843	134	31	[	[	X
dpc-3843	134	32	26	26	NUM
dpc-3843	134	33	]	]	PUNCT
dpc-3843	134	34	.	.	PUNCT
dpc-3843	135	1	when	when	SCONJ
dpc-3843	135	2	our	our	PRON
dpc-3843	135	3	results	result	NOUN
dpc-3843	135	4	and	and	CCONJ
dpc-3843	135	5	literature	literature	NOUN
dpc-3843	135	6	data	datum	NOUN
dpc-3843	135	7	are	be	AUX
dpc-3843	135	8	evaluated	evaluate	VERB
dpc-3843	135	9	together	together	ADV
dpc-3843	135	10	,	,	PUNCT
dpc-3843	135	11	we	we	PRON
dpc-3843	135	12	can	can	AUX
dpc-3843	135	13	suggest	suggest	VERB
dpc-3843	135	14	that	that	SCONJ
dpc-3843	135	15	defective	defective	ADJ
dpc-3843	135	16	serum	serum	NOUN
dpc-3843	135	17	tumstatin	tumstatin	NOUN
dpc-3843	135	18	release	release	NOUN
dpc-3843	135	19	in	in	ADP
dpc-3843	135	20	vitiligo	vitiligo	ADJ
dpc-3843	135	21	patients	patient	NOUN
dpc-3843	135	22	may	may	AUX
dpc-3843	135	23	contribute	contribute	VERB
dpc-3843	135	24	to	to	ADP
dpc-3843	135	25	neoangiogenesis	neoangiogenesis	NOUN
dpc-3843	135	26	and	and	CCONJ
dpc-3843	135	27	lesion	lesion	NOUN
dpc-3843	135	28	spread	spread	VERB
dpc-3843	135	29	.	.	PUNCT
dpc-3843	136	1	more	more	ADV
dpc-3843	136	2	clear	clear	ADJ
dpc-3843	136	3	results	result	NOUN
dpc-3843	136	4	can	can	AUX
dpc-3843	136	5	be	be	AUX
dpc-3843	136	6	obtained	obtain	VERB
dpc-3843	136	7	by	by	ADP
dpc-3843	136	8	staining	stain	VERB
dpc-3843	136	9	tumstatin	tumstatin	NOUN
dpc-3843	136	10	,	,	PUNCT
dpc-3843	136	11	mmp-9	mmp-9	NOUN
dpc-3843	136	12	and	and	CCONJ
dpc-3843	136	13	integrin	integrin	NOUN
dpc-3843	136	14	receptors	receptor	NOUN
dpc-3843	136	15	in	in	ADP
dpc-3843	136	16	biopsy	biopsy	NOUN
dpc-3843	136	17	samples	sample	NOUN
dpc-3843	136	18	from	from	ADP
dpc-3843	136	19	vitiligo	vitiligo	ADJ
dpc-3843	136	20	lesions	lesion	NOUN
dpc-3843	136	21	.	.	PUNCT
dpc-3843	137	1	the	the	DET
dpc-3843	137	2	third	third	ADJ
dpc-3843	137	3	etiological	etiological	ADJ
dpc-3843	137	4	mechanism	mechanism	NOUN
dpc-3843	137	5	we	we	PRON
dpc-3843	137	6	focus	focus	VERB
dpc-3843	137	7	on	on	ADP
dpc-3843	137	8	to	to	PART
dpc-3843	137	9	explain	explain	VERB
dpc-3843	137	10	is	be	AUX
dpc-3843	137	11	the	the	DET
dpc-3843	137	12	tinherent	tinherent	NOUN
dpc-3843	137	13	defect	defect	VERB
dpc-3843	137	14	in	in	ADP
dpc-3843	137	15	innate	innate	ADJ
dpc-3843	137	16	immunity	immunity	NOUN
dpc-3843	137	17	.	.	PUNCT
dpc-3843	138	1	for	for	ADP
dpc-3843	138	2	this	this	DET
dpc-3843	138	3	purpose	purpose	NOUN
dpc-3843	138	4	,	,	PUNCT
dpc-3843	138	5	we	we	PRON
dpc-3843	138	6	measured	measure	VERB
dpc-3843	138	7	serum	serum	NOUN
dpc-3843	138	8	chitinase	chitinase	NOUN
dpc-3843	138	9	1	1	NUM
dpc-3843	138	10	(	(	PUNCT
dpc-3843	138	11	chit-1	chit-1	PROPN
dpc-3843	138	12	)	)	PUNCT
dpc-3843	138	13	levels	level	NOUN
dpc-3843	138	14	in	in	ADP
dpc-3843	138	15	vitiligo	vitiligo	NOUN
dpc-3843	138	16	patients	patient	NOUN
dpc-3843	138	17	.	.	PUNCT
dpc-3843	139	1	we	we	PRON
dpc-3843	139	2	found	find	VERB
dpc-3843	139	3	a	a	DET
dpc-3843	139	4	significant	significant	ADJ
dpc-3843	139	5	increase	increase	NOUN
dpc-3843	139	6	in	in	ADP
dpc-3843	139	7	chit-1	chit-1	NUM
dpc-3843	139	8	levels	level	NOUN
dpc-3843	139	9	in	in	ADP
dpc-3843	139	10	vitiligo	vitiligo	ADJ
dpc-3843	139	11	patients	patient	NOUN
dpc-3843	139	12	compared	compare	VERB
dpc-3843	139	13	to	to	ADP
dpc-3843	139	14	the	the	DET
dpc-3843	139	15	control	control	NOUN
dpc-3843	139	16	group	group	NOUN
dpc-3843	139	17	.	.	PUNCT
dpc-3843	140	1	chit-1	chit-1	NUM
dpc-3843	140	2	produced	produce	VERB
dpc-3843	140	3	and	and	CCONJ
dpc-3843	140	4	released	release	VERB
dpc-3843	140	5	by	by	ADP
dpc-3843	140	6	macrophages	macrophage	NOUN
dpc-3843	140	7	and	and	CCONJ
dpc-3843	140	8	neutrophils	neutrophil	NOUN
dpc-3843	140	9	is	be	AUX
dpc-3843	140	10	involved	involve	VERB
dpc-3843	140	11	in	in	ADP
dpc-3843	140	12	the	the	DET
dpc-3843	140	13	regulation	regulation	NOUN
dpc-3843	140	14	of	of	ADP
dpc-3843	140	15	innate	innate	ADJ
dpc-3843	140	16	immunity	immunity	NOUN
dpc-3843	140	17	[	[	X
dpc-3843	140	18	13	13	NUM
dpc-3843	140	19	]	]	PUNCT
dpc-3843	140	20	.	.	PUNCT
dpc-3843	141	1	chit-1	chit-1	NUM
dpc-3843	141	2	is	be	AUX
dpc-3843	141	3	elevated	elevate	VERB
dpc-3843	141	4	in	in	ADP
dpc-3843	141	5	autoimmune	autoimmune	ADJ
dpc-3843	141	6	reactions	reaction	NOUN
dpc-3843	141	7	and	and	CCONJ
dpc-3843	141	8	t	t	PROPN
dpc-3843	141	9	hepler	hepler	NOUN
dpc-3843	141	10	-	-	PUNCT
dpc-3843	141	11	mediated	mediate	VERB
dpc-3843	141	12	inflammatory	inflammatory	ADJ
dpc-3843	141	13	reactions	reaction	NOUN
dpc-3843	141	14	[	[	X
dpc-3843	141	15	29	29	NUM
dpc-3843	141	16	]	]	PUNCT
dpc-3843	141	17	.	.	PUNCT
dpc-3843	142	1	increased	increase	VERB
dpc-3843	142	2	serum	serum	NOUN
dpc-3843	142	3	chit-1	chit-1	NUM
dpc-3843	142	4	levels	level	NOUN
dpc-3843	142	5	in	in	ADP
dpc-3843	142	6	vitiligo	vitiligo	NOUN
dpc-3843	142	7	are	be	AUX
dpc-3843	142	8	compatible	compatible	ADJ
dpc-3843	142	9	with	with	ADP
dpc-3843	142	10	the	the	DET
dpc-3843	142	11	autoimmune	autoimmune	ADJ
dpc-3843	142	12	and	and	CCONJ
dpc-3843	142	13	inflammatory	inflammatory	ADJ
dpc-3843	142	14	nature	nature	NOUN
dpc-3843	142	15	of	of	ADP
dpc-3843	142	16	the	the	DET
dpc-3843	142	17	disease	disease	NOUN
dpc-3843	142	18	and	and	CCONJ
dpc-3843	142	19	can	can	AUX
dpc-3843	142	20	be	be	AUX
dpc-3843	142	21	considered	consider	VERB
dpc-3843	142	22	as	as	ADP
dpc-3843	142	23	evidence	evidence	NOUN
dpc-3843	142	24	of	of	ADP
dpc-3843	142	25	impaired	impaired	ADJ
dpc-3843	142	26	innate	innate	ADJ
dpc-3843	142	27	immunity	immunity	NOUN
dpc-3843	142	28	.	.	PUNCT
dpc-3843	143	1	although	although	SCONJ
dpc-3843	143	2	increased	increase	VERB
dpc-3843	143	3	chit1	chit1	NOUN
dpc-3843	143	4	levels	level	NOUN
dpc-3843	143	5	are	be	AUX
dpc-3843	143	6	observed	observe	VERB
dpc-3843	143	7	in	in	ADP
dpc-3843	143	8	many	many	ADJ
dpc-3843	143	9	disease	disease	NOUN
dpc-3843	143	10	groups	group	NOUN
dpc-3843	143	11	requiring	require	VERB
dpc-3843	143	12	macrophage	macrophage	ADJ
dpc-3843	143	13	activation	activation	NOUN
dpc-3843	143	14	,	,	PUNCT
dpc-3843	143	15	chit1	chit1	PROPN
dpc-3843	143	16	also	also	ADV
dpc-3843	143	17	plays	play	VERB
dpc-3843	143	18	a	a	DET
dpc-3843	143	19	critical	critical	ADJ
dpc-3843	143	20	role	role	NOUN
dpc-3843	143	21	in	in	ADP
dpc-3843	143	22	the	the	DET
dpc-3843	143	23	regulation	regulation	NOUN
dpc-3843	143	24	of	of	ADP
dpc-3843	143	25	inflammation	inflammation	NOUN
dpc-3843	143	26	and	and	CCONJ
dpc-3843	143	27	innate	innate	ADJ
dpc-3843	143	28	immune	immune	ADJ
dpc-3843	143	29	response	response	NOUN
dpc-3843	143	30	[	[	X
dpc-3843	143	31	30	30	NUM
dpc-3843	143	32	]	]	PUNCT
dpc-3843	143	33	.	.	PUNCT
dpc-3843	144	1	although	although	SCONJ
dpc-3843	144	2	mammals	mammal	NOUN
dpc-3843	144	3	do	do	AUX
dpc-3843	144	4	not	not	PART
dpc-3843	144	5	have	have	VERB
dpc-3843	144	6	chitin	chitin	NOUN
dpc-3843	144	7	or	or	CCONJ
dpc-3843	144	8	chitin	chitin	NOUN
dpc-3843	144	9	synthases	synthase	NOUN
dpc-3843	144	10	genes	gene	NOUN
dpc-3843	144	11	,	,	PUNCT
dpc-3843	144	12	they	they	PRON
dpc-3843	144	13	can	can	AUX
dpc-3843	144	14	synthesize	synthesize	VERB
dpc-3843	144	15	this	this	DET
dpc-3843	144	16	molecule	molecule	NOUN
dpc-3843	144	17	by	by	ADP
dpc-3843	144	18	enzymatic	enzymatic	ADJ
dpc-3843	144	19	activity	activity	NOUN
dpc-3843	144	20	[	[	X
dpc-3843	144	21	31	31	NUM
dpc-3843	144	22	]	]	PUNCT
dpc-3843	144	23	.	.	PUNCT
dpc-3843	145	1	it	it	PRON
dpc-3843	145	2	is	be	AUX
dpc-3843	145	3	known	know	VERB
dpc-3843	145	4	that	that	SCONJ
dpc-3843	145	5	the	the	DET
dpc-3843	145	6	level	level	NOUN
dpc-3843	145	7	of	of	ADP
dpc-3843	145	8	chitinases	chitinase	NOUN
dpc-3843	145	9	increases	increase	NOUN
dpc-3843	145	10	in	in	ADP
dpc-3843	145	11	neurodegenerative	neurodegenerative	ADJ
dpc-3843	145	12	disorders	disorder	NOUN
dpc-3843	145	13	such	such	ADJ
dpc-3843	145	14	as	as	ADP
dpc-3843	145	15	multiple	multiple	ADJ
dpc-3843	145	16	sclerosis	sclerosis	NOUN
dpc-3843	145	17	,	,	PUNCT
dpc-3843	145	18	alzheimer	alzheimer	PROPN
dpc-3843	145	19	’s	’s	PART
dpc-3843	145	20	disease	disease	NOUN
dpc-3843	145	21	or	or	CCONJ
dpc-3843	145	22	amyotrophic	amyotrophic	ADJ
dpc-3843	145	23	lateral	lateral	ADJ
dpc-3843	145	24	sclerosis	sclerosis	NOUN
dpc-3843	145	25	with	with	ADP
dpc-3843	145	26	neuroinflammation	neuroinflammation	NOUN
dpc-3843	145	27	[	[	X
dpc-3843	145	28	30	30	NUM
dpc-3843	145	29	,	,	PUNCT
dpc-3843	145	30	32	32	NUM
dpc-3843	145	31	]	]	PUNCT
dpc-3843	145	32	.	.	PUNCT
dpc-3843	146	1	as	as	SCONJ
dpc-3843	146	2	the	the	DET
dpc-3843	146	3	increase	increase	NOUN
dpc-3843	146	4	in	in	ADP
dpc-3843	146	5	chit1	chit1	NOUN
dpc-3843	146	6	will	will	AUX
dpc-3843	146	7	increase	increase	VERB
dpc-3843	146	8	the	the	DET
dpc-3843	146	9	degradation	degradation	NOUN
dpc-3843	146	10	of	of	ADP
dpc-3843	146	11	chitin	chitin	NOUN
dpc-3843	146	12	,	,	PUNCT
dpc-3843	146	13	intermediate	intermediate	ADJ
dpc-3843	146	14	molecules	molecule	NOUN
dpc-3843	146	15	such	such	ADJ
dpc-3843	146	16	as	as	ADP
dpc-3843	146	17	chitinase	chitinase	NOUN
dpc-3843	146	18	-	-	PUNCT
dpc-3843	146	19	like	like	ADJ
dpc-3843	146	20	proteins	protein	NOUN
dpc-3843	146	21	are	be	AUX
dpc-3843	146	22	formed	form	VERB
dpc-3843	146	23	and	and	CCONJ
dpc-3843	146	24	act	act	VERB
dpc-3843	146	25	in	in	ADP
dpc-3843	146	26	innate	innate	ADJ
dpc-3843	146	27	immunity	immunity	NOUN
dpc-3843	146	28	similar	similar	ADJ
dpc-3843	146	29	to	to	ADP
dpc-3843	146	30	host	host	NOUN
dpc-3843	146	31	defense	defense	NOUN
dpc-3843	146	32	enzymes	enzyme	NOUN
dpc-3843	146	33	[	[	X
dpc-3843	146	34	14	14	NUM
dpc-3843	146	35	]	]	PUNCT
dpc-3843	146	36	.	.	PUNCT
dpc-3843	147	1	since	since	SCONJ
dpc-3843	147	2	abnormal	abnormal	ADJ
dpc-3843	147	3	sympathetic	sympathetic	ADJ
dpc-3843	147	4	innervation	innervation	NOUN
dpc-3843	147	5	and	and	CCONJ
dpc-3843	147	6	defective	defective	ADJ
dpc-3843	147	7	neuropeptide	neuropeptide	NOUN
dpc-3843	147	8	secretion	secretion	NOUN
dpc-3843	147	9	are	be	AUX
dpc-3843	147	10	involved	involve	VERB
dpc-3843	147	11	in	in	ADP
dpc-3843	147	12	the	the	DET
dpc-3843	147	13	etiology	etiology	NOUN
dpc-3843	147	14	of	of	ADP
dpc-3843	147	15	vitiligo	vitiligo	NOUN
dpc-3843	148	1	[	[	X
dpc-3843	148	2	16	16	NUM
dpc-3843	148	3	]	]	PUNCT
dpc-3843	148	4	,	,	PUNCT
dpc-3843	148	5	increased	increase	VERB
dpc-3843	148	6	chit1	chit1	NOUN
dpc-3843	148	7	levels	level	NOUN
dpc-3843	148	8	may	may	AUX
dpc-3843	148	9	trigger	trigger	VERB
dpc-3843	148	10	neuroinflammation	neuroinflammation	NOUN
dpc-3843	148	11	in	in	ADP
dpc-3843	148	12	the	the	DET
dpc-3843	148	13	epidermal	epidermal	ADJ
dpc-3843	148	14	-	-	PUNCT
dpc-3843	148	15	melanin	melanin	ADJ
dpc-3843	148	16	unit	unit	NOUN
dpc-3843	148	17	,	,	PUNCT
dpc-3843	148	18	resulting	result	VERB
dpc-3843	148	19	in	in	ADP
dpc-3843	148	20	impaired	impaired	ADJ
dpc-3843	148	21	innate	innate	ADJ
dpc-3843	148	22	immunity	immunity	NOUN
dpc-3843	148	23	and	and	CCONJ
dpc-3843	148	24	loss	loss	NOUN
dpc-3843	148	25	of	of	ADP
dpc-3843	148	26	melanocytes	melanocyte	NOUN
dpc-3843	148	27	.	.	PUNCT
dpc-3843	149	1	however	however	ADV
dpc-3843	149	2	,	,	PUNCT
dpc-3843	149	3	it	it	PRON
dpc-3843	149	4	may	may	AUX
dpc-3843	149	5	be	be	AUX
dpc-3843	149	6	possible	possible	ADJ
dpc-3843	149	7	to	to	PART
dpc-3843	149	8	reach	reach	VERB
dpc-3843	149	9	a	a	DET
dpc-3843	149	10	clearer	clear	ADJ
dpc-3843	149	11	conclusion	conclusion	NOUN
dpc-3843	149	12	by	by	ADP
dpc-3843	149	13	demonstrating	demonstrate	VERB
dpc-3843	149	14	chit1	chit1	NOUN
dpc-3843	149	15	overexpression	overexpression	NOUN
dpc-3843	149	16	in	in	ADP
dpc-3843	149	17	biopsies	biopsy	NOUN
dpc-3843	149	18	obtained	obtain	VERB
dpc-3843	149	19	from	from	ADP
dpc-3843	149	20	areas	area	NOUN
dpc-3843	149	21	affected	affect	VERB
dpc-3843	149	22	by	by	ADP
dpc-3843	149	23	vitiligo	vitiligo	NOUN
dpc-3843	149	24	.	.	PUNCT
dpc-3843	150	1	despite	despite	SCONJ
dpc-3843	150	2	the	the	DET
dpc-3843	150	3	small	small	ADJ
dpc-3843	150	4	number	number	NOUN
dpc-3843	150	5	of	of	ADP
dpc-3843	150	6	participants	participant	NOUN
dpc-3843	150	7	,	,	PUNCT
dpc-3843	150	8	our	our	PRON
dpc-3843	150	9	study	study	NOUN
dpc-3843	150	10	has	have	VERB
dpc-3843	150	11	clinical	clinical	ADJ
dpc-3843	150	12	value	value	NOUN
dpc-3843	150	13	in	in	ADP
dpc-3843	150	14	terms	term	NOUN
dpc-3843	150	15	of	of	ADP
dpc-3843	150	16	investigating	investigate	VERB
dpc-3843	150	17	three	three	NUM
dpc-3843	150	18	new	new	ADJ
dpc-3843	150	19	molecules	molecule	NOUN
dpc-3843	150	20	for	for	ADP
dpc-3843	150	21	vitiligo	vitiligo	NOUN
dpc-3843	150	22	etiology	etiology	NOUN
dpc-3843	150	23	as	as	ADP
dpc-3843	150	24	a	a	DET
dpc-3843	150	25	possible	possible	ADJ
dpc-3843	150	26	etiological	etiological	ADJ
dpc-3843	150	27	factor	factor	NOUN
dpc-3843	150	28	for	for	ADP
dpc-3843	150	29	the	the	DET
dpc-3843	150	30	first	first	ADJ
dpc-3843	150	31	time	time	NOUN
dpc-3843	150	32	.	.	PUNCT
dpc-3843	151	1	this	this	DET
dpc-3843	151	2	study	study	NOUN
dpc-3843	151	3	may	may	AUX
dpc-3843	151	4	lead	lead	VERB
dpc-3843	151	5	to	to	ADP
dpc-3843	151	6	the	the	DET
dpc-3843	151	7	development	development	NOUN
dpc-3843	151	8	of	of	ADP
dpc-3843	151	9	new	new	ADJ
dpc-3843	151	10	drug	drug	NOUN
dpc-3843	151	11	options	option	NOUN
dpc-3843	151	12	for	for	ADP
dpc-3843	151	13	the	the	DET
dpc-3843	151	14	treatment	treatment	NOUN
dpc-3843	151	15	of	of	ADP
dpc-3843	151	16	vitiligo	vitiligo	NOUN
dpc-3843	151	17	by	by	ADP
dpc-3843	151	18	showing	show	VERB
dpc-3843	151	19	the	the	DET
dpc-3843	151	20	anti	anti	ADJ
dpc-3843	151	21	-	-	ADJ
dpc-3843	151	22	adhesive	adhesive	ADJ
dpc-3843	151	23	effect	effect	NOUN
dpc-3843	151	24	of	of	ADP
dpc-3843	151	25	podxl	podxl	NOUN
dpc-3843	151	26	,	,	PUNCT
dpc-3843	151	27	the	the	DET
dpc-3843	151	28	anti	anti	ADJ
dpc-3843	151	29	-	-	ADJ
dpc-3843	151	30	angioinherent	angioinherent	ADJ
dpc-3843	151	31	effect	effect	NOUN
dpc-3843	151	32	of	of	ADP
dpc-3843	151	33	tumstatin	tumstatin	NOUN
dpc-3843	151	34	and	and	CCONJ
dpc-3843	151	35	the	the	DET
dpc-3843	151	36	effects	effect	NOUN
dpc-3843	151	37	of	of	ADP
dpc-3843	151	38	chit1	chit1	NOUN
dpc-3843	151	39	on	on	ADP
dpc-3843	151	40	neuroinflammation	neuroinflammation	NOUN
dpc-3843	151	41	and	and	CCONJ
dpc-3843	151	42	innate	innate	ADJ
dpc-3843	151	43	immunity	immunity	NOUN
dpc-3843	151	44	in	in	ADP
dpc-3843	151	45	vitiligo	vitiligo	ADJ
dpc-3843	151	46	patients	patient	NOUN
dpc-3843	151	47	.	.	PUNCT
dpc-3843	152	1	since	since	SCONJ
dpc-3843	152	2	podxl	podxl	PROPN
dpc-3843	152	3	inhibits	inhibit	VERB
dpc-3843	152	4	binding	bind	VERB
dpc-3843	152	5	via	via	ADP
dpc-3843	152	6	adapter	adapter	NOUN
dpc-3843	152	7	proteins	protein	NOUN
dpc-3843	152	8	in	in	ADP
dpc-3843	152	9	many	many	ADJ
dpc-3843	152	10	cells	cell	NOUN
dpc-3843	152	11	,	,	PUNCT
dpc-3843	152	12	it	it	PRON
dpc-3843	152	13	may	may	AUX
dpc-3843	152	14	cause	cause	VERB
dpc-3843	152	15	loss	loss	NOUN
dpc-3843	152	16	of	of	ADP
dpc-3843	152	17	melanocytes	melanocyte	NOUN
dpc-3843	152	18	by	by	ADP
dpc-3843	152	19	disrupting	disrupt	VERB
dpc-3843	152	20	the	the	DET
dpc-3843	152	21	integrity	integrity	NOUN
dpc-3843	152	22	of	of	ADP
dpc-3843	152	23	the	the	DET
dpc-3843	152	24	epidermal	epidermal	ADJ
dpc-3843	152	25	-	-	PUNCT
dpc-3843	152	26	melanin	melanin	ADJ
dpc-3843	152	27	unit	unit	NOUN
dpc-3843	152	28	[	[	X
dpc-3843	152	29	23	23	NUM
dpc-3843	152	30	]	]	PUNCT
dpc-3843	152	31	.	.	PUNCT
dpc-3843	153	1	while	while	SCONJ
dpc-3843	153	2	podxl	podxl	PROPN
dpc-3843	153	3	is	be	AUX
dpc-3843	153	4	necessary	necessary	ADJ
dpc-3843	153	5	for	for	ADP
dpc-3843	153	6	the	the	DET
dpc-3843	153	7	continuation	continuation	NOUN
dpc-3843	153	8	of	of	ADP
dpc-3843	153	9	the	the	DET
dpc-3843	153	10	functions	function	NOUN
dpc-3843	153	11	of	of	ADP
dpc-3843	153	12	many	many	ADJ
dpc-3843	153	13	organs	organ	NOUN
dpc-3843	153	14	such	such	ADJ
dpc-3843	153	15	as	as	ADP
dpc-3843	153	16	kidney	kidney	NOUN
dpc-3843	153	17	,	,	PUNCT
dpc-3843	153	18	pancreas	pancrea	NOUN
dpc-3843	153	19	,	,	PUNCT
dpc-3843	153	20	and	and	CCONJ
dpc-3843	153	21	breast	breast	NOUN
dpc-3843	153	22	,	,	PUNCT
dpc-3843	153	23	its	its	PRON
dpc-3843	153	24	pathological	pathological	ADJ
dpc-3843	153	25	expression	expression	NOUN
dpc-3843	153	26	may	may	AUX
dpc-3843	153	27	lead	lead	VERB
dpc-3843	153	28	to	to	ADP
dpc-3843	153	29	the	the	DET
dpc-3843	153	30	emergence	emergence	NOUN
dpc-3843	153	31	of	of	ADP
dpc-3843	153	32	different	different	ADJ
dpc-3843	153	33	diseases	disease	NOUN
dpc-3843	153	34	,	,	PUNCT
dpc-3843	153	35	including	include	VERB
dpc-3843	153	36	cancer	cancer	NOUN
dpc-3843	153	37	[	[	X
dpc-3843	153	38	11	11	NUM
dpc-3843	153	39	,	,	PUNCT
dpc-3843	153	40	24	24	NUM
dpc-3843	153	41	]	]	PUNCT
dpc-3843	153	42	.	.	PUNCT
dpc-3843	154	1	since	since	SCONJ
dpc-3843	154	2	these	these	DET
dpc-3843	154	3	functions	function	NOUN
dpc-3843	154	4	of	of	ADP
dpc-3843	154	5	podxl	podxl	NOUN
dpc-3843	154	6	in	in	ADP
dpc-3843	154	7	cell	cell	NOUN
dpc-3843	154	8	adhesion	adhesion	NOUN
dpc-3843	154	9	under	under	ADP
dpc-3843	154	10	physiological	physiological	ADJ
dpc-3843	154	11	conditions	condition	NOUN
dpc-3843	154	12	will	will	AUX
dpc-3843	154	13	be	be	AUX
dpc-3843	154	14	impaired	impair	VERB
dpc-3843	154	15	in	in	ADP
dpc-3843	154	16	case	case	NOUN
dpc-3843	154	17	of	of	ADP
dpc-3843	154	18	podxl	podxl	ADJ
dpc-3843	154	19	overexpression	overexpression	NOUN
dpc-3843	154	20	,	,	PUNCT
dpc-3843	154	21	it	it	PRON
dpc-3843	154	22	may	may	AUX
dpc-3843	154	23	contribute	contribute	VERB
dpc-3843	154	24	to	to	ADP
dpc-3843	154	25	melanocyte	melanocyte	NOUN
dpc-3843	154	26	loss	loss	NOUN
dpc-3843	154	27	and	and	CCONJ
dpc-3843	154	28	disease	disease	NOUN
dpc-3843	154	29	progression	progression	NOUN
dpc-3843	154	30	in	in	ADP
dpc-3843	154	31	vitiligo	vitiligo	NOUN
dpc-3843	154	32	patients	patient	NOUN
dpc-3843	154	33	.	.	PUNCT
dpc-3843	155	1	therefore	therefore	ADV
dpc-3843	155	2	,	,	PUNCT
dpc-3843	155	3	podxl	podxl	PROPN
dpc-3843	155	4	can	can	AUX
dpc-3843	155	5	be	be	AUX
dpc-3843	155	6	a	a	DET
dpc-3843	155	7	new	new	ADJ
dpc-3843	155	8	marker	marker	NOUN
dpc-3843	155	9	that	that	PRON
dpc-3843	155	10	may	may	AUX
dpc-3843	155	11	contribute	contribute	VERB
dpc-3843	155	12	to	to	ADP
dpc-3843	155	13	the	the	DET
dpc-3843	155	14	formation	formation	NOUN
dpc-3843	155	15	of	of	ADP
dpc-3843	155	16	vitiligo	vitiligo	NOUN
dpc-3843	155	17	,	,	PUNCT
dpc-3843	155	18	or	or	CCONJ
dpc-3843	155	19	it	it	PRON
dpc-3843	155	20	can	can	AUX
dpc-3843	155	21	be	be	AUX
dpc-3843	155	22	used	use	VERB
dpc-3843	155	23	as	as	ADP
dpc-3843	155	24	a	a	DET
dpc-3843	155	25	potential	potential	ADJ
dpc-3843	155	26	biomarker	biomarker	NOUN
dpc-3843	155	27	in	in	ADP
dpc-3843	155	28	the	the	DET
dpc-3843	155	29	differentiation	differentiation	NOUN
dpc-3843	155	30	of	of	ADP
dpc-3843	155	31	segmental	segmental	ADJ
dpc-3843	155	32	and	and	CCONJ
dpc-3843	155	33	nonsegmental	nonsegmental	NOUN
dpc-3843	155	34	vitiligo	vitiligo	VERB
dpc-3843	155	35	.	.	PUNCT
dpc-3843	156	1	in	in	ADP
dpc-3843	156	2	addition	addition	NOUN
dpc-3843	156	3	,	,	PUNCT
dpc-3843	156	4	it	it	PRON
dpc-3843	156	5	may	may	AUX
dpc-3843	156	6	offer	offer	VERB
dpc-3843	156	7	an	an	DET
dpc-3843	156	8	opportunity	opportunity	NOUN
dpc-3843	156	9	to	to	PART
dpc-3843	156	10	develop	develop	VERB
dpc-3843	156	11	new	new	ADJ
dpc-3843	156	12	treatment	treatment	NOUN
dpc-3843	156	13	options	option	NOUN
dpc-3843	156	14	if	if	SCONJ
dpc-3843	156	15	the	the	DET
dpc-3843	156	16	relationship	relationship	NOUN
dpc-3843	156	17	of	of	ADP
dpc-3843	156	18	podxl	podxl	NOUN
dpc-3843	156	19	with	with	ADP
dpc-3843	156	20	vitilgo	vitilgo	NOUN
dpc-3843	156	21	pathogenesis	pathogenesis	NOUN
dpc-3843	156	22	and	and	CCONJ
dpc-3843	156	23	subtypes	subtype	NOUN
dpc-3843	156	24	is	be	AUX
dpc-3843	156	25	understood	understand	VERB
dpc-3843	156	26	more	more	ADV
dpc-3843	156	27	clearly	clearly	ADV
dpc-3843	156	28	.	.	PUNCT
dpc-3843	157	1	the	the	DET
dpc-3843	157	2	second	second	ADJ
dpc-3843	157	3	etiological	etiological	ADJ
dpc-3843	157	4	mechanism	mechanism	NOUN
dpc-3843	157	5	we	we	PRON
dpc-3843	157	6	focus	focus	VERB
dpc-3843	157	7	on	on	ADP
dpc-3843	157	8	is	be	AUX
dpc-3843	157	9	endothelial	endothelial	ADJ
dpc-3843	157	10	dysfunction	dysfunction	NOUN
dpc-3843	157	11	and	and	CCONJ
dpc-3843	157	12	increased	increase	VERB
dpc-3843	157	13	neovascularization	neovascularization	NOUN
dpc-3843	157	14	due	due	ADP
dpc-3843	157	15	to	to	ADP
dpc-3843	157	16	type	type	NOUN
dpc-3843	157	17	iv	iv	NUM
dpc-3843	157	18	collagen	collagen	NOUN
dpc-3843	157	19	alpha	alpha	NOUN
dpc-3843	157	20	3	3	NUM
dpc-3843	157	21	destruction	destruction	NOUN
dpc-3843	157	22	in	in	ADP
dpc-3843	157	23	the	the	DET
dpc-3843	157	24	vascular	vascular	ADJ
dpc-3843	157	25	basement	basement	NOUN
dpc-3843	157	26	membrane	membrane	NOUN
dpc-3843	157	27	.	.	PUNCT
dpc-3843	158	1	for	for	ADP
dpc-3843	158	2	this	this	DET
dpc-3843	158	3	purpose	purpose	NOUN
dpc-3843	158	4	,	,	PUNCT
dpc-3843	158	5	we	we	PRON
dpc-3843	158	6	measured	measure	VERB
dpc-3843	158	7	serum	serum	NOUN
dpc-3843	158	8	tumstatin	tumstatin	NOUN
dpc-3843	158	9	levels	level	NOUN
dpc-3843	158	10	.	.	PUNCT
dpc-3843	159	1	we	we	PRON
dpc-3843	159	2	encountered	encounter	VERB
dpc-3843	159	3	significantly	significantly	ADV
dpc-3843	159	4	reduced	reduce	VERB
dpc-3843	159	5	serum	serum	NOUN
dpc-3843	159	6	tumstatin	tumstatin	NOUN
dpc-3843	159	7	levels	level	NOUN
dpc-3843	159	8	in	in	ADP
dpc-3843	159	9	vitiligo	vitiligo	ADJ
dpc-3843	159	10	patients	patient	NOUN
dpc-3843	159	11	compared	compare	VERB
dpc-3843	159	12	to	to	ADP
dpc-3843	159	13	the	the	DET
dpc-3843	159	14	control	control	NOUN
dpc-3843	159	15	group	group	NOUN
dpc-3843	159	16	.	.	PUNCT
dpc-3843	160	1	tumstatin	tumstatin	NOUN
dpc-3843	160	2	is	be	AUX
dpc-3843	160	3	a	a	DET
dpc-3843	160	4	molecule	molecule	NOUN
dpc-3843	160	5	derived	derive	VERB
dpc-3843	160	6	from	from	ADP
dpc-3843	160	7	the	the	DET
dpc-3843	160	8	destruction	destruction	NOUN
dpc-3843	160	9	of	of	ADP
dpc-3843	160	10	type	type	NOUN
dpc-3843	160	11	iv	iv	NUM
dpc-3843	160	12	collagen	collagen	NOUN
dpc-3843	160	13	alpha	alpha	NOUN
dpc-3843	160	14	3	3	NUM
dpc-3843	160	15	(	(	PUNCT
dpc-3843	160	16	col	col	NOUN
dpc-3843	160	17	-	-	ADJ
dpc-3843	160	18	ivα3	ivα3	ADJ
dpc-3843	160	19	)	)	PUNCT
dpc-3843	160	20	in	in	ADP
dpc-3843	160	21	the	the	DET
dpc-3843	160	22	vascular	vascular	ADJ
dpc-3843	160	23	basement	basement	NOUN
dpc-3843	160	24	membrane	membrane	NOUN
dpc-3843	160	25	and	and	CCONJ
dpc-3843	160	26	is	be	AUX
dpc-3843	160	27	an	an	DET
dpc-3843	160	28	angiogenesis	angiogenesis	NOUN
dpc-3843	160	29	inhibitor	inhibitor	NOUN
dpc-3843	160	30	that	that	PRON
dpc-3843	160	31	blocks	block	VERB
dpc-3843	160	32	new	new	ADJ
dpc-3843	160	33	endothelial	endothelial	ADJ
dpc-3843	160	34	formation	formation	NOUN
dpc-3843	160	35	and	and	CCONJ
dpc-3843	160	36	neovascularization	neovascularization	NOUN
dpc-3843	160	37	[	[	X
dpc-3843	160	38	25	25	NUM
dpc-3843	160	39	,	,	PUNCT
dpc-3843	160	40	26	26	NUM
dpc-3843	160	41	]	]	PUNCT
dpc-3843	160	42	.	.	PUNCT
dpc-3843	161	1	decreased	decrease	VERB
dpc-3843	161	2	tumstatin	tumstatin	NOUN
dpc-3843	161	3	levels	level	NOUN
dpc-3843	161	4	in	in	ADP
dpc-3843	161	5	vitiligo	vitiligo	ADJ
dpc-3843	161	6	patients	patient	NOUN
dpc-3843	161	7	may	may	AUX
dpc-3843	161	8	cause	cause	VERB
dpc-3843	161	9	increased	increase	VERB
dpc-3843	161	10	endothelial	endothelial	ADJ
dpc-3843	161	11	proliferation	proliferation	NOUN
dpc-3843	161	12	and	and	CCONJ
dpc-3843	161	13	subsequent	subsequent	ADJ
dpc-3843	161	14	new	new	ADJ
dpc-3843	161	15	and	and	CCONJ
dpc-3843	161	16	irregular	irregular	ADJ
dpc-3843	161	17	neovascularization	neovascularization	NOUN
dpc-3843	161	18	.	.	PUNCT
dpc-3843	162	1	in	in	ADP
dpc-3843	162	2	the	the	DET
dpc-3843	162	3	presence	presence	NOUN
dpc-3843	162	4	of	of	ADP
dpc-3843	162	5	increased	increase	VERB
dpc-3843	162	6	vascularity	vascularity	NOUN
dpc-3843	162	7	and	and	CCONJ
dpc-3843	162	8	defective	defective	ADJ
dpc-3843	162	9	endothelium	endothelium	NOUN
dpc-3843	162	10	,	,	PUNCT
dpc-3843	162	11	melanocytes	melanocyte	NOUN
dpc-3843	162	12	will	will	AUX
dpc-3843	162	13	be	be	AUX
dpc-3843	162	14	more	more	ADV
dpc-3843	162	15	exposed	expose	VERB
dpc-3843	162	16	to	to	ADP
dpc-3843	162	17	cytotoxic	cytotoxic	ADJ
dpc-3843	162	18	t	t	NOUN
dpc-3843	162	19	cells	cell	NOUN
dpc-3843	162	20	,	,	PUNCT
dpc-3843	162	21	as	as	SCONJ
dpc-3843	162	22	there	there	PRON
dpc-3843	162	23	will	will	AUX
dpc-3843	162	24	be	be	AUX
dpc-3843	162	25	more	more	ADJ
dpc-3843	162	26	blood	blood	NOUN
dpc-3843	162	27	flow	flow	NOUN
dpc-3843	162	28	to	to	ADP
dpc-3843	162	29	the	the	DET
dpc-3843	162	30	vitiligo	vitiligo	NOUN
dpc-3843	162	31	area	area	NOUN
dpc-3843	162	32	.	.	PUNCT
dpc-3843	163	1	consistent	consistent	ADJ
dpc-3843	163	2	with	with	ADP
dpc-3843	163	3	our	our	PRON
dpc-3843	163	4	findings	finding	NOUN
dpc-3843	163	5	,	,	PUNCT
dpc-3843	163	6	doppler	doppler	NOUN
dpc-3843	163	7	flowmetry	flowmetry	NOUN
dpc-3843	163	8	studies	study	NOUN
dpc-3843	163	9	have	have	AUX
dpc-3843	163	10	reported	report	VERB
dpc-3843	163	11	that	that	SCONJ
dpc-3843	163	12	blood	blood	NOUN
dpc-3843	163	13	flow	flow	NOUN
dpc-3843	163	14	in	in	ADP
dpc-3843	163	15	segmental	segmental	ADJ
dpc-3843	163	16	vitiligo	vitiligo	NOUN
dpc-3843	163	17	areas	area	NOUN
dpc-3843	163	18	is	be	AUX
dpc-3843	163	19	increased	increase	VERB
dpc-3843	163	20	by	by	ADP
dpc-3843	163	21	more	more	ADJ
dpc-3843	163	22	than	than	ADP
dpc-3843	163	23	three	three	NUM
dpc-3843	163	24	times	time	NOUN
dpc-3843	163	25	compared	compare	VERB
dpc-3843	163	26	to	to	ADP
dpc-3843	163	27	healthy	healthy	ADJ
dpc-3843	163	28	areas	area	NOUN
dpc-3843	163	29	[	[	X
dpc-3843	163	30	27	27	NUM
dpc-3843	163	31	]	]	PUNCT
dpc-3843	163	32	.	.	PUNCT
dpc-3843	164	1	with	with	ADP
dpc-3843	164	2	increased	increase	VERB
dpc-3843	164	3	blood	blood	NOUN
dpc-3843	164	4	flow	flow	NOUN
dpc-3843	164	5	,	,	PUNCT
dpc-3843	164	6	especially	especially	ADV
dpc-3843	164	7	melanocyte	melanocyte	NOUN
dpc-3843	164	8	-	-	PUNCT
dpc-3843	164	9	specific	specific	ADJ
dpc-3843	164	10	cytotoxic	cytotoxic	ADJ
dpc-3843	164	11	t	t	NOUN
dpc-3843	164	12	cells	cell	NOUN
dpc-3843	164	13	reaching	reach	VERB
dpc-3843	164	14	the	the	DET
dpc-3843	164	15	epidermal	epidermal	ADJ
dpc-3843	164	16	-	-	PUNCT
dpc-3843	164	17	melanin	melanin	NOUN
dpc-3843	164	18	unit	unit	NOUN
dpc-3843	164	19	and	and	CCONJ
dpc-3843	164	20	binding	bind	VERB
dpc-3843	164	21	to	to	ADP
dpc-3843	164	22	melanocytes	melanocyte	NOUN
dpc-3843	164	23	may	may	AUX
dpc-3843	164	24	lead	lead	VERB
dpc-3843	164	25	to	to	ADP
dpc-3843	164	26	rapid	rapid	ADJ
dpc-3843	164	27	depigmentation	depigmentation	NOUN
dpc-3843	164	28	and	and	CCONJ
dpc-3843	164	29	the	the	DET
dpc-3843	164	30	emergence	emergence	NOUN
dpc-3843	164	31	of	of	ADP
dpc-3843	164	32	vitiligo	vitiligo	ADJ
dpc-3843	164	33	clinic	clinic	NOUN
dpc-3843	164	34	[	[	X
dpc-3843	164	35	28	28	NUM
dpc-3843	164	36	]	]	PUNCT
dpc-3843	164	37	.	.	PUNCT
dpc-3843	165	1	the	the	DET
dpc-3843	165	2	basic	basic	ADJ
dpc-3843	165	3	mechanisms	mechanism	NOUN
dpc-3843	165	4	that	that	PRON
dpc-3843	165	5	initiate	initiate	VERB
dpc-3843	165	6	vascular	vascular	ADJ
dpc-3843	165	7	basal	basal	ADJ
dpc-3843	165	8	membrane	membrane	NOUN
dpc-3843	165	9	damage	damage	NOUN
dpc-3843	165	10	and	and	CCONJ
dpc-3843	165	11	lead	lead	VERB
dpc-3843	165	12	to	to	ADP
dpc-3843	165	13	neovascularization	neovascularization	NOUN
dpc-3843	165	14	in	in	ADP
dpc-3843	165	15	vitiligo	vitiligo	NOUN
dpc-3843	165	16	are	be	AUX
dpc-3843	165	17	unknown	unknown	ADJ
dpc-3843	165	18	.	.	PUNCT
dpc-3843	166	1	the	the	DET
dpc-3843	166	2	most	most	ADV
dpc-3843	166	3	accepted	accept	VERB
dpc-3843	166	4	theory	theory	NOUN
dpc-3843	166	5	is	be	AUX
dpc-3843	166	6	that	that	SCONJ
dpc-3843	166	7	catecholamines	catecholamine	NOUN
dpc-3843	166	8	and	and	CCONJ
dpc-3843	166	9	neuropeptides	neuropeptide	NOUN
dpc-3843	166	10	released	release	VERB
dpc-3843	166	11	uncontrollably	uncontrollably	ADV
dpc-3843	166	12	from	from	ADP
dpc-3843	166	13	sympathetic	sympathetic	ADJ
dpc-3843	166	14	neurons	neuron	NOUN
dpc-3843	166	15	initiate	initiate	VERB
dpc-3843	166	16	both	both	DET
dpc-3843	166	17	vascular	vascular	ADJ
dpc-3843	166	18	damage	damage	NOUN
dpc-3843	166	19	and	and	CCONJ
dpc-3843	166	20	vasodilation	vasodilation	NOUN
dpc-3843	166	21	[	[	X
dpc-3843	166	22	16	16	NUM
dpc-3843	166	23	]	]	PUNCT
dpc-3843	166	24	.	.	PUNCT
dpc-3843	167	1	our	our	PRON
dpc-3843	167	2	study	study	NOUN
dpc-3843	167	3	suggests	suggest	VERB
dpc-3843	167	4	that	that	SCONJ
dpc-3843	167	5	vascular	vascular	ADJ
dpc-3843	167	6	damage	damage	NOUN
dpc-3843	167	7	occurs	occur	VERB
dpc-3843	167	8	because	because	SCONJ
dpc-3843	167	9	the	the	DET
dpc-3843	167	10	conversion	conversion	NOUN
dpc-3843	167	11	of	of	ADP
dpc-3843	167	12	type	type	NOUN
dpc-3843	167	13	4	4	NUM
dpc-3843	167	14	collagen	collagen	NOUN
dpc-3843	167	15	in	in	ADP
dpc-3843	167	16	the	the	DET
dpc-3843	167	17	vascular	vascular	ADJ
dpc-3843	167	18	basement	basement	NOUN
dpc-3843	167	19	membrane	membrane	NOUN
dpc-3843	167	20	to	to	ADP
dpc-3843	167	21	tumstatin	tumstatin	NOUN
dpc-3843	167	22	is	be	AUX
dpc-3843	167	23	prevented	prevent	VERB
dpc-3843	167	24	due	due	ADJ
dpc-3843	167	25	to	to	ADP
dpc-3843	167	26	immune	immune	ADJ
dpc-3843	167	27	attack	attack	NOUN
dpc-3843	167	28	.	.	PUNCT
dpc-3843	168	1	under	under	ADP
dpc-3843	168	2	normal	normal	ADJ
dpc-3843	168	3	conditions	condition	NOUN
dpc-3843	168	4	,	,	PUNCT
dpc-3843	168	5	tumstatin	tumstatin	NOUN
dpc-3843	168	6	levels	level	NOUN
dpc-3843	168	7	are	be	AUX
dpc-3843	168	8	increased	increase	VERB
dpc-3843	168	9	by	by	ADP
dpc-3843	168	10	breaking	break	VERB
dpc-3843	168	11	down	down	ADP
dpc-3843	168	12	type	type	NOUN
dpc-3843	168	13	4	4	NUM
dpc-3843	168	14	collagen	collagen	NOUN
dpc-3843	168	15	in	in	ADP
dpc-3843	168	16	the	the	DET
dpc-3843	168	17	vascular	vascular	ADJ
dpc-3843	168	18	wall	wall	NOUN
dpc-3843	168	19	and	and	CCONJ
dpc-3843	168	20	neovascularization	neovascularization	NOUN
dpc-3843	168	21	is	be	AUX
dpc-3843	168	22	prevented	prevent	VERB
dpc-3843	168	23	[	[	X
dpc-3843	168	24	8	8	NUM
dpc-3843	168	25	,	,	PUNCT
dpc-3843	168	26	25	25	NUM
dpc-3843	168	27	]	]	PUNCT
dpc-3843	168	28	.	.	PUNCT
dpc-3843	169	1	matrix	matrix	NOUN
dpc-3843	169	2	metalloproteinase	metalloproteinase	NOUN
dpc-3843	169	3	9	9	NUM
dpc-3843	169	4	is	be	AUX
dpc-3843	169	5	involved	involve	VERB
dpc-3843	169	6	in	in	ADP
dpc-3843	169	7	the	the	DET
dpc-3843	169	8	formation	formation	NOUN
dpc-3843	169	9	of	of	ADP
dpc-3843	169	10	tumstatin	tumstatin	NOUN
dpc-3843	169	11	from	from	ADP
dpc-3843	169	12	col	col	NOUN
dpc-3843	169	13	-	-	ADJ
dpc-3843	169	14	ivα3	ivα3	ADJ
dpc-3843	169	15	.	.	PUNCT
dpc-3843	170	1	6	6	NUM
dpc-3843	170	2	original	original	ADJ
dpc-3843	170	3	article	article	NOUN
dpc-3843	170	4	|	|	ADV
dpc-3843	170	5	dermatol	dermatol	ADJ
dpc-3843	170	6	pract	pract	NOUN
dpc-3843	170	7	concept	concept	NOUN
dpc-3843	170	8	.	.	PUNCT
dpc-3843	171	1	2024;14(1):e2024095	2024;14(1):e2024095	NUM
dpc-3843	171	2	17	17	NUM
dpc-3843	171	3	.	.	PUNCT
dpc-3843	172	1	frisoli	frisoli	PROPN
dpc-3843	172	2	ml	ml	PROPN
dpc-3843	172	3	,	,	PUNCT
dpc-3843	172	4	essien	essien	PROPN
dpc-3843	172	5	k	k	PROPN
dpc-3843	172	6	,	,	PUNCT
dpc-3843	172	7	harris	harris	PROPN
dpc-3843	172	8	je	je	PROPN
dpc-3843	172	9	.	.	PROPN
dpc-3843	173	1	vitiligo	vitiligo	PROPN
dpc-3843	173	2	:	:	PUNCT
dpc-3843	173	3	mechanisms	mechanism	NOUN
dpc-3843	173	4	of	of	ADP
dpc-3843	173	5	pathogenesis	pathogenesis	NOUN
dpc-3843	173	6	and	and	CCONJ
dpc-3843	173	7	treatment	treatment	NOUN
dpc-3843	173	8	.	.	PUNCT
dpc-3843	174	1	annu	annu	NOUN
dpc-3843	174	2	.	.	PUNCT
dpc-3843	174	3	rev	rev	PROPN
dpc-3843	174	4	.	.	PROPN
dpc-3843	174	5	immunol	immunol	NOUN
dpc-3843	174	6	.	.	PUNCT
dpc-3843	175	1	2020;38:621–48	2020;38:621–48	NUM
dpc-3843	175	2	.	.	PUNCT
dpc-3843	176	1	18	18	NUM
dpc-3843	176	2	.	.	PUNCT
dpc-3843	177	1	montilla	montilla	PROPN
dpc-3843	177	2	am	am	NOUN
dpc-3843	177	3	,	,	PUNCT
dpc-3843	177	4	gómez	gómez	NOUN
dpc-3843	177	5	-	-	PUNCT
dpc-3843	177	6	garcía	garcía	ADJ
dpc-3843	177	7	f	f	NOUN
dpc-3843	177	8	,	,	PUNCT
dpc-3843	177	9	gómez	gómez	NOUN
dpc-3843	177	10	-	-	PUNCT
dpc-3843	177	11	arias	arias	PROPN
dpc-3843	177	12	pj	pj	PROPN
dpc-3843	177	13	,	,	PUNCT
dpc-3843	177	14	gay	gay	NOUN
dpc-3843	177	15	-	-	PUNCT
dpc-3843	177	16	mimbrera	mimbrera	NOUN
dpc-3843	177	17	 	 	SPACE
dpc-3843	177	18	j	j	PROPN
dpc-3843	177	19	,	,	PUNCT
dpc-3843	177	20	hernández	hernández	PROPN
dpc-3843	177	21	-	-	PUNCT
dpc-3843	177	22	parada	parada	PROPN
dpc-3843	177	23	j	j	PROPN
dpc-3843	177	24	,	,	PUNCT
dpc-3843	177	25	isla	isla	PROPN
dpc-3843	177	26	-	-	PUNCT
dpc-3843	177	27	tejera	tejera	NOUN
dpc-3843	177	28	b	b	PROPN
dpc-3843	177	29	et	et	PROPN
dpc-3843	177	30	al	al	PROPN
dpc-3843	177	31	.	.	PUNCT
dpc-3843	178	1	scoping	scope	VERB
dpc-3843	178	2	review	review	NOUN
dpc-3843	178	3	on	on	ADP
dpc-3843	178	4	the	the	DET
dpc-3843	178	5	use	use	NOUN
dpc-3843	178	6	of	of	ADP
dpc-3843	178	7	drugs	drug	NOUN
dpc-3843	178	8	targeting	target	VERB
dpc-3843	178	9	jak	jak	PROPN
dpc-3843	178	10	/	/	SYM
dpc-3843	178	11	stat	stat	PROPN
dpc-3843	178	12	pathway	pathway	NOUN
dpc-3843	178	13	in	in	ADP
dpc-3843	178	14	atopic	atopic	NOUN
dpc-3843	178	15	dermatitis	dermatitis	NOUN
dpc-3843	178	16	,	,	PUNCT
dpc-3843	178	17	vitiligo	vitiligo	VERB
dpc-3843	178	18	,	,	PUNCT
dpc-3843	178	19	and	and	CCONJ
dpc-3843	178	20	alopecia	alopecia	NOUN
dpc-3843	178	21	areata	areata	ADJ
dpc-3843	178	22	.	.	PUNCT
dpc-3843	179	1	dermatol	dermatol	NOUN
dpc-3843	179	2	.	.	PUNCT
dpc-3843	180	1	ther	ther	INTJ
dpc-3843	180	2	.	.	PUNCT
dpc-3843	181	1	(	(	PUNCT
dpc-3843	181	2	heidelb	heidelb	NOUN
dpc-3843	181	3	)	)	PUNCT
dpc-3843	181	4	.	.	PUNCT
dpc-3843	182	1	2019;9:655–83	2019;9:655–83	NUM
dpc-3843	182	2	.	.	NOUN
dpc-3843	182	3	19	19	NUM
dpc-3843	182	4	.	.	PUNCT
dpc-3843	183	1	gauthier	gauthier	PROPN
dpc-3843	183	2	y	y	PROPN
dpc-3843	183	3	,	,	PUNCT
dpc-3843	183	4	cario	cario	PROPN
dpc-3843	183	5	-	-	PUNCT
dpc-3843	183	6	andre	andre	PROPN
dpc-3843	183	7	m	m	PROPN
dpc-3843	183	8	,	,	PUNCT
dpc-3843	183	9	lepreux	lepreux	PROPN
dpc-3843	183	10	s	s	PROPN
dpc-3843	183	11	,	,	PUNCT
dpc-3843	183	12	pain	pain	NOUN
dpc-3843	183	13	c	c	NOUN
dpc-3843	183	14	,	,	PUNCT
dpc-3843	183	15	taieb	taieb	PROPN
dpc-3843	183	16	a.	a.	PROPN
dpc-3843	183	17	melanocyte	melanocyte	PROPN
dpc-3843	183	18	detachment	detachment	NOUN
dpc-3843	183	19	after	after	ADP
dpc-3843	183	20	skin	skin	NOUN
dpc-3843	183	21	friction	friction	NOUN
dpc-3843	183	22	in	in	ADP
dpc-3843	183	23	non	non	ADJ
dpc-3843	183	24	lesional	lesional	ADJ
dpc-3843	183	25	skin	skin	NOUN
dpc-3843	183	26	of	of	ADP
dpc-3843	183	27	patients	patient	NOUN
dpc-3843	183	28	with	with	ADP
dpc-3843	183	29	generalized	generalized	ADJ
dpc-3843	183	30	vitiligo	vitiligo	NOUN
dpc-3843	183	31	.	.	PUNCT
dpc-3843	184	1	br	br	PROPN
dpc-3843	184	2	.	.	PUNCT
dpc-3843	185	1	j.	j.	PROPN
dpc-3843	185	2	dermatol	dermatol	PROPN
dpc-3843	185	3	.	.	PUNCT
dpc-3843	186	1	2003;148:95–101	2003;148:95–101	NUM
dpc-3843	186	2	.	.	PUNCT
dpc-3843	187	1	20	20	NUM
dpc-3843	187	2	.	.	PUNCT
dpc-3843	188	1	le	le	PROPN
dpc-3843	188	2	poole	poole	PROPN
dpc-3843	188	3	ic	ic	PROPN
dpc-3843	188	4	,	,	PUNCT
dpc-3843	188	5	van	van	PROPN
dpc-3843	188	6	den	den	PROPN
dpc-3843	188	7	wijngaard	wijngaard	PROPN
dpc-3843	188	8	rmgj	rmgj	NOUN
dpc-3843	188	9	,	,	PUNCT
dpc-3843	188	10	westerhof	westerhof	PROPN
dpc-3843	188	11	w	w	PROPN
dpc-3843	188	12	,	,	PUNCT
dpc-3843	188	13	das	das	PROPN
dpc-3843	188	14	pk	pk	PROPN
dpc-3843	188	15	.	.	PROPN
dpc-3843	188	16	tenascin	tenascin	PROPN
dpc-3843	188	17	is	be	AUX
dpc-3843	188	18	overexpressed	overexpresse	VERB
dpc-3843	188	19	in	in	ADP
dpc-3843	188	20	vitiligo	vitiligo	ADJ
dpc-3843	188	21	lesional	lesional	ADJ
dpc-3843	188	22	skin	skin	NOUN
dpc-3843	188	23	and	and	CCONJ
dpc-3843	188	24	inhibits	inhibit	VERB
dpc-3843	188	25	melanocyte	melanocyte	NOUN
dpc-3843	188	26	adhesion	adhesion	NOUN
dpc-3843	188	27	.	.	PUNCT
dpc-3843	189	1	br	br	X
dpc-3843	189	2	.	.	PUNCT
dpc-3843	190	1	j.	j.	PROPN
dpc-3843	190	2	dermatol	dermatol	PROPN
dpc-3843	190	3	.	.	PUNCT
dpc-3843	191	1	1997;137:171–8	1997;137:171–8	NUM
dpc-3843	191	2	.	.	PROPN
dpc-3843	192	1	21	21	NUM
dpc-3843	192	2	.	.	PUNCT
dpc-3843	193	1	bastonini	bastonini	PROPN
dpc-3843	193	2	e	e	PROPN
dpc-3843	193	3	,	,	PUNCT
dpc-3843	193	4	bellei	bellei	PROPN
dpc-3843	193	5	b	b	PROPN
dpc-3843	193	6	,	,	PUNCT
dpc-3843	193	7	filoni	filoni	NOUN
dpc-3843	193	8	a	a	NOUN
dpc-3843	193	9	,	,	PUNCT
dpc-3843	193	10	kovacs	kovacs	PROPN
dpc-3843	193	11	d	d	PROPN
dpc-3843	193	12	,	,	PUNCT
dpc-3843	193	13	iacovelli	iacovelli	PROPN
dpc-3843	193	14	p	p	PRON
dpc-3843	193	15	,	,	PUNCT
dpc-3843	193	16	picardo	picardo	X
dpc-3843	193	17	m.	m.	NOUN
dpc-3843	193	18	involvement	involvement	NOUN
dpc-3843	193	19	of	of	ADP
dpc-3843	193	20	non‐melanocytic	non‐melanocytic	ADJ
dpc-3843	193	21	skin	skin	NOUN
dpc-3843	193	22	cells	cell	NOUN
dpc-3843	193	23	in	in	ADP
dpc-3843	193	24	vitiligo	vitiligo	PROPN
dpc-3843	193	25	.	.	PUNCT
dpc-3843	194	1	exp	exp	NOUN
dpc-3843	194	2	.	.	PUNCT
dpc-3843	194	3	dermatol	dermatol	NOUN
dpc-3843	194	4	.	.	PUNCT
dpc-3843	195	1	2019;28:667–73	2019;28:667–73	X
dpc-3843	195	2	.	.	PROPN
dpc-3843	196	1	22	22	NUM
dpc-3843	196	2	.	.	PUNCT
dpc-3843	197	1	becatti	becatti	PROPN
dpc-3843	197	2	m	m	PROPN
dpc-3843	197	3	,	,	PUNCT
dpc-3843	197	4	prignano	prignano	PROPN
dpc-3843	197	5	f	f	PROPN
dpc-3843	197	6	,	,	PUNCT
dpc-3843	197	7	fiorillo	fiorillo	VERB
dpc-3843	197	8	c	c	NOUN
dpc-3843	197	9	,	,	PUNCT
dpc-3843	197	10	pescitelli	pescitelli	PROPN
dpc-3843	197	11	l	l	PROPN
dpc-3843	197	12	,	,	PUNCT
dpc-3843	197	13	nassi	nassi	ADJ
dpc-3843	197	14	p	p	X
dpc-3843	197	15	,	,	PUNCT
dpc-3843	197	16	lotti	lotti	PROPN
dpc-3843	197	17	t	t	PROPN
dpc-3843	197	18	et	et	PROPN
dpc-3843	197	19	  	  	SPACE
dpc-3843	197	20	al	al	PROPN
dpc-3843	197	21	.	.	PUNCT
dpc-3843	198	1	the	the	DET
dpc-3843	198	2	involvement	involvement	NOUN
dpc-3843	198	3	of	of	ADP
dpc-3843	198	4	smac	smac	PROPN
dpc-3843	198	5	/	/	SYM
dpc-3843	198	6	diablo	diablo	PROPN
dpc-3843	198	7	,	,	PUNCT
dpc-3843	198	8	p53	p53	NOUN
dpc-3843	198	9	,	,	PUNCT
dpc-3843	198	10	nf	nf	PROPN
dpc-3843	198	11	-	-	PUNCT
dpc-3843	198	12	kb	kb	NOUN
dpc-3843	198	13	,	,	PUNCT
dpc-3843	198	14	and	and	CCONJ
dpc-3843	198	15	mapk	mapk	PROPN
dpc-3843	198	16	pathways	pathway	NOUN
dpc-3843	198	17	in	in	ADP
dpc-3843	198	18	apoptosis	apoptosis	NOUN
dpc-3843	198	19	of	of	ADP
dpc-3843	198	20	keratinocytes	keratinocyte	NOUN
dpc-3843	198	21	from	from	ADP
dpc-3843	198	22	perilesional	perilesional	ADJ
dpc-3843	198	23	vitiligo	vitiligo	NOUN
dpc-3843	198	24	skin	skin	NOUN
dpc-3843	198	25	:	:	PUNCT
dpc-3843	198	26	protective	protective	ADJ
dpc-3843	198	27	effects	effect	NOUN
dpc-3843	198	28	of	of	ADP
dpc-3843	198	29	curcumin	curcumin	NOUN
dpc-3843	198	30	and	and	CCONJ
dpc-3843	198	31	capsaicin	capsaicin	PROPN
dpc-3843	198	32	.	.	PUNCT
dpc-3843	198	33	antioxid	antioxid	PROPN
dpc-3843	198	34	.	.	PUNCT
dpc-3843	199	1	redox	redox	ADJ
dpc-3843	199	2	signal	signal	NOUN
dpc-3843	199	3	.	.	PUNCT
dpc-3843	200	1	2010;13:1309–21	2010;13:1309–21	NUM
dpc-3843	200	2	.	.	NOUN
dpc-3843	201	1	23	23	NUM
dpc-3843	201	2	.	.	PUNCT
dpc-3843	202	1	weinman	weinman	PROPN
dpc-3843	202	2	ej	ej	PROPN
dpc-3843	202	3	.	.	PUNCT
dpc-3843	202	4	new	new	ADJ
dpc-3843	202	5	functions	function	NOUN
dpc-3843	202	6	for	for	ADP
dpc-3843	202	7	the	the	DET
dpc-3843	202	8	nherf	nherf	NOUN
dpc-3843	202	9	family	family	NOUN
dpc-3843	202	10	of	of	ADP
dpc-3843	202	11	proteins	protein	NOUN
dpc-3843	202	12	.	.	PUNCT
dpc-3843	203	1	j.	j.	PROPN
dpc-3843	203	2	clin	clin	PROPN
dpc-3843	203	3	.	.	PUNCT
dpc-3843	204	1	invest	invest	VERB
dpc-3843	204	2	.	.	PUNCT
dpc-3843	205	1	2001;108:185	2001;108:185	NUM
dpc-3843	205	2	-	-	SYM
dpc-3843	205	3	6	6	NUM
dpc-3843	205	4	.	.	NOUN
dpc-3843	205	5	24	24	NUM
dpc-3843	205	6	.	.	PUNCT
dpc-3843	206	1	cipollone	cipollone	PROPN
dpc-3843	206	2	ja	ja	PROPN
dpc-3843	206	3	,	,	PUNCT
dpc-3843	206	4	graves	grave	VERB
dpc-3843	206	5	ml	ml	PROPN
dpc-3843	206	6	,	,	PUNCT
dpc-3843	206	7	köbel	köbel	PROPN
dpc-3843	206	8	m	m	PROPN
dpc-3843	206	9	,	,	PUNCT
dpc-3843	206	10	et	et	PROPN
dpc-3843	206	11	al	al	PROPN
dpc-3843	206	12	.	.	PUNCT
dpc-3843	207	1	the	the	DET
dpc-3843	207	2	anti	anti	ADJ
dpc-3843	207	3	-	-	ADJ
dpc-3843	207	4	adhesive	adhesive	ADJ
dpc-3843	207	5	mucin	mucin	NOUN
dpc-3843	207	6	podocalyxin	podocalyxin	NOUN
dpc-3843	207	7	may	may	AUX
dpc-3843	207	8	help	help	VERB
dpc-3843	207	9	initiate	initiate	VERB
dpc-3843	207	10	the	the	DET
dpc-3843	207	11	transperitoneal	transperitoneal	ADJ
dpc-3843	207	12	metastasis	metastasis	NOUN
dpc-3843	207	13	of	of	ADP
dpc-3843	207	14	high	high	ADJ
dpc-3843	207	15	grade	grade	NOUN
dpc-3843	207	16	serous	serous	ADJ
dpc-3843	207	17	ovarian	ovarian	ADJ
dpc-3843	207	18	carcinoma	carcinoma	NOUN
dpc-3843	207	19	.	.	PUNCT
dpc-3843	208	1	clin	clin	PROPN
dpc-3843	208	2	.	.	PUNCT
dpc-3843	209	1	exp	exp	PROPN
dpc-3843	209	2	.	.	PUNCT
dpc-3843	210	1	metastasis	metastasis	NOUN
dpc-3843	210	2	.	.	PUNCT
dpc-3843	211	1	2012;29:239–52	2012;29:239–52	X
dpc-3843	211	2	.	.	X
dpc-3843	212	1	25	25	NUM
dpc-3843	212	2	.	.	PUNCT
dpc-3843	213	1	maeshima	maeshima	PROPN
dpc-3843	213	2	y	y	PROPN
dpc-3843	213	3	,	,	PUNCT
dpc-3843	213	4	sudhakar	sudhakar	PROPN
dpc-3843	213	5	a	a	PROPN
dpc-3843	213	6	,	,	PUNCT
dpc-3843	213	7	lively	lively	PROPN
dpc-3843	213	8	jc	jc	PROPN
dpc-3843	213	9	,	,	PUNCT
dpc-3843	213	10	et	et	PROPN
dpc-3843	213	11	al	al	PROPN
dpc-3843	213	12	.	.	PROPN
dpc-3843	213	13	tumstatin	tumstatin	PROPN
dpc-3843	213	14	,	,	PUNCT
dpc-3843	213	15	an	an	DET
dpc-3843	213	16	endothelial	endothelial	ADJ
dpc-3843	213	17	cell	cell	NOUN
dpc-3843	213	18	-	-	PUNCT
dpc-3843	213	19	specific	specific	ADJ
dpc-3843	213	20	inhibitor	inhibitor	NOUN
dpc-3843	213	21	of	of	ADP
dpc-3843	213	22	protein	protein	NOUN
dpc-3843	213	23	synthesis	synthesis	NOUN
dpc-3843	213	24	.	.	PUNCT
dpc-3843	213	25	  	  	SPACE
dpc-3843	213	26	science	science	NOUN
dpc-3843	213	27	.	.	PUNCT
dpc-3843	214	1	2002;295(5552):140	2002;295(5552):140	NUM
dpc-3843	214	2	-	-	SYM
dpc-3843	214	3	143	143	NUM
dpc-3843	214	4	.	.	PUNCT
dpc-3843	214	5	doi:10.1126	doi:10.1126	PROPN
dpc-3843	214	6	/	/	SYM
dpc-3843	214	7	science.1065298	science.1065298	PROPN
dpc-3843	214	8	26	26	NUM
dpc-3843	214	9	.	.	PUNCT
dpc-3843	215	1	hamano	hamano	PROPN
dpc-3843	215	2	y	y	PROPN
dpc-3843	215	3	,	,	PUNCT
dpc-3843	215	4	zeisberg	zeisberg	PROPN
dpc-3843	215	5	m	m	PROPN
dpc-3843	215	6	,	,	PUNCT
dpc-3843	215	7	sugimoto	sugimoto	PROPN
dpc-3843	215	8	h	h	PROPN
dpc-3843	215	9	,	,	PUNCT
dpc-3843	215	10	et	et	PROPN
dpc-3843	215	11	al	al	PROPN
dpc-3843	215	12	.	.	PUNCT
dpc-3843	215	13	physiological	physiological	ADJ
dpc-3843	215	14	levels	level	NOUN
dpc-3843	215	15	of	of	ADP
dpc-3843	215	16	tumstatin	tumstatin	NOUN
dpc-3843	215	17	,	,	PUNCT
dpc-3843	215	18	a	a	DET
dpc-3843	215	19	fragment	fragment	NOUN
dpc-3843	215	20	of	of	ADP
dpc-3843	215	21	collagen	collagen	NOUN
dpc-3843	215	22	iv	iv	NUM
dpc-3843	215	23	α3	α3	NOUN
dpc-3843	215	24	chain	chain	NOUN
dpc-3843	215	25	,	,	PUNCT
dpc-3843	215	26	are	be	AUX
dpc-3843	215	27	generated	generate	VERB
dpc-3843	215	28	by	by	ADP
dpc-3843	215	29	mmp-9	mmp-9	VERB
dpc-3843	215	30	proteolysis	proteolysis	NOUN
dpc-3843	215	31	and	and	CCONJ
dpc-3843	215	32	suppress	suppress	VERB
dpc-3843	215	33	angiogenesis	angiogenesis	NOUN
dpc-3843	215	34	via	via	ADP
dpc-3843	215	35	αvβ3	αvβ3	NOUN
dpc-3843	215	36	integrin	integrin	NOUN
dpc-3843	215	37	.	.	PUNCT
dpc-3843	216	1	cancer	cancer	NOUN
dpc-3843	216	2	cell	cell	NOUN
dpc-3843	216	3	.	.	PUNCT
dpc-3843	217	1	2003;3:589–601	2003;3:589–601	X
dpc-3843	217	2	.	.	NOUN
dpc-3843	217	3	27	27	NUM
dpc-3843	217	4	.	.	PUNCT
dpc-3843	218	1	wu	wu	PROPN
dpc-3843	219	1	c	c	X
dpc-3843	219	2	-	-	PUNCT
dpc-3843	219	3	s	s	PROPN
dpc-3843	219	4	,	,	PUNCT
dpc-3843	219	5	yu	yu	PROPN
dpc-3843	219	6	h	h	PROPN
dpc-3843	219	7	-	-	PUNCT
dpc-3843	219	8	s	s	PROPN
dpc-3843	219	9	,	,	PUNCT
dpc-3843	219	10	chang	chang	PROPN
dpc-3843	219	11	h	h	PROPN
dpc-3843	219	12	-	-	PUNCT
dpc-3843	219	13	r	r	VERB
dpc-3843	219	14	,	,	PUNCT
dpc-3843	219	15	yu	yu	PROPN
dpc-3843	219	16	c	c	PROPN
dpc-3843	219	17	-	-	PUNCT
dpc-3843	219	18	l	l	NOUN
dpc-3843	219	19	,	,	PUNCT
dpc-3843	219	20	yu	yu	PROPN
dpc-3843	219	21	c	c	PROPN
dpc-3843	219	22	-	-	PUNCT
dpc-3843	219	23	l	l	NOUN
dpc-3843	219	24	,	,	PUNCT
dpc-3843	219	25	wu	wu	PROPN
dpc-3843	219	26	b	b	X
dpc-3843	219	27	-	-	PUNCT
dpc-3843	219	28	n.	n.	ADJ
dpc-3843	219	29	cutaneous	cutaneous	ADJ
dpc-3843	219	30	blood	blood	NOUN
dpc-3843	219	31	flow	flow	NOUN
dpc-3843	219	32	and	and	CCONJ
dpc-3843	219	33	adrenoceptor	adrenoceptor	NOUN
dpc-3843	219	34	response	response	NOUN
dpc-3843	219	35	increase	increase	NOUN
dpc-3843	219	36	in	in	ADP
dpc-3843	219	37	segmental	segmental	ADJ
dpc-3843	219	38	-	-	PUNCT
dpc-3843	219	39	type	type	NOUN
dpc-3843	219	40	vitiligo	vitiligo	NOUN
dpc-3843	219	41	lesions	lesion	NOUN
dpc-3843	219	42	.	.	PUNCT
dpc-3843	220	1	j.	j.	PROPN
dpc-3843	220	2	dermatol	dermatol	PROPN
dpc-3843	220	3	.	.	PUNCT
dpc-3843	221	1	sci	sci	PROPN
dpc-3843	221	2	.	.	PROPN
dpc-3843	221	3	2000;23:53–62	2000;23:53–62	NUM
dpc-3843	221	4	.	.	PUNCT
dpc-3843	222	1	28	28	NUM
dpc-3843	222	2	.	.	PUNCT
dpc-3843	222	3	westerhof	westerhof	PROPN
dpc-3843	222	4	w	w	PROPN
dpc-3843	222	5	,	,	PUNCT
dpc-3843	222	6	d’ischia	d’ischia	PROPN
dpc-3843	222	7	m.	m.	NOUN
dpc-3843	222	8	vitiligo	vitiligo	NOUN
dpc-3843	222	9	puzzle	puzzle	NOUN
dpc-3843	222	10	:	:	PUNCT
dpc-3843	222	11	the	the	DET
dpc-3843	222	12	pieces	piece	NOUN
dpc-3843	222	13	fall	fall	VERB
dpc-3843	222	14	in	in	ADP
dpc-3843	222	15	place	place	NOUN
dpc-3843	222	16	.	.	PUNCT
dpc-3843	223	1	pigment	pigment	NOUN
dpc-3843	223	2	cell	cell	NOUN
dpc-3843	223	3	res	re	NOUN
dpc-3843	223	4	.	.	PUNCT
dpc-3843	224	1	2007;20(5):345	2007;20(5):345	NUM
dpc-3843	224	2	-	-	SYM
dpc-3843	224	3	359	359	NUM
dpc-3843	224	4	.	.	PUNCT
dpc-3843	225	1	doi:10.1111	doi:10.1111	ADJ
dpc-3843	225	2	/	/	SYM
dpc-3843	225	3	j.1600	j.1600	PROPN
dpc-3843	225	4	-	-	PUNCT
dpc-3843	225	5	0749	0749	NUM
dpc-3843	225	6	.2007.00399.x	.2007.00399.x	PROPN
dpc-3843	225	7	29	29	NUM
dpc-3843	225	8	.	.	PUNCT
dpc-3843	226	1	sutherland	sutherland	PROPN
dpc-3843	226	2	te	te	PROPN
dpc-3843	226	3	,	,	PUNCT
dpc-3843	226	4	maizels	maizels	PROPN
dpc-3843	226	5	rm	rm	PROPN
dpc-3843	226	6	,	,	PUNCT
dpc-3843	226	7	allen	allen	PROPN
dpc-3843	226	8	je	je	PROPN
dpc-3843	226	9	.	.	PROPN
dpc-3843	226	10	chitinases	chitinase	NOUN
dpc-3843	226	11	and	and	CCONJ
dpc-3843	226	12	chitinase	chitinase	NOUN
dpc-3843	226	13	-	-	PUNCT
dpc-3843	226	14	like	like	ADJ
dpc-3843	226	15	proteins	protein	NOUN
dpc-3843	226	16	:	:	PUNCT
dpc-3843	226	17	potential	potential	ADJ
dpc-3843	226	18	therapeutic	therapeutic	ADJ
dpc-3843	226	19	targets	target	NOUN
dpc-3843	226	20	for	for	ADP
dpc-3843	226	21	the	the	DET
dpc-3843	226	22	treatment	treatment	NOUN
dpc-3843	226	23	of	of	ADP
dpc-3843	226	24	t	t	PROPN
dpc-3843	226	25	-	-	PUNCT
dpc-3843	226	26	helper	helper	NOUN
dpc-3843	226	27	type	type	NOUN
dpc-3843	226	28	2	2	NUM
dpc-3843	226	29	allergies	allergy	NOUN
dpc-3843	226	30	.	.	PUNCT
dpc-3843	227	1	clin	clin	PROPN
dpc-3843	227	2	.	.	PUNCT
dpc-3843	228	1	exp	exp	PROPN
dpc-3843	228	2	.	.	PROPN
dpc-3843	228	3	allergy	allergy	PROPN
dpc-3843	228	4	.	.	PUNCT
dpc-3843	229	1	2009;39:943–55	2009;39:943–55	NUM
dpc-3843	229	2	.	.	PROPN
dpc-3843	230	1	30	30	NUM
dpc-3843	230	2	.	.	PUNCT
dpc-3843	231	1	pinteac	pinteac	PROPN
dpc-3843	231	2	r	r	PROPN
dpc-3843	231	3	,	,	PUNCT
dpc-3843	231	4	montalban	montalban	PROPN
dpc-3843	231	5	x	x	PROPN
dpc-3843	231	6	,	,	PUNCT
dpc-3843	231	7	comabella	comabella	NOUN
dpc-3843	231	8	m.	m.	NOUN
dpc-3843	231	9	chitinases	chitinase	NOUN
dpc-3843	231	10	and	and	CCONJ
dpc-3843	231	11	chitinase	chitinase	NOUN
dpc-3843	231	12	-	-	PUNCT
dpc-3843	231	13	like	like	ADJ
dpc-3843	231	14	proteins	protein	NOUN
dpc-3843	231	15	as	as	ADP
dpc-3843	231	16	biomarkers	biomarker	NOUN
dpc-3843	231	17	in	in	ADP
dpc-3843	231	18	neurologic	neurologic	ADJ
dpc-3843	231	19	disorders	disorder	NOUN
dpc-3843	231	20	.	.	PUNCT
dpc-3843	232	1	neurol	neurol	NOUN
dpc-3843	232	2	.	.	PUNCT
dpc-3843	233	1	neuroimmunol	neuroimmunol	NOUN
dpc-3843	233	2	.	.	PUNCT
dpc-3843	234	1	neuroinflammation	neuroinflammation	PROPN
dpc-3843	234	2	.	.	PUNCT
dpc-3843	235	1	2021;8	2021;8	NUM
dpc-3843	235	2	:	:	PUNCT
dpc-3843	236	1	e921	e921	PROPN
dpc-3843	236	2	.	.	PROPN
dpc-3843	236	3	31	31	NUM
dpc-3843	236	4	.	.	PUNCT
dpc-3843	237	1	guan	guan	PROPN
dpc-3843	237	2	s	s	PROPN
dpc-3843	237	3	-	-	PUNCT
dpc-3843	237	4	p	p	X
dpc-3843	237	5	,	,	PUNCT
dpc-3843	237	6	mok	mok	PROPN
dpc-3843	237	7	y	y	PROPN
dpc-3843	237	8	-	-	PUNCT
dpc-3843	237	9	k	k	PROPN
dpc-3843	237	10	,	,	PUNCT
dpc-3843	237	11	koo	koo	PROPN
dpc-3843	237	12	k	k	PROPN
dpc-3843	237	13	-	-	PUNCT
dpc-3843	237	14	n	n	CCONJ
dpc-3843	237	15	,	,	PUNCT
dpc-3843	237	16	chu	chu	PROPN
dpc-3843	237	17	k	k	PROPN
dpc-3843	237	18	-	-	PROPN
dpc-3843	237	19	l	l	PROPN
dpc-3843	237	20	,	,	PUNCT
dpc-3843	237	21	wong	wong	PROPN
dpc-3843	237	22	ws	ws	PROPN
dpc-3843	237	23	.	.	PUNCT
dpc-3843	237	24	chitinases	chitinase	VERB
dpc-3843	237	25	:	:	PUNCT
dpc-3843	237	26	biomarkers	biomarker	NOUN
dpc-3843	237	27	for	for	ADP
dpc-3843	237	28	human	human	ADJ
dpc-3843	237	29	diseases	disease	NOUN
dpc-3843	237	30	.	.	PUNCT
dpc-3843	238	1	protein	protein	NOUN
dpc-3843	238	2	pept	pept	PROPN
dpc-3843	238	3	.	.	PUNCT
dpc-3843	239	1	lett	lett	PROPN
dpc-3843	239	2	.	.	PUNCT
dpc-3843	240	1	2009;16:490–8	2009;16:490–8	NUM
dpc-3843	240	2	.	.	PUNCT
dpc-3843	241	1	32	32	NUM
dpc-3843	241	2	.	.	PUNCT
dpc-3843	242	1	seibold	seibold	PROPN
dpc-3843	242	2	ma	ma	PROPN
dpc-3843	242	3	,	,	PUNCT
dpc-3843	242	4	reese	reese	PROPN
dpc-3843	242	5	ta	ta	PROPN
dpc-3843	242	6	,	,	PUNCT
dpc-3843	242	7	choudhry	choudhry	PROPN
dpc-3843	242	8	s	s	PROPN
dpc-3843	242	9	,	,	PUNCT
dpc-3843	242	10	et	et	PROPN
dpc-3843	243	1	al	al	AUX
dpc-3843	243	2	.	.	PROPN
dpc-3843	243	3	differential	differential	ADJ
dpc-3843	243	4	enzymatic	enzymatic	ADJ
dpc-3843	243	5	activity	activity	NOUN
dpc-3843	243	6	of	of	ADP
dpc-3843	243	7	common	common	ADJ
dpc-3843	243	8	haplotypic	haplotypic	ADJ
dpc-3843	243	9	versions	version	NOUN
dpc-3843	243	10	of	of	ADP
dpc-3843	243	11	the	the	DET
dpc-3843	243	12	human	human	ADJ
dpc-3843	243	13	acidic	acidic	ADJ
dpc-3843	243	14	mammalian	mammalian	NOUN
dpc-3843	243	15	chitinase	chitinase	NOUN
dpc-3843	243	16	protein	protein	NOUN
dpc-3843	243	17	.	.	PUNCT
dpc-3843	244	1	j.	j.	PROPN
dpc-3843	244	2	biol	biol	PROPN
dpc-3843	244	3	.	.	PUNCT
dpc-3843	245	1	chem	chem	NOUN
dpc-3843	245	2	.	.	PUNCT
dpc-3843	246	1	2009;284:19650–8	2009;284:19650–8	NOUN
dpc-3843	246	2	.	.	PUNCT
dpc-3843	247	1	reference	reference	NOUN
dpc-3843	247	2	1	1	NUM
dpc-3843	247	3	.	.	PUNCT
dpc-3843	247	4	taïeb	taïeb	PROPN
dpc-3843	247	5	a	a	PRON
dpc-3843	247	6	,	,	PUNCT
dpc-3843	247	7	picardo	picardo	X
dpc-3843	247	8	m.	m.	NOUN
dpc-3843	247	9	the	the	DET
dpc-3843	247	10	definition	definition	NOUN
dpc-3843	247	11	and	and	CCONJ
dpc-3843	247	12	assessment	assessment	NOUN
dpc-3843	247	13	of	of	ADP
dpc-3843	247	14	vitiligo	vitiligo	NOUN
dpc-3843	247	15	:	:	PUNCT
dpc-3843	247	16	a	a	DET
dpc-3843	247	17	consensus	consensus	NOUN
dpc-3843	247	18	report	report	NOUN
dpc-3843	247	19	of	of	ADP
dpc-3843	247	20	the	the	DET
dpc-3843	247	21	vitiligo	vitiligo	ADJ
dpc-3843	247	22	european	european	PROPN
dpc-3843	247	23	task	task	PROPN
dpc-3843	247	24	force	force	NOUN
dpc-3843	247	25	.	.	PUNCT
dpc-3843	248	1	pigment	pigment	NOUN
dpc-3843	248	2	cell	cell	NOUN
dpc-3843	248	3	res	re	NOUN
dpc-3843	248	4	.	.	PUNCT
dpc-3843	249	1	2007;20:27–35	2007;20:27–35	NUM
dpc-3843	249	2	.	.	X
dpc-3843	249	3	2	2	NUM
dpc-3843	249	4	.	.	NUM
dpc-3843	249	5	burns	burns	PROPN
dpc-3843	249	6	t	t	PROPN
dpc-3843	249	7	,	,	PUNCT
dpc-3843	249	8	breathnach	breathnach	NOUN
dpc-3843	249	9	s	s	PROPN
dpc-3843	249	10	,	,	PUNCT
dpc-3843	249	11	cox	cox	PROPN
dpc-3843	249	12	n	n	CCONJ
dpc-3843	249	13	,	,	PUNCT
dpc-3843	249	14	griffiths	griffiths	PROPN
dpc-3843	249	15	c.	c.	PROPN
dpc-3843	249	16	rook	rook	PROPN
dpc-3843	249	17	’s	’s	PART
dpc-3843	249	18	textbook	textbook	NOUN
dpc-3843	249	19	of	of	ADP
dpc-3843	249	20	dermatology	dermatology	NOUN
dpc-3843	249	21	.	.	PUNCT
dpc-3843	250	1	eight	eight	NUM
dpc-3843	250	2	.	.	PUNCT
dpc-3843	251	1	oxford	oxford	NOUN
dpc-3843	251	2	:	:	PUNCT
dpc-3843	251	3	blackwell	blackwell	PROPN
dpc-3843	251	4	science	science	NOUN
dpc-3843	251	5	.	.	PUNCT
dpc-3843	252	1	2010	2010	NUM
dpc-3843	252	2	.	.	PUNCT
dpc-3843	253	1	doi:10.1002/9781444317633	doi:10.1002/9781444317633	NOUN
dpc-3843	253	2	.	.	PUNCT
dpc-3843	254	1	3	3	X
dpc-3843	254	2	.	.	X
dpc-3843	254	3	bergqvist	bergqvist	PROPN
dpc-3843	254	4	c	c	PROPN
dpc-3843	254	5	,	,	PUNCT
dpc-3843	254	6	ezzedine	ezzedine	PROPN
dpc-3843	254	7	k.	k.	PROPN
dpc-3843	254	8	vitiligo	vitiligo	PROPN
dpc-3843	254	9	:	:	PUNCT
dpc-3843	254	10	a	a	DET
dpc-3843	254	11	review	review	NOUN
dpc-3843	254	12	.	.	PUNCT
dpc-3843	255	1	dermatology	dermatology	NOUN
dpc-3843	255	2	.	.	PUNCT
dpc-3843	256	1	2020;236:571–92	2020;236:571–92	X
dpc-3843	256	2	.	.	PUNCT
dpc-3843	256	3	4	4	X
dpc-3843	256	4	.	.	X
dpc-3843	256	5	picardo	picardo	PROPN
dpc-3843	256	6	m	m	PROPN
dpc-3843	256	7	,	,	PUNCT
dpc-3843	256	8	dell’anna	dell’anna	ADJ
dpc-3843	256	9	ml	ml	NOUN
dpc-3843	256	10	,	,	PUNCT
dpc-3843	256	11	ezzedine	ezzedine	PROPN
dpc-3843	256	12	k	k	PROPN
dpc-3843	256	13	,	,	PUNCT
dpc-3843	256	14	hamzavi	hamzavi	PROPN
dpc-3843	256	15	i	i	PRON
dpc-3843	256	16	,	,	PUNCT
dpc-3843	256	17	harris	harris	PROPN
dpc-3843	256	18	je	je	PROPN
dpc-3843	256	19	,	,	PUNCT
dpc-3843	256	20	parsad	parsad	PROPN
dpc-3843	256	21	d	d	X
dpc-3843	256	22	et	et	PROPN
dpc-3843	256	23	al	al	PROPN
dpc-3843	256	24	.	.	PROPN
dpc-3843	256	25	vitiligo	vitiligo	PROPN
dpc-3843	256	26	.	.	PUNCT
dpc-3843	257	1	nat	nat	PROPN
dpc-3843	257	2	.	.	PUNCT
dpc-3843	258	1	rev	rev	PROPN
dpc-3843	258	2	.	.	PUNCT
dpc-3843	259	1	dis	dis	PROPN
dpc-3843	259	2	.	.	PUNCT
dpc-3843	260	1	prim	prim	ADJ
dpc-3843	260	2	.	.	PUNCT
dpc-3843	261	1	2015;1:15011	2015;1:15011	NUM
dpc-3843	261	2	.	.	PUNCT
dpc-3843	262	1	5	5	NUM
dpc-3843	262	2	.	.	X
dpc-3843	262	3	sandoval	sandoval	PROPN
dpc-3843	262	4	-	-	PUNCT
dpc-3843	262	5	cruz	cruz	PROPN
dpc-3843	262	6	m	m	PROPN
dpc-3843	262	7	,	,	PUNCT
dpc-3843	262	8	garcía	garcía	ADJ
dpc-3843	262	9	-	-	PUNCT
dpc-3843	262	10	carrasco	carrasco	PROPN
dpc-3843	262	11	m	m	PROPN
dpc-3843	262	12	,	,	PUNCT
dpc-3843	262	13	sánchez	sánchez	PROPN
dpc-3843	262	14	-	-	PUNCT
dpc-3843	262	15	porras	porras	PROPN
dpc-3843	262	16	r	r	PROPN
dpc-3843	262	17	,	,	PUNCT
dpc-3843	262	18	mendoza	mendoza	PROPN
dpc-3843	262	19	-	-	PUNCT
dpc-3843	262	20	pinto	pinto	NOUN
dpc-3843	262	21	c	c	NOUN
dpc-3843	262	22	,	,	PUNCT
dpc-3843	262	23	jiménez	jiménez	PROPN
dpc-3843	262	24	-	-	PUNCT
dpc-3843	262	25	hernández	hernández	PROPN
dpc-3843	262	26	m	m	PROPN
dpc-3843	262	27	,	,	PUNCT
dpc-3843	262	28	munguía	munguía	NOUN
dpc-3843	262	29	-	-	PUNCT
dpc-3843	262	30	realpozo	realpozo	NOUN
dpc-3843	262	31	 	 	SPACE
dpc-3843	262	32	p	p	PROPN
dpc-3843	262	33	et	et	PROPN
dpc-3843	262	34	 	 	SPACE
dpc-3843	262	35	al	al	PROPN
dpc-3843	262	36	.	.	PROPN
dpc-3843	262	37	immunopathogenesis	immunopathogenesis	NOUN
dpc-3843	262	38	of	of	ADP
dpc-3843	262	39	vitiligo	vitiligo	NOUN
dpc-3843	262	40	.	.	PUNCT
dpc-3843	263	1	autoimmun	autoimmun	PROPN
dpc-3843	263	2	.	.	PUNCT
dpc-3843	264	1	rev	rev	PROPN
dpc-3843	264	2	.	.	PROPN
dpc-3843	264	3	2011	2011	NUM
dpc-3843	264	4	;	;	PUNCT
dpc-3843	264	5	10:762–5	10:762–5	NUM
dpc-3843	264	6	.	.	NOUN
dpc-3843	265	1	6	6	NUM
dpc-3843	265	2	.	.	X
dpc-3843	266	1	richmond	richmond	PROPN
dpc-3843	266	2	jm	jm	PROPN
dpc-3843	266	3	,	,	PUNCT
dpc-3843	266	4	frisoli	frisoli	PROPN
dpc-3843	266	5	ml	ml	PROPN
dpc-3843	266	6	,	,	PUNCT
dpc-3843	266	7	harris	harris	PROPN
dpc-3843	266	8	je	je	PROPN
dpc-3843	266	9	.	.	PROPN
dpc-3843	266	10	innate	innate	ADJ
dpc-3843	266	11	immune	immune	ADJ
dpc-3843	266	12	mechanisms	mechanism	NOUN
dpc-3843	266	13	in	in	ADP
dpc-3843	266	14	vitiligo	vitiligo	NOUN
dpc-3843	266	15	:	:	PUNCT
dpc-3843	266	16	danger	danger	NOUN
dpc-3843	266	17	from	from	ADP
dpc-3843	266	18	within	within	ADP
dpc-3843	266	19	.	.	PUNCT
dpc-3843	267	1	curr	curr	PROPN
dpc-3843	267	2	.	.	PUNCT
dpc-3843	268	1	opin	opin	NOUN
dpc-3843	268	2	.	.	PUNCT
dpc-3843	269	1	immunol	immunol	NOUN
dpc-3843	269	2	.	.	PUNCT
dpc-3843	270	1	2013;25:676–82	2013;25:676–82	X
dpc-3843	270	2	.	.	NOUN
dpc-3843	270	3	7	7	NUM
dpc-3843	270	4	.	.	NOUN
dpc-3843	270	5	attili	attili	ADJ
dpc-3843	270	6	v	v	NOUN
dpc-3843	270	7	,	,	PUNCT
dpc-3843	270	8	attili	attili	ADJ
dpc-3843	270	9	s.	s.	PROPN
dpc-3843	270	10	segmental	segmental	PROPN
dpc-3843	270	11	and	and	CCONJ
dpc-3843	270	12	generalized	generalized	ADJ
dpc-3843	270	13	vitiligo	vitiligo	NOUN
dpc-3843	270	14	:	:	PUNCT
dpc-3843	270	15	both	both	DET
dpc-3843	270	16	forms	form	NOUN
dpc-3843	270	17	demonstrate	demonstrate	VERB
dpc-3843	270	18	inflammatory	inflammatory	ADJ
dpc-3843	270	19	histopathological	histopathological	ADJ
dpc-3843	270	20	features	feature	NOUN
dpc-3843	270	21	and	and	CCONJ
dpc-3843	270	22	clinical	clinical	ADJ
dpc-3843	270	23	mosaicism	mosaicism	NOUN
dpc-3843	270	24	.	.	PUNCT
dpc-3843	271	1	indian	indian	PROPN
dpc-3843	271	2	j.	j.	PROPN
dpc-3843	271	3	dermatol	dermatol	PROPN
dpc-3843	271	4	.	.	PUNCT
dpc-3843	272	1	2013;58:433	2013;58:433	NUM
dpc-3843	272	2	.	.	NOUN
dpc-3843	272	3	8	8	NUM
dpc-3843	272	4	.	.	X
dpc-3843	272	5	hamano	hamano	PROPN
dpc-3843	272	6	y	y	PROPN
dpc-3843	272	7	,	,	PUNCT
dpc-3843	272	8	kalluri	kalluri	PROPN
dpc-3843	272	9	r.	r.	PROPN
dpc-3843	272	10	tumstatin	tumstatin	PROPN
dpc-3843	272	11	,	,	PUNCT
dpc-3843	272	12	the	the	DET
dpc-3843	272	13	nc1	nc1	PROPN
dpc-3843	272	14	domain	domain	NOUN
dpc-3843	272	15	of	of	ADP
dpc-3843	272	16	α3	α3	ADJ
dpc-3843	272	17	chain	chain	NOUN
dpc-3843	272	18	of	of	ADP
dpc-3843	272	19	type	type	NOUN
dpc-3843	272	20	iv	iv	NUM
dpc-3843	272	21	collagen	collagen	NOUN
dpc-3843	272	22	,	,	PUNCT
dpc-3843	272	23	is	be	AUX
dpc-3843	272	24	an	an	DET
dpc-3843	272	25	endogenous	endogenous	ADJ
dpc-3843	272	26	inhibitor	inhibitor	NOUN
dpc-3843	272	27	of	of	ADP
dpc-3843	272	28	pathological	pathological	ADJ
dpc-3843	272	29	angiogenesis	angiogenesis	NOUN
dpc-3843	272	30	and	and	CCONJ
dpc-3843	272	31	suppresses	suppress	VERB
dpc-3843	272	32	tumor	tumor	NOUN
dpc-3843	272	33	growth	growth	NOUN
dpc-3843	272	34	.	.	PUNCT
dpc-3843	273	1	biochem	biochem	PROPN
dpc-3843	273	2	.	.	PUNCT
dpc-3843	274	1	biophys	biophy	NOUN
dpc-3843	274	2	.	.	PUNCT
dpc-3843	275	1	res	re	NOUN
dpc-3843	275	2	.	.	PUNCT
dpc-3843	276	1	commun	commun	PROPN
dpc-3843	276	2	.	.	PUNCT
dpc-3843	277	1	2005;333:292–8	2005;333:292–8	X
dpc-3843	277	2	.	.	PUNCT
dpc-3843	278	1	9	9	NUM
dpc-3843	278	2	.	.	PUNCT
dpc-3843	278	3	maeshima	maeshima	PROPN
dpc-3843	278	4	y	y	PROPN
dpc-3843	278	5	,	,	PUNCT
dpc-3843	278	6	colorado	colorado	PROPN
dpc-3843	278	7	pc	pc	PROPN
dpc-3843	278	8	,	,	PUNCT
dpc-3843	278	9	torre	torre	PROPN
dpc-3843	278	10	a	a	PRON
dpc-3843	278	11	,	,	PUNCT
dpc-3843	278	12	holthaus	holthaus	PROPN
dpc-3843	278	13	ka	ka	PROPN
dpc-3843	278	14	,	,	PUNCT
dpc-3843	278	15	grunkemeyer	grunkemeyer	PROPN
dpc-3843	278	16	 	 	SPACE
dpc-3843	278	17	ja	ja	PROPN
dpc-3843	278	18	,	,	PUNCT
dpc-3843	278	19	ericksen	ericksen	NOUN
dpc-3843	278	20	mb	mb	ADP
dpc-3843	278	21	et	et	PROPN
dpc-3843	278	22	al	al	PROPN
dpc-3843	278	23	.	.	PROPN
dpc-3843	278	24	distinct	distinct	ADJ
dpc-3843	278	25	antitumor	antitumor	PROPN
dpc-3843	278	26	properties	property	NOUN
dpc-3843	278	27	of	of	ADP
dpc-3843	278	28	a	a	DET
dpc-3843	278	29	type	type	NOUN
dpc-3843	278	30	iv	iv	NUM
dpc-3843	278	31	collagen	collagen	NOUN
dpc-3843	278	32	domain	domain	NOUN
dpc-3843	278	33	derived	derive	VERB
dpc-3843	278	34	from	from	ADP
dpc-3843	278	35	basement	basement	NOUN
dpc-3843	278	36	membrane	membrane	NOUN
dpc-3843	278	37	.	.	PUNCT
dpc-3843	279	1	j.	j.	PROPN
dpc-3843	279	2	biol	biol	PROPN
dpc-3843	279	3	.	.	PUNCT
dpc-3843	280	1	chem	chem	NOUN
dpc-3843	280	2	.	.	PUNCT
dpc-3843	281	1	2000;275:21340–8	2000;275:21340–8	ADJ
dpc-3843	281	2	.	.	PUNCT
dpc-3843	282	1	10	10	NUM
dpc-3843	282	2	.	.	PUNCT
dpc-3843	283	1	kerjaschki	kerjaschki	PROPN
dpc-3843	283	2	d	d	PROPN
dpc-3843	283	3	,	,	PUNCT
dpc-3843	283	4	sharkey	sharkey	PROPN
dpc-3843	283	5	dj	dj	PROPN
dpc-3843	283	6	,	,	PUNCT
dpc-3843	283	7	farquhar	farquhar	PROPN
dpc-3843	283	8	mg	mg	PROPN
dpc-3843	283	9	.	.	PUNCT
dpc-3843	283	10	identification	identification	NOUN
dpc-3843	283	11	and	and	CCONJ
dpc-3843	283	12	characterization	characterization	NOUN
dpc-3843	283	13	of	of	ADP
dpc-3843	283	14	podocalyxin	podocalyxin	NOUN
dpc-3843	283	15	--	--	PUNCT
dpc-3843	283	16	the	the	DET
dpc-3843	283	17	major	major	ADJ
dpc-3843	283	18	sialoprotein	sialoprotein	NOUN
dpc-3843	283	19	of	of	ADP
dpc-3843	283	20	the	the	DET
dpc-3843	283	21	renal	renal	ADJ
dpc-3843	283	22	glomerular	glomerular	ADJ
dpc-3843	283	23	epithelial	epithelial	ADJ
dpc-3843	283	24	cell	cell	NOUN
dpc-3843	283	25	.	.	PUNCT
dpc-3843	284	1	j.	j.	PROPN
dpc-3843	284	2	cell	cell	PROPN
dpc-3843	284	3	biol	biol	PROPN
dpc-3843	284	4	.	.	PUNCT
dpc-3843	285	1	1984;98:1591–6	1984;98:1591–6	X
dpc-3843	285	2	.	.	PROPN
dpc-3843	286	1	11	11	NUM
dpc-3843	286	2	.	.	PUNCT
dpc-3843	287	1	doyonnas	doyonnas	PROPN
dpc-3843	287	2	r	r	PROPN
dpc-3843	287	3	,	,	PUNCT
dpc-3843	287	4	kershaw	kershaw	PROPN
dpc-3843	287	5	db	db	PROPN
dpc-3843	287	6	,	,	PUNCT
dpc-3843	287	7	duhme	duhme	NOUN
dpc-3843	287	8	c	c	NOUN
dpc-3843	287	9	,	,	PUNCT
dpc-3843	287	10	merkens	merkens	PROPN
dpc-3843	287	11	h	h	NOUN
dpc-3843	287	12	,	,	PUNCT
dpc-3843	287	13	chelliah	chelliah	PROPN
dpc-3843	287	14	s	s	PROPN
dpc-3843	287	15	,	,	PUNCT
dpc-3843	287	16	graf	graf	PROPN
dpc-3843	287	17	t	t	PROPN
dpc-3843	287	18	et	et	PROPN
dpc-3843	287	19	al	al	PROPN
dpc-3843	287	20	.	.	PROPN
dpc-3843	287	21	anuria	anuria	PROPN
dpc-3843	287	22	,	,	PUNCT
dpc-3843	287	23	omphalocele	omphalocele	PROPN
dpc-3843	287	24	,	,	PUNCT
dpc-3843	287	25	and	and	CCONJ
dpc-3843	287	26	perinatal	perinatal	ADJ
dpc-3843	287	27	lethality	lethality	NOUN
dpc-3843	287	28	in	in	ADP
dpc-3843	287	29	mice	mouse	NOUN
dpc-3843	287	30	lacking	lack	VERB
dpc-3843	287	31	the	the	DET
dpc-3843	287	32	cd34	cd34	PROPN
dpc-3843	287	33	-	-	PUNCT
dpc-3843	287	34	related	relate	VERB
dpc-3843	287	35	protein	protein	NOUN
dpc-3843	287	36	podocalyxin	podocalyxin	NOUN
dpc-3843	287	37	.	.	PUNCT
dpc-3843	288	1	j.	j.	PROPN
dpc-3843	288	2	exp	exp	PROPN
dpc-3843	288	3	.	.	PROPN
dpc-3843	288	4	med	med	PROPN
dpc-3843	288	5	.	.	PUNCT
dpc-3843	289	1	2001;194:13–28	2001;194:13–28	NUM
dpc-3843	289	2	.	.	PROPN
dpc-3843	289	3	12	12	NUM
dpc-3843	289	4	.	.	PUNCT
dpc-3843	289	5	le	le	PROPN
dpc-3843	289	6	tran	tran	PROPN
dpc-3843	289	7	n	n	PROPN
dpc-3843	289	8	,	,	PUNCT
dpc-3843	289	9	wang	wang	PROPN
dpc-3843	289	10	y	y	PROPN
dpc-3843	289	11	,	,	PUNCT
dpc-3843	289	12	nie	nie	PROPN
dpc-3843	289	13	g.	g.	PROPN
dpc-3843	289	14	podocalyxin	podocalyxin	VERB
dpc-3843	289	15	in	in	ADP
dpc-3843	289	16	normal	normal	ADJ
dpc-3843	289	17	tissue	tissue	NOUN
dpc-3843	289	18	and	and	CCONJ
dpc-3843	289	19	epithelial	epithelial	ADJ
dpc-3843	289	20	cancer	cancer	NOUN
dpc-3843	289	21	.	.	PUNCT
dpc-3843	290	1	cancers	cancer	NOUN
dpc-3843	290	2	(	(	PUNCT
dpc-3843	290	3	basel	basel	PROPN
dpc-3843	290	4	)	)	PUNCT
dpc-3843	290	5	.	.	PUNCT
dpc-3843	291	1	2021;13:2863	2021;13:2863	NUM
dpc-3843	291	2	.	.	NOUN
dpc-3843	291	3	13	13	NUM
dpc-3843	291	4	.	.	PUNCT
dpc-3843	291	5	boot	boot	PROPN
dpc-3843	291	6	rg	rg	PROPN
dpc-3843	291	7	,	,	PUNCT
dpc-3843	291	8	blommaart	blommaart	PROPN
dpc-3843	291	9	efc	efc	PROPN
dpc-3843	291	10	,	,	PUNCT
dpc-3843	291	11	swart	swart	PROPN
dpc-3843	291	12	e	e	PROPN
dpc-3843	291	13	,	,	PUNCT
dpc-3843	291	14	ghauharali	ghauharali	ADJ
dpc-3843	291	15	-	-	PUNCT
dpc-3843	291	16	van	van	PROPN
dpc-3843	291	17	der	der	NOUN
dpc-3843	291	18	vlugt	vlugt	PROPN
dpc-3843	291	19	 	 	SPACE
dpc-3843	291	20	k	k	PROPN
dpc-3843	291	21	,	,	PUNCT
dpc-3843	291	22	bijl	bijl	PROPN
dpc-3843	291	23	n	n	CCONJ
dpc-3843	291	24	,	,	PUNCT
dpc-3843	291	25	moe	moe	PROPN
dpc-3843	291	26	c	c	PROPN
dpc-3843	291	27	et	et	PROPN
dpc-3843	291	28	al	al	PROPN
dpc-3843	291	29	.	.	PUNCT
dpc-3843	291	30	identification	identification	NOUN
dpc-3843	291	31	of	of	ADP
dpc-3843	291	32	a	a	DET
dpc-3843	291	33	novel	novel	ADJ
dpc-3843	291	34	acidic	acidic	ADJ
dpc-3843	291	35	mammalian	mammalian	NOUN
dpc-3843	291	36	chitinase	chitinase	NOUN
dpc-3843	291	37	distinct	distinct	ADJ
dpc-3843	291	38	from	from	ADP
dpc-3843	291	39	chitotriosidase	chitotriosidase	NOUN
dpc-3843	291	40	.	.	PUNCT
dpc-3843	292	1	j.	j.	PROPN
dpc-3843	292	2	biol	biol	PROPN
dpc-3843	292	3	.	.	PUNCT
dpc-3843	293	1	chem	chem	PROPN
dpc-3843	293	2	.	.	PUNCT
dpc-3843	294	1	2001;276:6770–8	2001;276:6770–8	ADV
dpc-3843	294	2	.	.	PUNCT
dpc-3843	295	1	14	14	NUM
dpc-3843	295	2	.	.	PUNCT
dpc-3843	296	1	sutherland	sutherland	PROPN
dpc-3843	296	2	te	te	PROPN
dpc-3843	296	3	.	.	PUNCT
dpc-3843	297	1	chitinase	chitinase	NOUN
dpc-3843	297	2	-	-	PUNCT
dpc-3843	297	3	like	like	ADJ
dpc-3843	297	4	proteins	protein	NOUN
dpc-3843	297	5	as	as	ADP
dpc-3843	297	6	regulators	regulator	NOUN
dpc-3843	297	7	of	of	ADP
dpc-3843	297	8	innate	innate	ADJ
dpc-3843	297	9	immunity	immunity	NOUN
dpc-3843	297	10	and	and	CCONJ
dpc-3843	297	11	tissue	tissue	NOUN
dpc-3843	297	12	repair	repair	NOUN
dpc-3843	297	13	:	:	PUNCT
dpc-3843	297	14	helpful	helpful	ADJ
dpc-3843	297	15	lessons	lesson	NOUN
dpc-3843	297	16	for	for	ADP
dpc-3843	297	17	asthma	asthma	NOUN
dpc-3843	297	18	?	?	PUNCT
dpc-3843	298	1	biochem	biochem	PROPN
dpc-3843	298	2	.	.	PUNCT
dpc-3843	299	1	soc	soc	PROPN
dpc-3843	299	2	.	.	PUNCT
dpc-3843	300	1	trans	trans	PROPN
dpc-3843	300	2	.	.	PUNCT
dpc-3843	301	1	2018;46:141–51	2018;46:141–51	PROPN
dpc-3843	301	2	.	.	PROPN
dpc-3843	301	3	15	15	NUM
dpc-3843	301	4	.	.	PUNCT
dpc-3843	301	5	ezzedine	ezzedine	PROPN
dpc-3843	302	1	k	k	PROPN
dpc-3843	302	2	,	,	PUNCT
dpc-3843	302	3	lim	lim	PROPN
dpc-3843	302	4	hw	hw	PROPN
dpc-3843	302	5	,	,	PUNCT
dpc-3843	302	6	suzuki	suzuki	PROPN
dpc-3843	302	7	t	t	PROPN
dpc-3843	302	8	,	,	PUNCT
dpc-3843	302	9	katayama	katayama	PROPN
dpc-3843	302	10	i	i	PROPN
dpc-3843	302	11	,	,	PUNCT
dpc-3843	302	12	hamzavi	hamzavi	PROPN
dpc-3843	302	13	i	i	PRON
dpc-3843	302	14	,	,	PUNCT
dpc-3843	302	15	lan	lan	PROPN
dpc-3843	302	16	cce	cce	PROPN
dpc-3843	302	17	et	et	PROPN
dpc-3843	302	18	al	al	PROPN
dpc-3843	302	19	.	.	PROPN
dpc-3843	302	20	revised	revise	VERB
dpc-3843	302	21	classification	classification	NOUN
dpc-3843	302	22	/	/	SYM
dpc-3843	302	23	nomenclature	nomenclature	NOUN
dpc-3843	302	24	of	of	ADP
dpc-3843	302	25	vitiligo	vitiligo	ADJ
dpc-3843	302	26	and	and	CCONJ
dpc-3843	302	27	related	related	ADJ
dpc-3843	302	28	issues	issue	NOUN
dpc-3843	302	29	:	:	PUNCT
dpc-3843	302	30	the	the	DET
dpc-3843	302	31	vitiligo	vitiligo	ADJ
dpc-3843	302	32	global	global	ADJ
dpc-3843	302	33	issues	issue	NOUN
dpc-3843	302	34	consensus	consensus	NOUN
dpc-3843	302	35	conference	conference	NOUN
dpc-3843	302	36	.	.	PUNCT
dpc-3843	303	1	pigment	pigment	ADJ
dpc-3843	303	2	cell	cell	NOUN
dpc-3843	303	3	melanoma	melanoma	NOUN
dpc-3843	303	4	res	re	NOUN
dpc-3843	303	5	.	.	PUNCT
dpc-3843	304	1	2012;25	2012;25	NUM
dpc-3843	304	2	:	:	PUNCT
dpc-3843	305	1	e1–13	e1–13	NOUN
dpc-3843	305	2	.	.	X
dpc-3843	306	1	16	16	NUM
dpc-3843	306	2	.	.	PUNCT
dpc-3843	307	1	katz	katz	PROPN
dpc-3843	307	2	el	el	PROPN
dpc-3843	307	3	,	,	PUNCT
dpc-3843	307	4	harris	harris	PROPN
dpc-3843	307	5	je	je	PROPN
dpc-3843	307	6	.	.	PUNCT
dpc-3843	307	7	translational	translational	ADJ
dpc-3843	307	8	research	research	NOUN
dpc-3843	307	9	in	in	ADP
dpc-3843	307	10	vitiligo	vitiligo	PROPN
dpc-3843	307	11	.	.	PUNCT
dpc-3843	308	1	front	front	ADJ
dpc-3843	308	2	.	.	PUNCT
dpc-3843	309	1	immunol	immunol	NOUN
dpc-3843	309	2	.	.	PUNCT
dpc-3843	309	3	2021	2021	NUM
dpc-3843	309	4	.	.	PUNCT
dpc-3843	310	1	doi:10.3389	doi:10.3389	PROPN
dpc-3843	310	2	/	/	SYM
dpc-3843	310	3	fimmu.2021.624517	fimmu.2021.624517	PROPN
dpc-3843	310	4	.	.	PUNCT